Sabra Health Care REIT (SBRA) 10-K 22 Feb 21 2020 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2020	Feb. 17, 2021	Jun. 30, 2020
Document and Entity Information [Abstract]
Document Type	10-K
Document Annual Report	true
Current Fiscal Year End Date	--12-31
Document Period End Date	Dec. 31, 2020
Document Transition Report	false
Entity File Number	001-34950
Entity Registrant Name	SABRA HEALTH CARE REIT, INC.
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	27-2560479
Entity Address, Address Line One	18500 Von Karman Avenue
Entity Address, Address Line Two	Suite 550
Entity Address, City or Town	Irvine
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92612
City Area Code	888
Local Phone Number	393-8248
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	SBRA
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 2.9
Entity Common Stock, Shares Outstanding		210,719,844
Entity Central Index Key	0001492298
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Amendment Flag	false
Documents Incorporated by Reference	Portions of the Proxy Statement for the registrant’s 2021 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission not later than 120 days after December 31, 2020, are incorporated by reference in Part III herein.

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Assets
Real estate investments, net of accumulated depreciation of $681,657 and $539,213 as of December 31, 2020 and 2019, respectively	$ 5,285,038	$ 5,341,370
Loans receivable and other investments, net	102,839	107,374
Investment in unconsolidated joint venture	288,761	319,460
Cash and cash equivalents	59,076	39,097
Restricted cash	6,447	10,046
Lease intangible assets, net	82,796	101,509
Accounts receivable, prepaid expenses and other assets, net	160,646	150,443
Total assets	5,985,603	6,069,299
Liabilities
Secured debt, net	79,065	113,070
Term loans, net	1,044,916	1,040,258
Senior unsecured notes, net	1,248,393	1,248,773
Accounts payable and accrued liabilities	146,276	108,792
Lease intangible liabilities, net	57,725	69,946
Total liabilities	2,576,375	2,580,839
Commitments and contingencies (Note 15)
Equity
Preferred stock, $0.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of December 31, 2020 and 2019	0	0
Common stock, $0.01 par value; 500,000,000 shares authorized, 210,560,815 and 205,208,018 shares issued and outstanding as of December 31, 2020 and 2019, respectively	2,106	2,052
Additional paid-in capital	4,163,228	4,072,079
Cumulative distributions in excess of net income	(716,195)	(573,283)
Accumulated other comprehensive loss	(39,911)	(12,388)
Total equity	3,409,228	3,488,460
Total liabilities and equity	$ 5,985,603	$ 6,069,299

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Assets
Accumulated depreciation	$ 681,657	$ 539,213
Equity
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	210,560,815	205,208,018
Common stock, shares outstanding (in shares)	210,560,815	205,208,018

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Revenues:
Rental and related revenues	$ 430,584	$ 452,138	$ 536,605
Interest and other income	11,940	81,540	16,667
Resident fees and services	156,045	128,058	70,137
Total revenues	598,569	661,736	623,409
Expenses:
Depreciation and amortization	176,737	181,549	191,379
Interest	100,424	126,610	147,106
General and administrative	32,755	30,886	37,094
Provision for straight-line rent reserves, loan losses and other reserves	1,855	1,238	39,075
Impairment of real estate	4,003	121,819	1,413
Total expenses	447,327	570,574	465,613
Other income (expense):
Loss on extinguishment of debt	(531)	(16,340)	(2,917)
Other income	2,154	2,094	4,480
Net gain on sales of real estate	2,861	2,300	128,198
Total other income (expense)	4,484	(11,946)	129,761
Income before loss from unconsolidated joint venture and income tax expense	155,726	79,216	287,557
Loss from unconsolidated joint venture	(16,599)	(6,796)	(5,431)
Income tax expense	(710)	(3,402)	(3,011)
Net income	138,417	69,018	279,115
Net income attributable to noncontrolling interest	0	(22)	(33)
Net income attributable to Sabra Health Care REIT, Inc.	138,417	68,996	279,082
Preferred stock dividends	0	0	(9,768)
Net income attributable to common stockholders	$ 138,417	$ 68,996	$ 269,314
Net income attributable to common stockholders, per:
Basic common share (in dollars per share)	$ 0.67	$ 0.37	$ 1.51
Diluted common share (in dollars per share)	$ 0.67	$ 0.37	$ 1.51
Weighted-average number of common shares outstanding, basic (in shares)	206,223,503	187,172,210	178,305,738
Weighted-average number of common shares outstanding, diluted (in shares)	207,252,830	188,127,092	178,721,744
Revenue, Product and Service [Extensible List]	sbra:ResidentFeesAndServicesMember	sbra:ResidentFeesAndServicesMember	sbra:ResidentFeesAndServicesMember
Triple-Net Portfolio
Expenses:
Operating expenses	$ 20,590	$ 22,215	$ 0
Senior Housing - Managed
Expenses:
Operating expenses	$ 110,963	$ 86,257	$ 49,546

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Statement of Comprehensive Income [Abstract]
Net income		$ 138,417	$ 69,018	$ 279,115
Unrealized (loss) gain, net of tax:
Foreign currency translation (loss) gain		(315)	679	720
Unrealized (loss) gain on cash flow hedges	[1]	(27,208)	(25,368)	292
Total other comprehensive (loss) income		(27,523)	(24,689)	1,012
Comprehensive income		110,894	44,329	280,127
Comprehensive income attributable to noncontrolling interest		0	(22)	(33)
Comprehensive income attributable to Sabra Health Care REIT, Inc.		$ 110,894	$ 44,307	$ 280,094
[1]	Amounts are net of income tax benefit of $138,000, $49,000 and $48,000 for the years ended December 31, 2020, 2019 and 2018, respectively.

CONSOLIDATED STATEMENTS OF CO_2

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Statement of Comprehensive Income [Abstract]
Income tax benefit on unrealized gains (losses) on cash flow hedges	$ 138	$ 49	$ 48

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect	Total Stockholders’ Equity	Total Stockholders’ EquityCumulative Effect	Preferred Stock	Common Stock	Additional Paid-in Capital	Cumulative Distributions in Excess of Net Income	Cumulative Distributions in Excess of Net IncomeCumulative Effect	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss)Cumulative Effect	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2017					5,750,000	178,255,843
Beginning balance at Dec. 31, 2017	$ 3,437,249	$ 0	$ 3,432,807		$ 58	$ 1,783	$ 3,636,913	$ (217,236)	$ (795)	$ 11,289	$ 795	$ 4,442
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	279,115		279,082					279,082				33
Other comprehensive income (loss)	217		217							217
Distributions to noncontrolling interests	(142)											(142)
Amortization of stock-based compensation	9,574		9,574				9,574
Preferred stock redemption (in shares)					(5,750,000)
Preferred stock redemption	(143,750)		(143,750)		$ (58)		(138,191)	(5,501)
Common stock issuance, net (in shares)						50,685
Common stock issuance, net	(371)		(371)			$ 0	(371)
Preferred dividends	(4,267)		(4,267)					(4,267)
Common dividends	(322,878)		(322,878)					(322,878)
Ending balance (in shares) at Dec. 31, 2018					0	178,306,528
Ending balance at Dec. 31, 2018	$ 3,254,747	(32,502)	3,250,414	$ (32,502)	$ 0	$ 1,783	3,507,925	(271,595)	(32,502)	12,301		4,333
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201602Member
Net income	$ 69,018		68,996					68,996				22
Other comprehensive income (loss)	(24,689)		(24,689)							(24,689)
Buyout of noncontrolling interests	0		4,039				4,039					(4,039)
Distributions to noncontrolling interests	(316)											(316)
Amortization of stock-based compensation	12,567		12,567				12,567
Common stock issuance, net (in shares)						26,901,490
Common stock issuance, net	547,817		547,817			$ 269	547,548
Common dividends	(338,182)		(338,182)					(338,182)
Ending balance (in shares) at Dec. 31, 2019					0	205,208,018
Ending balance at Dec. 31, 2019	$ 3,488,460	$ (167)	3,488,460	$ (167)	$ 0	$ 2,052	4,072,079	(573,283)	$ (167)	(12,388)		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201613Member
Net income	$ 138,417		138,417					138,417				0
Other comprehensive income (loss)	(27,523)		(27,523)							(27,523)
Amortization of stock-based compensation	10,769		10,769				10,769
Common stock issuance, net (in shares)						5,352,797
Common stock issuance, net	80,434		80,434			$ 54	80,380
Common dividends	(281,162)		(281,162)					(281,162)
Ending balance (in shares) at Dec. 31, 2020					0	210,560,815
Ending balance at Dec. 31, 2020	$ 3,409,228		$ 3,409,228		$ 0	$ 2,106	$ 4,163,228	$ (716,195)		$ (39,911)		$ 0

CONSOLIDATED STATEMENTS OF EQ_2

CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Statement of Stockholders' Equity [Abstract]
Common dividends (in dollars per share)	$ 1.35	$ 1.80	$ 1.80

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net income	$ 138,417	$ 69,018	$ 279,115
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	176,737	181,549	191,379
Non-cash rental and related revenues	(4,458)	(19,449)	(36,443)
Non-cash interest income	(2,351)	(2,212)	(2,300)
Non-cash interest expense	8,418	10,080	10,137
Stock-based compensation expense	7,907	9,819	7,648
Non-cash lease termination income	0	(10,579)	0
Loss on extinguishment of debt	531	16,340	2,917
Provision for loan losses and other reserves	1,855	1,238	39,075
Net gain on sales of real estate	(2,861)	(2,300)	(128,198)
Impairment of real estate	4,003	121,819	1,413
Loss from unconsolidated joint venture	16,599	6,796	5,431
Distributions of earnings from unconsolidated joint venture	12,795	13,865	8,910
Changes in operating assets and liabilities:
Accounts receivable, prepaid expenses and other assets, net	(6,398)	(9,639)	(6,753)
Accounts payable and accrued liabilities	3,658	(13,870)	(11,745)
Net cash provided by operating activities	354,852	372,475	360,586
Cash flows from investing activities:
Acquisition of real estate	(92,945)	(51,136)	(261,511)
Origination and fundings of loans receivable	(1,651)	(13,065)	(50,731)
Origination and fundings of preferred equity investments	(20,069)	0	(5,313)
Additions to real estate	(47,354)	(25,451)	(27,697)
Repayments of loans receivable	4,093	18,367	51,789
Repayments of preferred equity investments	3,419	5,079	6,870
Net proceeds from sales of real estate	16,751	329,050	382,560
Investment in unconsolidated joint venture	0	0	(354,461)
Distributions in excess of earnings from unconsolidated joint venture	1,305	0	0
Net cash (used in) provided by investing activities	(136,451)	262,844	(258,494)
Cash flows from financing activities:
Net repayments of revolving credit facility	0	(624,000)	(17,000)
Proceeds from issuance of senior unsecured notes	0	638,779	0
Principal payments on senior unsecured notes	0	(700,000)	0
Principal payments on term loans	0	(145,000)	0
Principal payments on secured debt	(3,072)	(3,436)	(140,338)
Payments of deferred financing costs	(830)	(15,598)	(352)
Payments related to extinguishment of debt	0	(10,502)	(2,043)
Distributions to noncontrolling interest	0	(316)	(142)
Preferred stock redemption	0	0	(143,750)
Issuance of common stock, net	80,092	549,328	(499)
Dividends paid on common stock	(278,299)	(335,435)	(325,220)
Net cash used in financing activities	(202,109)	(646,180)	(629,344)
Net increase (decrease) in cash, cash equivalents and restricted cash	16,292	(10,861)	(527,252)
Effect of foreign currency translation on cash, cash equivalents and restricted cash	88	346	(539)
Cash, cash equivalents and restricted cash, beginning of period	49,143	59,658	587,449
Cash, cash equivalents and restricted cash, end of period	65,523	49,143	59,658
Supplemental disclosure of cash flow information:
Interest paid	92,589	123,854	137,668
Income taxes paid	2,439	3,911	1,800
Supplemental disclosure of non-cash investing activities:
Decrease in loans receivable and other investments due to acquisition of real estate	20,731	0	0
Secured debt assumed by buyers in connection with sales of real estate	$ 31,830	$ 0	$ 0

BUSINESS

BUSINESS	12 Months Ended
	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BUSINESS	BUSINESS Overview Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) was incorporated on May 10, 2010 as a wholly owned subsidiary of Sun Healthcare Group, Inc. (“Sun”) and commenced operations on November 15, 2010 following Sabra’s separation from Sun. Sabra elected to be treated as a real estate investment trust (“REIT”) with the filing of its United States (“U.S.”) federal income tax return for the taxable year beginning January 1, 2011. Sabra believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. Sabra’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. Sabra primarily generates revenues by leasing properties to tenants and operators throughout the U.S. and Canada. Sabra owns substantially all of its assets and properties and conducts its operations through Sabra Health Care Limited Partnership, a Delaware limited partnership (the “Operating Partnership”), of which Sabra is the sole general partner and a wholly owned subsidiary of Sabra is currently the only limited partner, or by subsidiaries of the Operating Partnership. The Company’s investment portfolio is primarily comprised of skilled nursing/transitional care facilities, senior housing communities (“Senior Housing - Leased”) and specialty hospitals and other facilities, in each case leased to third-party operators; senior housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing - Managed”); investments in loans receivable; preferred equity investments; and a 49% equity interest in the Enlivant Joint Venture (as defined below). COVID-19 In March 2020, the World Health Organization declared COVID-19 a pandemic, and the United States declared a national emergency with respect to COVID-19. In the intervening months, COVID-19 has spread globally and led governments and other authorities around the world, including federal, state and local authorities in the United States, to impose measures intended to control its spread, including restrictions on freedom of movement and business operations such as travel bans, border closings, business closures, quarantines and shelter-in-place orders. Although some of these governmental restrictions have since been lifted or scaled back, a recent surge of COVID-19 infections has resulted in the re-imposition of certain restrictions and may lead to other restrictions being re-implemented in response to efforts to reduce the spread of COVID-19. In December 2020, distribution of the COVID-19 vaccine began to all 50 states, and while states have the authority over who receives the vaccine, the Centers for Disease Control and Prevention recommended that the initial distribution prioritize healthcare workers and residents of long-term care facilities. However, governmental restrictions may remain in place for a significant amount of time. The ongoing COVID-19 pandemic and measures intended to prevent its spread have negatively impacted and are expected to continue to negatively impact the Company and its operations in a number of ways, including but not limited to: • Decreased occupancy and increased operating costs for the Company’s tenants and borrowers, which have negatively impacted their operating results and may adversely impact their ability to make full and timely rental payments and debt service payments, respectively, to the Company. In some cases, the Company may have to restructure tenants’ long-term rent obligations and may not be able to do so on terms that are as favorable to the Company as those currently in place. Reduced or modified rental and debt service amounts could result in the determination that the full amounts of the Company’s investments are not recoverable, which could result in an impairment charge. To date, the impact of COVID-19 on the Company’s skilled nursing/transitional care facility operators has been significantly mitigated by the assistance they have received or expect to receive from state and federal assistance programs, including through the CARES Act (as defined and further described under “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Skilled Nursing Facility Reimbursement Rates” in Part II, Item 7), although these benefits on an individual operator basis vary and may not provide enough relief to meet their rental obligations to the Company. As of September 1, 2020, eligible assisted living facility operators may apply for funding through the CARES Act, and the assistance received or expected to be received will partially mitigate the negative impact of COVID-19 on the Company’s eligible assisted living facility operators. As of December 31, 2020, the Company’s tenants and borrowers have continued to pay expected cash rents and debt service obligations consistent with past practice. However, the longer the duration of the COVID-19 pandemic, the more likely that the Company’s tenants and borrowers will begin to default on these obligations. Such defaults could materially and adversely affect the Company’s results of operations and liquidity, in addition to resulting in potential impairment charges. • Decreased occupancy and increased operating costs within the Company’s Senior Housing - Managed portfolio and in the Company’s 49% equity interest in a joint venture with affiliates of Enlivant and TPG Real Estate, the real estate platform of TPG, that owns senior housing communities managed by Enlivant (the “Enlivant Joint Venture”), which have negatively impacted and are expected to continue to negatively impact the operating results of these investments. As noted above, as of September 1, 2020, eligible assisted living facility operators may apply for funding through the CARES Act, and the assistance received or expected to be received will partially mitigate the negative impact of COVID-19 on the Company’s Senior Housing - Managed portfolio and the Enlivant Joint Venture. In addition, on October 1, 2020, the Department of Health and Human Services announced $20 billion of new funding for assisted living facility operators that have already received funds and to those who were previously ineligible. During the year ended December 31, 2020, the Company recognized government grants under the CARES Act and other programs of $5.3 million. Prolonged deterioration in the operating results for the Company’s investments in its Senior Housing - Managed portfolio and the Enlivant Joint Venture could result in the determination that the full amounts of the Company’s investments are not recoverable, which could result in an impairment charge. The Company’s financial results as of and for the year ended December 31, 2020 reflect the results of the Company’s evaluation of the impact of COVID-19 on its business including, but not limited to, its evaluation of potential impairments of long-lived or other assets, measurement of credit losses on financial instruments, evaluation of any lease modifications, evaluation of lease accounting impact, estimates of fair value and the Company’s ability to continue as a going concern.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation and Basis of Presentation The accompanying consolidated financial statements include the accounts of Sabra and its wholly owned subsidiaries as of December 31, 2020 and 2019 and for the years ended December 31, 2020, 2019 and 2018. All significant intercompany transactions and balances have been eliminated in consolidation. The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). GAAP requires the Company to identify entities for which control is achieved through voting rights or other means and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity’s activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity’s activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity’s activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. If the Company were determined to be the primary beneficiary of the VIE, the Company would consolidate investments in the VIE. The Company may change its original assessment of a VIE due to events such as modifications of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk and the disposal of all or a portion of an interest held by the primary beneficiary. The Company identifies the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company performs this analysis on an ongoing basis. As of December 31, 2020, the Company determined that it was not the primary beneficiary of any VIEs. As it relates to investments in loans, in addition to the Company’s assessment of VIEs and whether the Company is the primary beneficiary of those VIEs, the Company evaluates the loan terms and other pertinent facts to determine whether the loan investment should be accounted for as a loan or as a real estate joint venture. If an investment has the characteristics of a real estate joint venture, including if the Company participates in the majority of the borrower’s expected residual profit, the Company would account for the investment as an investment in a real estate joint venture and not as a loan investment. Expected residual profit is defined as the amount of profit, whether called interest or another name, such as an equity kicker, above a reasonable amount of interest and fees expected to be earned by a lender. At December 31, 2020 and 2019, none of the Company’s investments in loans were accounted for as real estate joint ventures. As it relates to investments in joint ventures, the Company assesses any limited partners’ rights and their impact on the presumption of control of the limited partnership by any single partner. The Company also applies this guidance to managing member interests in limited liability companies. The Company reassesses its determination of which entity controls the joint venture if: there is a change to the terms or in the exercisability of the rights of any partners or members, the sole general partner or managing member increases or decreases its ownership interests, or there is an increase or decrease in the number of outstanding ownership interests. As of December 31, 2020, the Company’s determination of which entity controls its investments in joint ventures has not changed as a result of any reassessment. Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates. Reclassifications Certain amounts in the Company’s consolidated statements of income for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations. Out of Period Adjustments During the three months ended September 30, 2020, the Company identified certain historical errors in the recording of depreciation and amortization expense related to the basis difference in the Enlivant Joint Venture and not correctly expensing the allocable portion of the basis difference upon the sale of assets in the Enlivant Joint Venture. These errors impacted the Company’s investment in unconsolidated joint venture and loss from unconsolidated joint venture as well as its consolidated statements of income, consolidated statements of comprehensive income and consolidated statements of equity since 2018, which impacted the annual periods previously issued. These errors resulted in understating (overstating) previously recorded loss from unconsolidated joint venture and overstating (understating) previously recorded net income by $0.1 million and ($1.7) million for the years ended December 31, 2019 and 2018, respectively. These out of period adjustments were recorded during the year ended December 31, 2020, resulting in a decrease to loss from unconsolidated joint venture and an increase to net income of $1.6 million. Management evaluated the impact of the errors to the current period and prior period financial statements and determined that the impact was not material to any of the impacted periods. Real Estate Investments and Rental Revenue Recognition Real Estate Acquisition Valuation All assets acquired and liabilities assumed in an acquisition of real estate accounted for as a business combination are measured at their acquisition date fair values. For acquisitions of real estate accounted for as an asset acquisition, the fair value of consideration transferred by the Company (including transaction costs) is allocated to all assets acquired and liabilities assumed on a relative fair value basis. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of above market lease, tenant origination and absorption costs and tenant relationship intangible assets is included in lease intangible assets, net on the accompanying consolidated balance sheets. The acquisition value of below market lease intangible liabilities is included in lease intangible liabilities, net on the accompanying consolidated balance sheets. Acquisition costs associated with real estate acquisitions deemed asset acquisitions are capitalized, and costs associated with real estate acquisitions deemed business combinations are expensed as incurred. Restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the Company’s evaluation of the specific characteristics of each tenant’s lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income. Depreciation and Amortization Real estate costs related to the acquisition and improvement of properties are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term of any property subject to a ground lease. Tenant improvements are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of tenant origination and absorption costs and tenant relationship lease intangibles are included in depreciation and amortization on the accompanying consolidated statements of income. Amortization of above and below market lease intangibles is included in rental income on the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, five five 40 years; and furniture and equipment, three Impairment of Real Estate Investments The Company regularly monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate investments may not be recoverable or realized. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through the future cash flows and the eventual disposition of the investment. In some instances, there may be various potential outcomes for an investment and its potential future cash flows. In these instances, the future cash flows used to assess recoverability are based on several assumptions and are probability-weighted based on the Company’s best estimates as of the date of evaluation. These assumptions include, among others, cash flow projections, holding period, market capitalization rates, and letters of intent, purchase and sale agreements and recent sales data for comparable properties. When necessary, a discount rate assumption may be used to determine fair value. The assumptions are generally based on management’s experience in its local real estate markets, and the effects of current market conditions, which are subject to economic and market uncertainties. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments. Revenue Recognition The Company recognizes rental revenue from tenants, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, on a straight-line basis over the term of the related leases when it is probable that substantially all rents over the life of a lease are collectible. Certain of the Company’s leases provide for contingent rents equal to a percentage of the facility’s revenue in excess of specified base amounts or other thresholds. Such revenue is recognized when actual results reported by the tenant, or estimates of tenant results, exceed the applicable base amount or other threshold. The Company assesses the collectability of rents on a lease-by-lease basis, and in doing so, considers such things as historical bad debts, tenant creditworthiness, current economic trends, facility operating performance, lease structure, credit enhancements (including guarantees), current developments relevant to a tenant’s business specifically and to its business category generally, and changes in tenants’ payment patterns. The Company’s assessment includes an estimation of a tenant’s ability to fulfill all of its rental obligations over the remaining lease term. In addition, with respect to tenants in bankruptcy, management makes estimates of the expected recovery of pre-petition and post-petition claims in assessing the estimated collectability of the related receivable. If at any time the Company cannot determine that it is probable that substantially all rents over the life of a lease are collectible, rental revenue will be recognized only to the extent of payments received, and all receivables associated with the lease will be written off irrespective of amounts expected to be collectible. Any recoveries of these amounts will be recorded in future periods upon receipt of payment. Write-offs of receivables and any recoveries of previously written-off receivables are recorded as adjustments to rental revenue. Revenue from resident fees and services is recorded monthly as services are provided and includes resident room and care charges, ancillary services charges and other resident charges. Government Grants Government assistance provided to the Company in the form of an income grant, which is not related to long-lived assets and is not required to be repaid, is recognized as grant income when there is reasonable assurance that the grant will be received and the Company will comply with any conditions associated with the grant. Additionally, grants are recognized over the periods in which the Company recognizes the qualifying expenses and/or lost income for which the grants are intended to compensate. As of December 31, 2020, the amount of qualifying expenditures exceeded amounts recognized under the CARES Act and other programs, and the Company had complied with all grant conditions. Accordingly, during the year ended December 31, 2020, the Company recognized $1.8 million of grants in resident fees and services and $3.5 million of grants in loss from unconsolidated joint venture in the accompanying consolidated statements of income. Assets Held for Sale, Dispositions and Discontinued Operations The Company generally considers real estate to be “held for sale” when the following criteria are met: (i) management commits to a plan to sell the property, (ii) the property is available for sale immediately, (iii) the property is actively being marketed for sale at a price that is reasonable in relation to its current fair value, (iv) the sale of the property within one year is considered probable and (v) significant changes to the plan to sell are not expected. Real estate that is held for sale and its related assets are classified as assets held for sale and are included in accounts receivable, prepaid expenses and other assets, net on the accompanying consolidated balance sheets. Secured indebtedness and other liabilities related to real estate held for sale are classified as liabilities related to assets held for sale and are included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets. Real estate classified as held for sale is no longer depreciated and is reported at the lower of its carrying value or its estimated fair value less estimated costs to sell. As of December 31, 2020 and 2019, the Company did not have any assets held for sale. For sales of real estate where the Company has collected the consideration to which it is entitled in exchange for transferring the real estate, the related assets and liabilities are removed from the balance sheet and the resultant gain or loss is recorded in the period in which the transaction closes. Any post-sale involvement is accounted for as separate performance obligations, and when the separate performance obligations are satisfied, the portion of the sales price allocated to each such obligation is recognized. Additionally, the Company records the operating results related to real estate that has been disposed of or classified as held for sale as discontinued operations for all periods presented if it represents a strategic shift that has or will have a major effect on the Company’s operations and financial results. Investment in Unconsolidated Joint Venture The Company reports investments in unconsolidated entities over whose operating and financial policies it has the ability to exercise significant influence under the equity method of accounting. Under this method of accounting, the Company’s share of the investee’s earnings or losses is included in the Company’s consolidated statements of income. The initial carrying value of the investment is based on the amount paid to purchase the joint venture interest. Differences between the Company’s cost basis and the basis reflected at the joint venture level are generally amortized over the lives of the related assets and liabilities, and such amortization is included in the Company’s share of earnings of the joint venture. In addition, distributions received from unconsolidated entities are classified based on the nature of the activity or activities that generated the distribution. The Company regularly monitors events and changes in circumstances that could indicate that the carrying amounts of its equity method investments may not be recoverable or realized. When indicators of potential impairment are identified, the Company evaluates its equity method investments for impairment based on a comparison of the fair value of the investment to its carrying value. The fair value is estimated based on discounted cash flows that include all estimated cash inflows and outflows over a specified holding period and any estimated debt premiums or discounts. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its equity method investment, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its equity method investment. Loans Receivable and Interest Income Loans Receivable The Company’s loans receivable are reflected at amortized cost on the accompanying consolidated balance sheets. The amortized cost of a loan receivable is the outstanding unpaid principal balance, net of unamortized discounts, costs and fees directly associated with the origination of the loan. Loans acquired in connection with a business combination are recorded at their acquisition date fair value. The Company determines the fair value of loans receivable based on estimates of expected discounted cash flows, collateral, credit risk and other factors. The Company does not establish a valuation allowance at the acquisition date, as the amount of estimated future cash flows reflects its judgment regarding their uncertainty. The Company recognizes the difference between the acquisition date fair value and the total expected cash flows as interest income using the effective interest method over the life of the applicable loan. The Company immediately recognizes in income any unamortized balances if the loan is repaid before its contractual maturity. On a quarterly basis, the Company evaluates the collectability of its loan portfolio, including the portion of unfunded loan commitments expected to be funded, and establishes an allowance for credit losses. The allowance for credit losses is calculated using the related amortization schedules, payment histories and loan-to-value ratios. The following rates are applied to determine the aggregate expected losses, which is recorded as the allowance for credit losses: (i) a default rate, (ii) a liquidation cost rate and (iii) a distressed property reduction rate. If no loan-to-value ratio is available, a loss severity rate is applied in place of the liquidation cost rate and the distressed property reduction rate. The default rate is based on average charge-off and delinquency rates from the Federal Reserve, and the other rates are based on industry research and historical performance of a similar portfolio of financial assets. The allowance for credit losses is a valuation allowance that reflects management’s estimate of losses inherent in the loan portfolio as of the balance sheet date. The reserve is adjusted through provision for loan losses and other reserves on the Company’s consolidated statements of income and is decreased by charge-offs to specific loans when losses are confirmed. Interest Income Interest income on the Company’s loans receivable is recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination costs are amortized over the term of the loan as an adjustment to interest income. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on nonaccrual status, and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines that the collection of interest according to the contractual terms of the loan or through the receipts of assets in satisfaction of contractual amounts due is probable, the Company will resume the accrual of interest. In instances where borrowers are in default under the terms of their loans, the Company may continue recognizing interest income provided that all amounts owed under the contractual terms of the loan, including accrued and unpaid interest, do not exceed the estimated fair value of the collateral, less costs to sell. On a quarterly basis, the Company evaluates the collectability of its interest income receivable and establishes a reserve for amounts not expected to be collected. The Company’s evaluation includes reviewing credit quality indicators such as payment status, changes affecting the operations of the facilities securing the loans, and national and regional economic factors. The reserve is a valuation allowance that reflects management’s estimate of losses inherent in the interest income receivable balance as of the balance sheet date. The reserve is adjusted through provision for loan losses and other reserves on the Company’s consolidated statements of income and is decreased by charge-offs to specific receivables when losses are confirmed. Preferred Equity Investments and Preferred Return Preferred equity investments are accounted for at unreturned capital contributions, plus accrued and unpaid preferred returns. The Company recognizes preferred return income on a monthly basis based on the outstanding investment including any previously accrued and unpaid return. As a preferred member of the preferred equity joint ventures in which the Company participates, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to currently pay the accrued preferred return. The Company regularly monitors events and changes in circumstances that could indicate that the carrying amounts of its preferred equity investments may not be recoverable or realized. On a quarterly basis, the Company evaluates its preferred equity investments for impairment based on a comparison of the fair value of the investment to its carrying value. The fair value is estimated based on discounted cash flows that include all estimated cash inflows and outflows over a specified holding period. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its preferred equity investment, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its preferred equity investment. Cash and Cash Equivalents The Company considers all short-term (with an original maturity of three months or less), highly-liquid investments utilized as part of the Company’s cash-management activities to be cash equivalents. Cash equivalents may include cash and short-term investments. Short-term investments are stated at cost, which approximates fair value. The Company’s cash and cash equivalents balance exceeded federally insurable limits as of December 31, 2020. To date, the Company has experienced no loss or lack of access to cash in its operating accounts. The Company has a corporate banking relationship with Bank of America, N.A. in which it deposits the majority of its cash. Restricted Cash Restricted cash primarily consists of amounts held by an exchange accommodation titleholder or by secured debt lenders to provide for future real estate tax expenditures, tenant improvements and capital expenditures. Pursuant to the terms of the Company’s leases with certain tenants, the Company has assigned its interests in certain of these restricted cash accounts with secured debt lenders to the tenants, and this amount is included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets. As of December 31, 2020 and 2019, restricted cash totaled $6.4 million and $10.0 million, respectively, and restricted cash obligations totaled $3.5 million and $5.6 million, respectively. Stock-Based Compensation Stock-based compensation expense for stock-based awards granted to Sabra’s employees (team members) and its non-employee directors is recognized in the statements of income based on the estimated grant date fair value, as adjusted. Compensation expense for awards with graded vesting schedules is generally recognized ratably over the period from the grant date to the date when the award is no longer contingent on the recipient providing additional services. Compensation expense for awards with performance-based vesting conditions is recognized based on the Company’s estimate of the ultimate value of such award after considering the Company’s expectations of future performance. Forfeitures of stock-based awards are recognized as they occur. Deferred Financing Costs Deferred financing costs representing fees paid to third parties are amortized over the terms of the respective financing agreements using the interest method. Deferred financing costs related to secured debt, term loans and senior unsecured notes are recorded as a reduction of the related debt liability, and deferred financing costs related to the revolving credit facility are recorded in accounts receivable, prepaid expenses and other assets, net. Unamortized deferred financing costs are generally expensed when the associated debt is refinanced or repaid before maturity. Costs incurred in seeking financings that do not close are expensed in the period in which it is determined that the financing will not close. Income Taxes The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. The Company believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute at least 90% of the Company’s annual REIT taxable income to stockholders (which is computed without regard to the dividends-paid deduction or net capital gains and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax on income that it distributes as dividends to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to U.S. federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the Internal Revenue Service grants the Company relief under certain statutory provisions. Such an event could materially and adversely affect the Company’s net income and net cash available for distribution to stockholders. However, the Company believes that it is organized and operates in such a manner as to qualify for treatment as a REIT. As a result of certain investments, the Company now records income tax expense or benefit with respect to certain of its entities that are taxed as taxable REIT subsidiaries under provisions similar to those applicable to regular corporations and not under the REIT provisions. The Company accounts for deferred income taxes using the asset and liability method and recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the Company’s financial statements or tax returns. Under this method, the Company determines deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes a change in the Company’s judgment about expected future tax consequences of events, is included in the tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss and tax credit carryforwards. A valuation allowance is provided if the Company believes it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes a change in the Company’s judgment about the realizability of the related deferred tax asset, is included in the tax provision when such changes occur. The Company evaluates its tax positions using a two-step approach: step one (recognition) occurs when the Company concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination, and step two (measurement) is only addressed if step one has been satisfied (i.e., the position is more likely than not to be sustained). Under step two, the tax benefit is measured as the largest amount of benefit (determined on a cumulative probability basis) that is more likely than not to be realized upon ultimate settlement. The Company will recognize tax penalties relating to unrecognized tax benefits as additional tax expense. Foreign Currency Certain of the Company’s subsidiaries’ functional currencies are the local currencies of their respective foreign jurisdictions. The Company translates the results of operations of its foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period presented, and it translates balance sheet accounts using exchange rates in effect at the end of the period presented. The Company records resulting currency translation adjustments in accumulated other comprehensive loss, a component of stockholders’ equity, on its consolidated balance sheets, and it records foreign currency transaction gains and losses as a component of interest and other income on its consolidated statements of income. Derivative Instruments The Company uses certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception, the Company must make an assessment that the transaction that the Company intends to hedge is probable of occurring, and this assessment must be updated each reporting period. The Company recognizes all derivative instruments as assets or liabilities on the consolidated balance sheets at their fair value. For derivatives designated and qualified as a hedge, the change in fair value of the effective portion of the derivatives is recognized in accumulated other comprehensive loss. Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria for hedge accounting would be recognized in earnings. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategy for undertaking various he

RECENT REAL ESTATE ACQUISITIONS

RECENT REAL ESTATE ACQUISITIONS	12 Months Ended
	Dec. 31, 2020
Business Combinations [Abstract]
RECENT REAL ESTATE ACQUISITIONS	RECENT REAL ESTATE ACQUISITIONS During the year ended December 31, 2020, the Company acquired three Senior Housing - Leased communities and one Senior Housing - Managed community. These investments were part of the Company’s proprietary development pipeline, and $20.7 million was previously funded through its preferred equity investments in these developments. During the year ended December 31, 2019, the Company acquired one Senior Housing - Leased community, three specialty hospitals/other facilities and one Senior Housing - Managed community. The consideration was allocated as follows (in thousands): Year Ended December 31, 2020 2019 Land $ 5,800 $ 10,049 Building and improvements 104,952 39,434 Tenant origination and absorption costs intangible assets 2,578 1,438 Tenant relationship intangible assets 347 215 Total consideration $ 113,677 $ 51,136 The tenant origination and absorption costs intangible assets and tenant relationship intangible assets had weighted-average amortization periods as of the respective dates of acquisition of seven years and 25 years, respectively, for acquisitions completed during the year ended December 31, 2020, and six years and 21 years, respectively, for acquisitions completed during the year ended December 31, 2019. For the year ended December 31, 2020, the Company recognized $12.5 million and $4.8 million of total revenues and net income attributable to common stockholders, respectively, from the facilities acquired during the year ended December 31, 2020. For the year ended December 31, 2019, the Company recognized $0.8 million and $0.4 million of total revenues and net income attributable to common stockholders, respectively, from the facilities acquired during the year ended December 31, 2019.

REAL ESTATE PROPERTIES HELD FOR

REAL ESTATE PROPERTIES HELD FOR INVESTMENT	12 Months Ended
	Dec. 31, 2020
Real Estate Investments, Net [Abstract]
REAL ESTATE PROPERTIES HELD FOR INVESTMENT	REAL ESTATE PROPERTIES HELD FOR INVESTMENT Real Estate Investments The Company’s real estate properties held for investment consisted of the following (dollars in thousands): As of December 31, 2020 Property Type Number of Number of Total Accumulated Total Skilled Nursing/Transitional Care 287 31,761 $ 3,644,470 $ (385,094) $ 3,259,376 Senior Housing - Leased 65 4,282 707,634 (87,600) 620,034 Senior Housing - Managed 47 4,924 942,996 (142,538) 800,458 Specialty Hospitals and Other 27 1,092 670,793 (66,021) 604,772 426 42,059 5,965,893 (681,253) 5,284,640 Corporate Level 802 (404) 398 $ 5,966,695 $ (681,657) $ 5,285,038 As of December 31, 2019 Property Type Number of Number of Total Accumulated Total Skilled Nursing/Transitional Care 296 33,290 $ 3,701,666 $ (306,565) $ 3,395,101 Senior Housing - Leased 62 3,820 630,688 (72,278) 558,410 Senior Housing - Managed 46 4,809 907,771 (112,893) 794,878 Specialty Hospitals and Other 25 1,193 639,721 (47,124) 592,597 429 43,112 5,879,846 (538,860) 5,340,986 Corporate Level 737 (353) 384 $ 5,880,583 $ (539,213) $ 5,341,370 December 31, 2020 December 31, 2019 Building and improvements $ 5,120,598 $ 5,042,435 Furniture and equipment 249,034 239,229 Land improvements 2,220 1,534 Land 594,843 597,385 5,966,695 5,880,583 Accumulated depreciation (681,657) (539,213) $ 5,285,038 $ 5,341,370 Operating Leases As of December 31, 2020, the substantial majority of the Company’s real estate properties (excluding 47 Senior Housing - Managed communities) were leased under triple-net operating leases with expirations ranging from less than one year to 16 years. As of December 31, 2020, the leases had a weighted-average remaining term of eight years. The leases generally include provisions to extend the lease terms and other negotiated terms and conditions. The Company, through its subsidiaries, retains substantially all of the risks and benefits of ownership of the real estate assets leased to the tenants. The Company may receive additional security under these operating leases in the form of letters of credit and security deposits from the lessee or guarantees from the parent of the lessee. Security deposits received in cash related to tenant leases are included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets and totaled $17.5 million and $10.5 million as of December 31, 2020 and 2019, respectively, and letters of credit deposited with the Company totaled approximately $85 million and $83 million as of December 31, 2020 and 2019, respectively. In addition, the Company’s tenants have deposited with the Company $16.9 million and $14.3 million as of December 31, 2020 and 2019, respectively, for future real estate taxes, insurance expenditures and tenant improvements related to the Company’s properties and their operations, and these amounts are included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets. Lessor costs that are paid by the lessor and reimbursed by the lessee are included in the measurement of variable lease revenue and the associated expense. As a result, the Company recognized variable lease revenue and the associated expense of $20.9 million and $17.6 million during the years ended December 31, 2020 and 2019, respectively. The Company monitors the creditworthiness of its tenants by reviewing credit ratings (if available) and evaluating the ability of the tenants to meet their lease obligations to the Company based on the tenants’ financial performance, including the evaluation of any parent guarantees (or the guarantees of other related parties) of tenant lease obligations. As formal credit ratings may not be available for most of the Company’s tenants, the primary basis for the Company’s evaluation of the credit quality of its tenants (and more specifically the tenant’s ability to pay their rent obligations to the Company) is the tenant’s lease coverage ratio or the parent’s fixed charge coverage ratio for those entities with a parent guarantee. These coverage ratios include earnings before interest, taxes, depreciation, amortization and rent (“EBITDAR”) to rent and earnings before interest, taxes, depreciation, amortization, rent and management fees (“EBITDARM”) to rent at the lease level and consolidated EBITDAR to total fixed charges at the parent guarantor level when such a guarantee exists. The Company obtains various financial and operational information from its tenants each month and reviews this information in conjunction with the above-described coverage metrics to identify financial and operational trends, evaluate the impact of the industry’s operational and financial environment (including the impact of government reimbursement), and evaluate the management of the tenant’s operations. These metrics help the Company identify potential areas of concern relative to its tenants’ credit quality and ultimately the tenant’s ability to generate sufficient liquidity to meet its obligations, including its obligation to continue to pay the rent due to the Company. During the year ended December 31, 2020, the auditors for Genesis Healthcare, Inc. (“Genesis”) and subsidiaries of Signature Healthcare (“Signature”) that lease facilities from the Company each expressed substantial doubt over the respective abilities of Genesis and Signature to continue as a going concern. Accordingly, the Company concluded that its leases with Genesis and Signature should no longer be accounted for on an accrual basis and wrote off $14.3 million of non-cash rent receivable balances and lease intangibles related to these leases. For the year ended December 31, 2020, no tenant relationship represented 10% or more of the Company’s total revenues. As of December 31, 2020, the future minimum rental payments from the Company’s properties held for investment under non-cancelable operating leases were as follows and may materially differ from actual future rental payments received (in thousands): 2021 $ 434,074 2022 418,547 2023 408,367 2024 409,357 2025 399,984 Thereafter 1,561,535 $ 3,631,864 Senior Housing - Managed Communities The Company’s Senior Housing - Managed communities offer residents certain ancillary services that are not contemplated in the lease with each resident (i.e., housekeeping, laundry, guest meals, etc.). These services are provided and paid for in addition to the standard services included in each resident lease (i.e., room and board, standard meals, etc.). The Company bills residents for ancillary services one month in arrears and recognizes revenue as the services are provided, as the Company has no continuing performance obligation related to those services. Resident fees and services includes ancillary service revenue of $0.9 million, $0.8 million and $0.5 million for the years ended December 31, 2020, 2019 and 2018, respectively. Investment in Unconsolidated Joint Venture The Company has a 49% equity interest in the Enlivant Joint Venture with affiliates of Enlivant and TPG Real Estate, the real estate platform of TPG, that owns senior housing communities managed by Enlivant. During the year ended December 31, 2020, the Enlivant Joint Venture sold 12 senior housing communities for aggregate gross proceeds of $18.2 million, and the Company recorded an aggregate net loss on sale of real estate related to unconsolidated joint venture of $3.3 million. During the year ended December 31, 2019, the Enlivant Joint Venture sold two senior housing communities for aggregate gross proceeds of $6.3 million, and the Company recorded an aggregate net loss on sale of real estate related to unconsolidated joint venture of $1.7 million. As of December 31, 2020, the Enlivant Joint Venture owned 158 senior housing communities, and the book value of the Company’s investment in the Enlivant Joint Venture was $288.8 million. The following tables present summarized financial information for the Enlivant Joint Venture and, except for basis adjustments and loss from unconsolidated joint venture, reflect the historical cost basis of the assets which pre-dated the Company’s investment in the Enlivant Joint Venture (in thousands): As of December 31, 2020 2019 Total assets $ 490,541 $ 504,920 Total liabilities 824,410 815,299 Member’s deficit (333,869) (310,379) Year Ended December 31, 2020 2019 2018 Total revenues $ 299,031 $ 312,055 $ 303,486 Operating expenses 240,331 231,659 228,458 Net income 5,196 13,161 10,378 Company’s share of net income $ 2,546 $ 6,449 $ 5,085 Basis adjustments 19,145 13,245 10,516 Loss from unconsolidated joint venture $ (16,599) $ (6,796) $ (5,431) The Enlivant Joint Venture has experienced decreased occupancy and increased operating costs as a result of the impact from the COVID-19 pandemic that, if they continue to negatively impact the operating results of the Enlivant Joint Venture for a prolonged period, could result in the determination that the full amount of the Company’s investment is not recoverable, resulting in a possible impairment charge. Net Investment in Sales-Type Lease During the year ended December 31, 2020, the Company modified its direct financing lease and reassessed the classification of this lease in accordance with Topic 842 and determined the lease should be accounted for as a sales-type lease. As of December 31, 2020, the Company had a $24.2 million net investment in one skilled nursing/transitional care facility leased to an operator under a sales-type lease, as the tenant is obligated to purchase the property at the end of the lease term. The net investment in sales-type lease is recorded in accounts receivable, prepaid expenses and other assets, net on the accompanying consolidated balance sheets and represents the present value of total rental payments of $2.3 million, plus the estimated purchase price of $24.8 million, less the unearned lease income of $2.8 million and allowance for credit losses of $0.1 million as of December 31, 2020. Unearned lease income represents the excess of the minimum lease payments and residual value over the cost of the investment. Unearned lease income is deferred and amortized to income over the lease term to provide a constant yield when collectability of the lease payments is reasonably assured. Income from the Company’s net investment in sales-type lease was $2.7 million, $2.7 million and $2.6 million for the years ended December 31, 2020, 2019 and 2018, respectively, and is reflected in interest and other income on the accompanying consolidated statements of income. Upon adoption of Topic 326 on January 1, 2020 and as of the adoption date, the Company recorded a $0.2 million reduction in equity and increase to its allowance for credit losses due to the cumulative effect of the changes contemplated by Topic 326. During the year ended December 31, 2020, the Company reduced its allowance for credit losses by $0.1 million. Future minimum lease payments contractually due under the sales-type lease at December 31, 2020, were as follows: $2.3 million for 2021, $2.4 million for 2022 and $0.8 million for 2023.

IMPAIRMENT OF REAL ESTATE AND D

IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS	12 Months Ended
	Dec. 31, 2020
Discontinued Operations and Disposal Groups [Abstract]
IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS	IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS 2020 Impairment of Real Estate During the year ended December 31, 2020, the Company recognized a $4.0 million real estate impairment related to one skilled nursing/transitional care facility sold during the year and three senior housing communities. Dispositions During the year ended December 31, 2020, the Company completed the sale of eight skilled nursing/transitional care facilities for aggregate consideration, net of closing costs, of $50.0 million. The net carrying value of the assets and liabilities of these facilities was $47.1 million, which resulted in an aggregate $2.9 million net gain on sale. During the year ended December 31, 2020, the Company recognized $4.0 million of net income, which includes the $2.9 million net gain on sale and $0.6 million of real estate impairment, during the year ended December 31, 2019, the Company recognized $12.6 million of net loss, which includes $15.5 million of real estate impairment, and during the year ended December 31, 2018, the Company recognized $5.4 million of net income, in each case from these facilities. The sale of these facilities does not represent a strategic shift that has or will have a major effect on the Company’s operations and financial results, and therefore the results of operations attributable to these facilities have remained in continuing operations. 2019 Impairment of Real Estate During the year ended December 31, 2019, the Company recognized a $121.8 million real estate impairment, of which $95.2 million related to the 30 Senior Care Centers facilities that the Company sold and one additional Senior Care Centers facility that the Company transitioned to another operator, and the remaining $26.6 million related to six skilled nursing/transitional care facilities that were subsequently sold, and four senior housing communities. Dispositions During the year ended December 31, 2019, the Company completed the sale of 39 skilled nursing/transitional care facilities and seven senior housing communities for aggregate consideration, net of closing costs, of $323.6 million. The net carrying value of the assets and liabilities of these facilities was $321.3 million, resulting in an aggregate $2.3 million net gain on sale. During the year ended December 31, 2019, the Company recognized $84.9 million of net loss, which includes $89.4 million of real estate impairment and the $2.3 million net gain on sale, and during the year ended December 31, 2018, recognized $19.1 million of net income, which includes $0.9 million of real estate impairment, in each case from these facilities. The sale of these facilities does not represent a strategic shift that has or will have a major effect on the Company’s operations and financial results, and therefore the results of operations attributable to these facilities have remained in continuing operations. 2018 Impairment of Real Estate During the year ended December 31, 2018, the Company recognized a $1.4 million real estate impairment, of which $0.9 million related to one skilled nursing/transitional care facility that was subsequently sold and $0.5 million related to one senior housing community sold during the year. Dispositions During the year ended December 31, 2018, the Company completed the sale of 51 skilled nursing/transitional care facilities, six senior housing communities and one Senior Housing - Managed community for aggregate consideration, net of closing costs, of $382.6 million. The net carrying value of the assets and liabilities of these facilities was $254.4 million, resulting in an aggregate $128.2 million net gain on sale. During the year ended December 31, 2018, the Company recognized $151.3 million of net income, which includes the $128.2 million net gain on sale and $0.5 million of real estate impairment. The sale of these facilities does not represent a strategic shift that has or will have a major effect on the Company’s operations and financial results, and therefore the results of operations attributable to these facilities have remained in continuing operations.

INTANGIBLE ASSETS AND LIABILITI

INTANGIBLE ASSETS AND LIABILITIES	12 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS AND LIABILITIES	INTANGIBLE ASSETS AND LIABILITIES The following table summarizes the Company’s intangible assets and liabilities as of December 31, 2020 and 2019 (in thousands): December 31, 2020 2019 Lease Intangible Assets: Above market leases $ 35,695 $ 51,040 Tenant origination and absorption costs 60,413 65,234 Tenant relationship 23,289 23,150 Gross lease intangible assets 119,397 139,424 Accumulated amortization (36,601) (37,915) Lease intangible assets, net $ 82,796 $ 101,509 Lease Intangible Liabilities: Below market leases $ 89,389 $ 99,133 Accumulated amortization (31,664) (29,187) Lease intangible liabilities, net $ 57,725 $ 69,946 The following is a summary of real estate intangible amortization income (expense) for the years ended December 31, 2020, 2019 and 2018 (in thousands): Year Ended December 31, 2020 2019 2018 Increase (decrease) to rental income related to above/below market leases, net $ 849 $ 508 $ (7,701) Depreciation and amortization related to tenant origination and absorption costs and tenant relationship (10,620) (17,674) (16,118) The remaining unamortized balance for these outstanding intangible assets and liabilities as of December 31, 2020 will be amortized for the years ending December 31 as follows (dollars in thousands): Lease Intangible Lease Intangible 2021 $ 10,277 $ 8,012 2022 9,936 7,269 2023 8,895 7,269 2024 8,480 7,168 2025 8,012 6,228 Thereafter 37,196 21,779 $ 82,796 $ 57,725 Weighted-average remaining amortization period 10.3 years 8.5 years

LOANS RECEIVABLE AND OTHER INVE

LOANS RECEIVABLE AND OTHER INVESTMENTS	12 Months Ended
	Dec. 31, 2020
Receivables [Abstract]
LOANS RECEIVABLE AND OTHER INVESTMENTS	LOANS RECEIVABLE AND OTHER INVESTMENTS As of December 31, 2020 and 2019, the Company’s loans receivable and other investments consisted of the following (dollars in thousands): December 31, 2020 Investment Quantity Property Type Principal Balance as of December 31, 2020 (1) Book Value Book Value Weighted Average Contractual Interest Rate / Rate of Return Weighted Average Annualized Effective Interest Rate / Rate of Return Maturity Date Loans Receivable: Mortgage 1 Specialty Hospital $ 19,000 $ 19,000 $ 19,000 10.0 % 10.0 % 01/31/27 Construction 1 Senior Housing 3,343 3,352 2,487 8.0 % 7.8 % 09/30/22 Other 16 Multiple 42,977 39,005 42,147 6.8 % 6.9 % 03/01/21- 08/31/28 18 65,320 61,357 63,634 7.8 % 7.9 % Allowance for loan losses — (2,458) (564) $ 65,320 $ 58,899 $ 63,070 Other Investments: Preferred Equity 6 Skilled Nursing / Senior Housing 43,724 43,940 44,304 11.3 % 11.3 % N/A Total 24 $ 109,044 $ 102,839 $ 107,374 9.2 % 9.3 % (1) Principal balance includes amounts funded and accrued but unpaid interest / preferred return and excludes capitalizable fees. As of December 31, 2020 and 2019, the Company had four loans receivable investments, with an aggregate principal balance of $2.1 million and $27.7 million, respectively, that were considered to have deteriorated credit quality. As of December 31, 2020 and 2019, the book value of the outstanding loans with deteriorated credit quality was $0.5 million and $4.2 million, respectively. The following table presents changes in the accretable yield for the years ended December 31, 2020 and 2019 (in thousands): Year Ended December 31, 2020 2019 2018 Accretable yield, beginning of period $ 39 $ 449 $ 2,483 Accretion recognized in earnings (27) (377) (2,761) Reduction due to payoff — (33) — Net reclassification from nonaccretable difference — — 727 Accretable yield, end of period $ 12 $ 39 $ 449 During the year ended December 31, 2020, the Company increased its allowance for loan losses by $1.9 million. As of December 31, 2020, the Company had a $2.5 million allowance for loan losses. As of December 31, 2020, two loans receivable investments with no book value were on nonaccrual status. As of December 31, 2020, the Company did not consider any preferred equity investments to be impaired, and no preferred equity investments were on nonaccrual status. During the year ended December 31, 2019, the Company recorded a $1.2 million provision for specific loan losses and increased its portfolio-based loan loss reserve by $4,000. As of December 31, 2019, the Company had no asset-specific loan loss reserve and a $0.6 million portfolio-based loan loss reserve. As of December 31, 2019, the Company did not consider any loans receivable investments to be impaired. As of December 31, 2019, two loans receivable investments with no book value were on nonaccrual status. As of December 31, 2019, the Company did not consider any preferred equity investments to be impaired, and no preferred equity investments were on nonaccrual status.

DEBT

DEBT	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
DEBT	DEBT Secured Indebtedness The Company’s secured debt consists of the following (dollars in thousands): Interest Rate Type Principal Balance as of (1) Principal Balance as of (1) Weighted Average Interest Rate at (2) Maturity Date Fixed Rate $ 80,199 $ 114,777 3.39 % December 2021 - (1) Principal balance does not include deferred financing costs, net of $1.1 million and $1.7 million as of December 31, 2020 and 2019, respectively. (2) Weighted average interest rate includes private mortgage insurance. During the year ended December 31, 2020, the Company sold three facilities that secured an aggregate $31.8 million of debt which was assumed by the buyers of the facilities and recognized a $0.5 million loss on extinguishment of debt related to write-offs of deferred financing costs in connection with the sales. During the year ended December 31, 2018, the Company (i) prepaid a $98.5 million variable rate secured term loan and recognized a $2.0 million loss on extinguishment of debt related to prepayment penalty fees associated with the early repayment of the loan and (ii) repaid $37.6 million of fixed rate debt secured by facilities sold during the year ended December 31, 2018 and recognized a $0.9 million loss on extinguishment of debt related to write-offs of deferred financing costs in connection with this repayment. Senior Unsecured Notes The Company’s senior unsecured notes consist of the following (dollars in thousands): Principal Balance as of December 31, Title Maturity Date 2020 (1) 2019 (1) 4.80% senior unsecured notes due 2024 (“2024 Notes”) June 1, 2024 $ 300,000 $ 300,000 5.125% senior unsecured notes due 2026 (“2026 Notes”) August 15, 2026 500,000 500,000 5.38% senior unsecured notes due 2027 (“2027 Notes”) May 17, 2027 100,000 100,000 3.90% senior unsecured notes due 2029 (“2029 Notes”) October 15, 2029 350,000 350,000 $ 1,250,000 $ 1,250,000 (1) Principal balance does not include premium, net of $6.4 million and deferred financing costs, net of $8.0 million as of December 31, 2020 and does not include premium, net of $7.6 million and deferred financing costs, net of $8.8 million as of December 31, 2019. 5.5% Notes Due 2021 . On January 23, 2014, the Operating Partnership and Sabra Capital Corporation, wholly owned subsidiaries of the Company (the “Issuers”), issued $350.0 million aggregate principal amount of 5.5% senior unsecured notes due 2021 (the “Original 2021 Notes”), and on October 10, 2014, they issued $150.0 million aggregate principal amount of 5.5% senior unsecured notes due 2021, which were treated as a single class with, and had the same terms as, the Original 2021 Notes (the additional notes and the Original 2021 Notes, together, the “2021 Notes”). The 2021 Notes accrued interest at a rate of 5.5% per annum payable semiannually on February 1 and August 1 of each year. On June 29, 2019, the Issuers redeemed all $500.0 million aggregate principal amount outstanding of the 2021 Notes at a cash redemption price of 101.375% of the principal amount being redeemed, plus accrued and unpaid interest. The redemption resulted in $10.1 million of redemption related costs and write-offs for the year ended December 31, 2019, consisting of $6.9 million in payments made to noteholders and legal fees for early redemption and $3.2 million of write-offs associated with unamortized deferred financing and premium costs. These amounts are included in loss on extinguishment of debt on the accompanying consolidated statements of income. 5.375% Notes Due 2023. On May 23, 2013, the Issuers issued $200.0 million aggregate principal amount of 5.375% senior unsecured notes due 2023 (the “2023 Notes”). The 2023 Notes accrued interest at a rate of 5.375% per annum payable semiannually on June 1 and December 1 of each year. On October 27, 2019, the Issuers redeemed all $200.0 million aggregate principal amount outstanding of the 2023 Notes at a cash redemption price of 101.792% of the principal amount being redeemed, plus accrued and unpaid interest. The redemption resulted in $5.6 million of redemption related costs and write-offs for the year ended December 31, 2019, consisting of $3.6 million in payments made to noteholders and legal fees for early redemption and $2.0 million of write-offs associated with unamortized deferred financing costs. These amounts are included in loss on extinguishment of debt on the accompanying consolidated statements of income. 4.80% Notes Due 2024. On May 29, 2019, the Issuers completed an underwritten public offering of $300.0 million aggregate principal amount of 4.80% senior unsecured notes due 2024 (the “2024 Notes”). The net proceeds were $295.3 million after deducting underwriting discounts and other offering expenses. The net proceeds, together with borrowings under the Revolving Credit Facility, were used to redeem the 2021 Notes as discussed above. The 2024 Notes accrue interest at a rate of 4.80% per annum payable semiannually on June 1 and December 1 of each year. Upon redemption of the 2023 Notes as discussed above, Sabra Capital Corporation’s obligations as a co-issuer under the 2024 Notes were automatically released and discharged. The 2024 Notes are redeemable at the option of the Operating Partnership, in whole or in part at any time and from time to time, prior to May 1, 2024, at a price equal to 100% of the principal amount, together with any accrued and unpaid interest to, but not including, the redemption date, plus a make-whole premium. The Operating Partnership may also redeem the 2024 Notes on or after May 1, 2024, at a price equal to 100% of the principal amount, together with any accrued and unpaid interest to, but not including, the redemption date. Assuming the 2024 Notes are not redeemed, the 2024 Notes mature on June 1, 2024. 5.125% Notes Due 2026 . In connection with the Company’s merger with Care Capital Properties (“CCP”), on August 17, 2017, the Operating Partnership assumed $500.0 million aggregate principal amount of 5.125% senior unsecured notes due 2026 (the “2026 Notes”) issued by Care Capital Properties, LP in July 2016. The 2026 Notes accrue interest at a rate of 5.125% per annum payable semiannually on February 15 and August 15 of each year. The Operating Partnership may, at its option, redeem the 2026 Notes at any time in whole or from time to time in part prior to their stated maturity. The redemption price for 2026 Notes that are redeemed will be equal to (i) 100% of their principal amount, together with accrued and unpaid interest thereon, if any, to (but excluding) the date of redemption, plus, (ii) if redeemed prior to May 15, 2026, a make-whole premium. Assuming the 2026 Notes are not redeemed, the 2026 Notes mature on August 15, 2026. 5.38% Notes Due 2027 . In connection with the Company’s merger with CCP, on August 17, 2017, the Operating Partnership assumed $100.0 million aggregate principal amount of unregistered 5.38% senior unsecured notes due 2027 (the “2027 Notes”) issued by Care Capital Properties, LP in May 2016. The 2027 Notes accrue interest at a rate of 5.38% per annum payable semiannually on May 17 and November 17 of each year. The Operating Partnership may prepay the 2027 Notes, in whole at any time or in part from time to time, at 100% of the principal amount to be prepaid plus a make-whole premium. Assuming the 2027 Notes are not redeemed, the 2027 Notes mature on May 17, 2027. 3.90% Notes Due 2029. On October 7, 2019, the Issuers completed an underwritten public offering of $350.0 million aggregate principal amount of 3.90% senior unsecured notes due 2029 (the “2029 Notes”). The net proceeds were $340.5 million after deducting underwriting discounts and other offering expenses. A portion of the net proceeds was used to redeem all of the 2023 Notes as discussed above, and the remaining net proceeds were used to repay borrowings outstanding on the Revolving Credit Facility. The 2029 Notes accrue interest at a rate of 3.90% per annum payable semiannually on April 15 and October 15 of each year. Upon redemption of the 2023 Notes as discussed above, Sabra Capital Corporation’s obligations as a co-issuer under the 2029 Notes were automatically released and discharged. The 2029 Notes are redeemable at the option of the Operating Partnership, in whole or in part at any time and from time to time, prior to July 15, 2029, at a price equal to 100% of the principal amount, together with any accrued and unpaid interest to, but not including, the redemption date, plus a make-whole premium. The Operating Partnership may also redeem the 2029 Notes on or after July 15, 2029, at a price equal to 100% of the principal amount, together with any accrued and unpaid interest to, but not including, the redemption date. Assuming the 2029 Notes are not redeemed, the 2029 Notes mature on October 15, 2029. The obligations under the 2024 Notes and 2027 Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by Sabra and one of its non-operating subsidiaries, subject to release under certain customary circumstances. The obligations under the 2026 Notes and 2029 Notes are fully and unconditionally guaranteed, on an unsecured basis, by Sabra; provided, however, that such guarantee is subject to release under certain customary circumstances. The indenture governing the 2024 Notes contains restrictive covenants that, among other things, restrict the ability of Sabra, the Issuers and their restricted subsidiary to: (i) incur or guarantee additional indebtedness; (ii) incur or guarantee secured indebtedness; and (iii) merge or consolidate or sell all or substantially all of their assets. The indenture governing the 2024 Notes also provides for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the 2024 Notes, the failure to comply with certain covenants and agreements specified in the indenture for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then-outstanding 2024 Notes may become due and payable immediately. The indenture governing the 2024 Notes requires Sabra, the Issuers and their restricted subsidiary to maintain Total Unencumbered Assets (as defined in the indentures) of at least 150% of the Company’s unsecured indebtedness. The indenture governing the 2026 Notes contains certain covenants that, among other things, limits the ability of Sabra, the Issuers and their subsidiaries to: (i) consummate a merger, consolidate or sell all or substantially all of our consolidated assets and (ii) incur secured or unsecured indebtedness. In addition, Sabra, the Operating Partnership and their subsidiaries are required to maintain at all times consolidated unencumbered total asset value in an amount not less than 150% of the aggregate outstanding principal amount of the Company’s consolidated unsecured debt. The agreement governing the 2027 Notes provides for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the 2027 Notes, the failure to comply with certain covenants and agreements specified in the agreement governing the 2027 Notes for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. In addition, certain change of control events constitute an event of default under the agreement governing the 2027 Notes. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then-outstanding 2027 Notes may become due and payable immediately. The indenture governing the 2029 Notes contains restrictive covenants that, among other things, restrict the ability of Sabra, the Issuers and their subsidiaries to: (i) incur or guarantee additional indebtedness; (ii) incur or guarantee secured indebtedness; and (iii) merge or consolidate or sell all or substantially all of their assets. The indenture governing the 2029 Notes also provides for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the 2029 Notes, the failure to comply with certain covenants and agreements specified in the indenture for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then-outstanding 2029 Notes may become due and payable immediately. The indenture governing the 2029 Notes requires Sabra, the Issuers and their subsidiaries to maintain Total Unencumbered Assets (as defined in the indentures) of at least 150% of the Company’s unsecured indebtedness. The Company was in compliance with all applicable financial covenants under the indentures and agreements (the “Senior Notes Indentures”) governing the 2024 Notes, 2026 Notes, 2027 Notes and 2029 Notes (collectively, the “Senior Notes”) outstanding as of December 31, 2020. Credit Agreement On September 9, 2019, the Operating Partnership and Sabra Canadian Holdings, LLC (together, the “Borrowers”), Sabra and the other parties thereto entered into a fifth amended and restated unsecured credit agreement (the “Credit Agreement”). The Credit Agreement includes a $1.0 billion revolving credit facility (the “Revolving Credit Facility”), $955.0 million in U.S. dollar term loans and a CAD $125.0 million Canadian dollar term loan (collectively, the “Term Loans”). Further, up to $175.0 million of the Revolving Credit Facility may be used for borrowings in certain foreign currencies. The Credit Agreement also contains an accordion feature that can increase the total available borrowings to $2.75 billion, subject to terms and conditions. The Revolving Credit Facility has a maturity date of September 9, 2023, and includes two six-month extension options. $105.0 million of the U.S. dollar Term Loans has a maturity date of September 9, 2022, $350.0 million of the U.S. dollar Term Loans has a maturity date of September 9, 2023, and the other Term Loans have a maturity date of September 9, 2024. As of December 31, 2020, there were no amounts outstanding under the Revolving Credit Facility and $1.0 billion available for borrowing. Borrowings under the Revolving Credit Facility bear interest on the outstanding principal amount at a rate equal to a ratings-based applicable interest margin plus, at the Operating Partnership’s option, either (a) LIBOR or (b) a base rate determined as the greater of (i) the federal funds rate plus 0.5%, (ii) the prime rate, and (iii) one-month LIBOR plus 1.0% (the “Base Rate”). The ratings-based applicable interest margin for borrowings will vary based on the Debt Ratings, as defined in the Credit Agreement, and will range from 0.775% to 1.45% per annum for LIBOR based borrowings and 0.00% to 0.45% per annum for borrowings at the Base Rate. As of December 31, 2020, the interest rate on the Revolving Credit Facility was 1.24%. In addition, the Operating Partnership pays a facility fee ranging between 0.125% and 0.300% per annum based on the aggregate amount of commitments under the Revolving Credit Facility regardless of amounts outstanding thereunder. The U.S. dollar Term Loans bear interest on the outstanding principal amount at a rate equal to a ratings-based applicable interest margin plus, at the Operating Partnership’s option, either (a) LIBOR or (b) the Base Rate. The ratings-based applicable interest margin for borrowings will vary based on the Debt Ratings and will range from 0.85% to 1.65% per annum for LIBOR based borrowings and 0.00% to 0.65% per annum for borrowings at the Base Rate. As of December 31, 2020, the interest rate on the U.S. dollar Term Loans was 1.39%. The Canadian dollar Term Loan bears interest on the outstanding principal amount at a rate equal to the Canadian Dollar Offered Rate (“CDOR”) plus an interest margin that ranges from 0.85% to 1.65% depending on the Debt Ratings. As of December 31, 2020, the interest rate on the Canadian dollar Term Loan was 1.71%. The Company has interest rate swaps that fix the LIBOR portion of the interest rate for $845.0 million of LIBOR-based borrowings under its U.S. dollar Term Loans at a weighted average rate of 1.24% and an interest rate swap that fixes the CDOR portion of the interest rate for CAD $125.0 million of CDOR-based borrowings under its Canadian dollar Term Loan at a rate of 0.93%. In addition, CAD $125.0 million of the Canadian dollar Term Loan is designated as a net investment hedge. See Note 9, “Derivative and Hedging Instruments,” for further information. The obligations of the Borrowers under the Credit Agreement are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by Sabra and one of its non-operating subsidiaries, subject to release under certain customary circumstances. The Credit Agreement contains customary covenants that include restrictions or limitations on the ability to pay dividends, incur additional indebtedness, engage in non-healthcare related business activities, enter into transactions with affiliates and sell or otherwise transfer certain assets as well as customary events of default. The Credit Agreement also requires Sabra, through the Operating Partnership, to comply with specified financial covenants, which include a maximum total leverage ratio, a minimum secured debt leverage ratio, a minimum fixed charge coverage ratio, a maximum unsecured leverage ratio, a minimum tangible net worth requirement and a minimum unsecured interest coverage ratio. As of December 31, 2020, the Company was in compliance with all applicable financial covenants under the Credit Agreement. Interest Expense During the years ended December 31, 2020, 2019 and 2018, the Company incurred interest expense of $100.4 million, $126.6 million and $147.1 million, respectively. Interest expense includes non-cash interest expense of $8.4 million, $10.1 million and $10.1 million for the years ended December 31, 2020, 2019 and 2018, respectively. As of December 31, 2020 and 2019, the Company had $16.1 million and $16.7 million, respectively, of accrued interest included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets. Maturities The following is a schedule of maturities for the Company’s outstanding debt as of December 31, 2020 (in thousands): Secured Term Loans Senior Notes Total 2021 $ 18,419 $ — $ — $ 18,419 2022 2,412 105,000 — 107,412 2023 2,478 350,000 — 352,478 2024 2,545 598,100 300,000 900,645 2025 2,615 — — 2,615 Thereafter 51,730 — 950,000 1,001,730 Total Debt 80,199 1,053,100 1,250,000 2,383,299 Premium, net — — 6,442 6,442 Deferred financing costs, net (1,134) (8,184) (8,049) (17,367) Total Debt, Net $ 79,065 $ 1,044,916 $ 1,248,393 $ 2,372,374

DERIVATIVE AND HEDGING INSTRUME

DERIVATIVE AND HEDGING INSTRUMENTS	12 Months Ended
	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE AND HEDGING INSTRUMENTS	DERIVATIVE AND HEDGING INSTRUMENTSThe Company is exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign exchange rates. The Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates and foreign exchange rates. The Company’s derivative financial instruments are used to manage differences in the amount of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s investments and borrowings. Certain of the Company’s foreign operations expose the Company to fluctuations of foreign interest rates and exchange rates. These fluctuations may impact the value in the Company’s functional currency, the U.S. dollar, of the Company’s investment in foreign operations, the cash receipts and payments related to these foreign operations and payments of interest and principal under Canadian dollar denominated debt. The Company enters into derivative financial instruments to protect the value of its foreign investments and fix a portion of the interest payments for certain debt obligations. The Company does not enter into derivatives for speculative purposes. Cash Flow Hedges The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps and collars as part of its interest rate risk management strategy. In May 2019, the Company terminated three forward starting interest rate swaps, resulting in a payment to counterparties totaling $12.6 million. The balance of the loss in other comprehensive income will be reclassified to earnings through 2029. As of December 31, 2020, approximately $13.0 million of losses, which are included in accumulated other comprehensive income, are expected to be reclassified into earnings in the next 12 months. Net Investment Hedges The Company is exposed to fluctuations in foreign exchange rates on investments it holds in Canada. The Company uses cross currency interest rate swaps to hedge its exposure to changes in foreign exchange rates on these foreign investments. The following presents the notional amount of derivative instruments as of the dates indicated (in thousands): December 31, 2020 December 31, 2019 Derivatives designated as cash flow hedges: Denominated in U.S. Dollars (1) $ 1,340,000 $ 1,490,000 Denominated in Canadian Dollars (2) $ 250,000 $ 125,000 Derivatives designated as net investment hedges: Denominated in Canadian Dollars $ 52,778 $ 54,489 Financial instrument designated as net investment hedge: Denominated in Canadian Dollars $ 125,000 $ 125,000 Derivatives not designated as net investment hedges: Denominated in Canadian Dollars $ 3,522 $ 1,811 (1) Balance includes swaps with an aggregate notional amount of $400.0 million, which accretes to $600.0 million in January 2023, and two forward starting interest rate swaps and one forward starting interest rate collar with an effective date of January 2021. The forward starting interest rate swaps and forward starting interest rate collar have an aggregate notional amount of $245.0 million. Balance as of December 31, 2020 also includes six forward starting interest rate swaps with an effective date of May 2024 and an aggregate notional amount of $250.0 million. (2) Balance as of December 31, 2020 includes two forward starting interest rate swaps with an effective date of January 2021 and an aggregate notional amount of CAD $125.0 million. Derivative and Financial Instruments Designated as Hedging Instruments The following is a summary of the derivative and financial instruments designated as hedging instruments held by the Company at December 31, 2020 and 2019 (dollars in thousands): Count as of December 31, 2020 Fair Value Maturity Dates December 31, Type Designation 2020 2019 Balance Sheet Location Assets: Interest rate swaps Cash flow — $ — $ 4,239 N/A Accounts receivable, prepaid expenses and other assets, net Forward starting interest rate swaps Cash flow 6 10,652 — 2034 Accounts receivable, prepaid expenses and other assets, net Cross currency interest rate swaps Net investment 2 2,150 3,238 2025 Accounts receivable, prepaid expenses and other assets, net $ 12,802 $ 7,477 Liabilities: Interest rate swaps Cash flow 10 $ 23,849 $ — 2021-2024 Accounts payable and accrued liabilities Interest rate collar Cash flow 1 1,626 — 2024 Accounts payable and accrued liabilities Forward starting interest rate swaps Cash flow 4 10,723 494 2024 Accounts payable and accrued liabilities Forward starting interest rate collar Cash flow 1 820 132 2024 Accounts payable and accrued liabilities CAD term loan Net investment 1 98,100 96,025 2024 Term loans, net $ 135,118 $ 96,651 The following presents the effect of the Company’s derivative and financial instruments designated as hedging instruments on the consolidated statements of income and the consolidated statements of equity for the years ended December 31, 2020, 2019 and 2018: (Loss) Gain Recognized in Other Comprehensive Income (Loss) Gain Reclassified from Accumulated Other Comprehensive Income Into Income Income Statement Location For the year ended December 31, 2020 2019 2018 2020 2019 2018 Cash Flow Hedges: Interest rate products $ (35,320) $ (19,932) $ 2,707 $ (8,072) $ 5,545 $ 3,099 Interest expense Net Investment Hedges: Foreign currency products (758) (772) 3,554 — — — N/A CAD term loan (2,075) (4,325) 7,888 — — — N/A $ (38,153) $ (25,029) $ 14,149 $ (8,072) $ 5,545 $ 3,099 During the years ended December 31, 2020, 2019 and 2018, no cash flow hedges were determined to be ineffective. Derivatives Not Designated as Hedging Instruments As of December 31, 2020, the Company had one outstanding cross currency interest rate swap, of which a portion was not designated as a hedging instrument, in an asset position with a fair value of $0.1 million and included this amount in accounts receivable, prepaid expenses and other assets, net on the consolidated balance sheets. During the years ended December 31, 2020, 2019 and 2018, the Company recorded $0.1 million of other expense and $5,000 and $34,000 of other income, respectively, related to the portion of derivatives not designated as hedging instruments. Offsetting Derivatives The Company enters into master netting arrangements, which reduce credit risk by permitting net settlement of transactions with the same counterparty. The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of December 31, 2020 and 2019 (in thousands): As of December 31, 2020 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 12,802 $ — $ 12,802 $ (7,420) $ — $ 5,382 Offsetting Liabilities: Derivatives $ 37,018 $ — $ 37,018 $ (7,420) $ — $ 29,598 As of December 31, 2019 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 7,477 $ — $ 7,477 $ (544) $ — $ 6,933 Offsetting Liabilities: Derivatives $ 626 $ — $ 626 $ (544) $ — $ 82 Credit-risk-related Contingent Features The Company has agreements with each of its derivative counterparties that contain a provision pursuant to which the Company could be declared in default on the derivative obligation if the Company defaults on any of its indebtedness, including a default where repayment of the indebtedness has not been accelerated by the lender. As of December 31, 2020, the fair value of derivatives in a net liability position, which includes accrued interest but excludes any adjustment for nonperformance risk, related to these agreements was $30.5 million. As of December 31, 2020, the Company has not posted any collateral related to these agreements. If the Company had breached any of these provisions at December 31, 2020, it could have been required to settle its obligations under the agreements at their termination value of $29.6 million.

FAIR VALUE DISCLOSURES

FAIR VALUE DISCLOSURES	12 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE DISCLOSURES	FAIR VALUE DISCLOSURES Financial Instruments The fair value for certain financial instruments is derived using a combination of market quotes, pricing models and other valuation techniques that involve significant management judgment. The price transparency of financial instruments is a key determinant of the degree of judgment involved in determining the fair value of the Company’s financial instruments. Financial instruments for which actively quoted prices or pricing parameters are available and whose markets contain orderly transactions will generally have a higher degree of price transparency than financial instruments whose markets are inactive or consist of non-orderly trades. The Company evaluates several factors when determining if a market is inactive or when market transactions are not orderly. The carrying values of cash and cash equivalents, restricted cash, accounts payable, accrued liabilities and the Credit Agreement are reasonable estimates of fair value because of the short-term maturities of these instruments. Fair values for other financial instruments are derived as follows: Loans receivable : These instruments are presented on the accompanying consolidated balance sheets at their amortized cost and not at fair value. The fair values of the loans receivable were estimated using an internal valuation model that considered the expected cash flows for the loans receivable, as well as the underlying collateral value and other credit enhancements as applicable. The Company utilized discount rates ranging from 6% to 12% with a weighted average rate of 9% in its fair value calculation. As such, the Company classifies these instruments as Level 3. Preferred equity investments : These instruments are presented on the accompanying consolidated balance sheets at their cost and not at fair value. The fair values of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows for the preferred equity investments, the underlying collateral value and other credit enhancements. The Company utilized discount rates ranging from 10% to 15% with a weighted average rate of 11% in its fair value calculation. As such, the Company classifies these instruments as Level 3. Derivative instruments : The Company’s derivative instruments are presented at fair value on the accompanying consolidated balance sheets. The Company estimates the fair value of derivative instruments, including its interest rate swaps and cross currency swaps, using the assistance of a third party using inputs that are observable in the market, which include forward yield curves and other relevant information. Although the Company has determined that the majority of the inputs used to value its derivative financial instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivative financial instruments utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by itself and its counterparties. The Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of its derivative financial instruments. As a result, the Company has determined that its derivative financial instruments valuations in their entirety are classified in Level 2 of the fair value hierarchy. Senior Notes : These instruments are presented on the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums/discounts and not at fair value. The fair values of the Senior Notes were determined using third-party market quotes derived from orderly trades. As such, the Company classifies these instruments as Level 2. Secured indebtedness : These instruments are presented on the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums/discounts and not at fair value. The fair values of the Company’s secured debt were estimated using a discounted cash flow analysis based on management’s estimates of current market interest rates for instruments with similar characteristics, including remaining loan term, loan-to-value ratio, type of collateral and other credit enhancements. The Company utilized rates ranging from 2% to 3% with a weighted average rate of 3% in its fair value calculation. As such, the Company classifies these instruments as Level 3. The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2020 and 2019 whose carrying amounts do not approximate their fair value (in thousands): December 31, 2020 December 31, 2019 Face Value (1) Carrying Amount (2) Fair Face Value (1) Carrying Amount (2) Fair Financial assets: Loans receivable $ 65,320 $ 58,899 $ 60,421 $ 67,527 $ 63,070 $ 59,832 Preferred equity investments 43,724 43,940 44,597 43,893 44,304 44,493 Financial liabilities: Senior Notes 1,250,000 1,248,393 1,362,678 1,250,000 1,248,773 1,328,714 Secured indebtedness 80,199 79,065 79,326 114,777 113,070 105,510 (1) Face value represents amounts contractually due under the terms of the respective agreements. (2) Carrying amount represents the book value of financial instruments, including unamortized premiums/discounts and deferred financing costs. The Company determined the fair value of financial instruments as of December 31, 2020 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands): Fair Value Measurements Using Total Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Financial assets: Loans receivable $ 60,421 $ — $ — $ 60,421 Preferred equity investments 44,597 — — 44,597 Financial liabilities: Senior Notes 1,362,678 — 1,362,678 — Secured indebtedness 79,326 — — 79,326 Disclosure of the fair value of financial instruments is based on pertinent information available to the Company at the applicable dates and requires a significant amount of judgment. Transaction volume for certain of the Company’s financial instruments remains relatively low, which has made the estimation of fair values difficult. Therefore, both the actual results and the Company’s estimate of fair value at a future date could be materially different. Items Measured at Fair Value on a Recurring Basis During the year ended December 31, 2020, the Company recorded the following amounts measured at fair value (in thousands): Fair Value Measurements Using Total Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Recurring Basis: Financial assets: Forward starting interest rate swaps $ 10,652 $ — $ 10,652 $ — Cross currency interest rate swaps 2,150 — 2,150 — Financial liabilities: Interest rate swaps 23,849 — 23,849 — Interest rate collar 1,626 — 1,626 — Forward starting interest rate swaps 10,723 — 10,723 — Forward starting interest rate collars 820 — 820 —

EQUITY

EQUITY	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
EQUITY	EQUITY Preferred Stock The Company redeemed all 5,750,000 shares of its 7.125% Series A Cumulative Redeemable Preferred Stock (the “Series A Preferred Stock”) on June 1, 2018 (the “Redemption Date”) for $25.00 per share, plus accrued and unpaid dividends to, but not including, the Redemption Date, without interest, in the amount of $0.4453125 per share of Series A Preferred Stock, for a total redemption price per share of Series A Preferred Stock equal to $25.4453125. As a result of the redemption, the Company incurred a charge of $5.5 million related to the original issuance costs of the Series A Preferred Stock. The charge is presented as an additional preferred stock dividend in the Company’s consolidated statements of income for the year ended December 31, 2018. Common Stock On February 25, 2019, the Company established an at-the-market equity offering program (the “Prior ATM Program”) to sell shares of its common stock having an aggregate gross sales price of up to $500.0 million from time to time through a consortium of banks acting as sales agents. On December 5, 2019, the Prior ATM Program automatically terminated in accordance with its terms upon the issuance and sale of the maximum aggregate amount of the shares subject to the Prior ATM Program. On December 11, 2019, the Company established a new ATM program (the “ATM Program”) pursuant to which shares of its common stock having an aggregate gross sales price of up to $400.0 million may be sold from time to time (i) by the Company through a consortium of banks acting as sales agents or directly to the banks acting as principals or (ii) by a consortium of banks acting as forward sellers on behalf of any forward purchasers pursuant to a forward sale agreement. The use of a forward sale agreement would allow the Company to lock in a share price on the sale of shares at the time the agreement is effective, but defer receiving the proceeds from the sale of the shares until a later date. The Company may also elect to cash settle or net share settle all or a portion of its obligations under any forward sale agreement. During the year ended December 31, 2020, the Company sold 3.7 million shares under the ATM Program at an average price of $16.23 per share, generating gross proceeds of $60.0 million, before $0.9 million of commissions (excluding sales utilizing the forward feature of the ATM Program, as described below). During the year ended December 31, 2019, the Company sold an aggregate 26.8 million shares under the ATM Program and Prior ATM Program at an average price of $20.92 per share, generating gross proceeds of $560.0 million, before $7.7 million of commissions. Additionally, during the year ended December 31, 2020, the Company utilized the forward feature of the ATM Program to allow for the sale of up to an aggregate sales price of $45.3 million of the Company’s common stock at an initial weighted average price of $17.44 per share, net of commissions. The forward sale agreements have a one year term during which time the Company may settle the forward sales by delivery of physical shares of common stock to the forward purchasers or, at the Company’s election, in cash or net shares. The forward sale price that the Company expects to receive upon settlement will be the initial forward price established upon the effective date, subject to adjustments for (i) the forward purchasers’ stock borrowing costs and (ii) certain fixed price reductions during the term of the agreement. During the year ended December 31, 2020, the Company settled 1.4 million shares at a weighted average net price of $17.45 per share, after commissions, resulting in net proceeds of $25.0 million. As of December 31, 2020, 1.1 million shares remained outstanding under the forward sale agreements, with an initial weighted average price of $17.44, net of commissions. As of December 31, 2020, the Company had $234.7 million available under the ATM Program. Other Common Stock Issuances During the years ended December 31, 2020 and 2019, the Company issued 0.2 million and 0.1 million shares of common stock as a result of restricted stock unit vestings, respectively. Upon any payment of shares to team members as a result of restricted stock unit vestings, the team members’ related tax withholding obligation will generally be satisfied by the Company, reducing the number of shares to be delivered by a number of shares necessary to satisfy the related applicable tax withholding obligation. During the years ended December 31, 2020, 2019 and 2018, the Company incurred $3.2 million, $1.5 million and $0.4 million, respectively, in tax withholding obligations on behalf of its team members that were satisfied through a reduction in the number of shares delivered to those participants. Accumulated Other Comprehensive Loss The following is a summary of the Company’s accumulated other comprehensive loss (in thousands): Year Ended December 31, 2020 2019 Foreign currency translation loss $ (1,831) $ (1,516) Unrealized loss on cash flow hedges (38,080) (10,872) Total accumulated other comprehensive loss $ (39,911) $ (12,388)

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	12 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION All stock-based awards are subject to the terms of the 2009 Performance Incentive Plan, which was assumed by the Company effective as of November 15, 2010 in connection with the Company’s separation from Sun and was most recently amended and restated in April 2017. The 2009 Performance Incentive Plan provides for the granting of stock-based compensation, including stock options, time-based stock units, funds from operations-based stock units (“FFO Units”), relative total stockholder return-based stock units (“TSR Units”) and performance-based restricted stock units to directors, officers and other team members in connection with their employment with or services provided to the Company. Restricted Stock Units and Performance-Based Restricted Stock Units Under the 2009 Performance Incentive Plan, restricted stock units and performance-based restricted stock units generally have a contractual life or vest over a three withholding obligation. The value of the shares withheld is dependent on the closing price of the Company’s common stock on the date the relevant transaction occurs. The following table summarizes additional information concerning restricted stock units at December 31, 2020: Restricted Stock Units Weighted Average Grant Date Fair Value Per Unit Unvested as of December 31, 2019 1,737,862 $ 18.35 Granted 623,523 17.13 Vested (540,751) 17.84 Dividends reinvested 157,905 18.44 Cancelled/forfeited (163,124) 20.70 Unvested as of December 31, 2020 1,815,415 $ 17.88 As of December 31, 2020, the weighted average remaining vesting period of restricted stock units was 2.6 years. The weighted average fair value per share at the date of grant for restricted stock units for the years ended December 31, 2020, 2019 and 2018 was $17.13, $20.59 and $16.02, respectively. The total fair value of units vested during the years ended December 31, 2020, 2019 and 2018 was $10.7 million, $7.9 million and $3.6 million, respectively. The fair value of the TSR Units is estimated on the date of grant using a Monte Carlo valuation model that uses the assumptions noted in the table below. The risk-free rate is based on the U.S. Treasury yield curve in effect at the grant date for the expected performance period. Expected volatility is based on historical volatility for the most recent 3-year period ending on the grant date for the Company and the selected peer companies, and is calculated on a daily basis. The following are the key assumptions used in this valuation: 2020 2019 2018 Risk free interest rate 0.17% - 1.63% 1.57% - 2.54% 2.36% - 2.59% Expected stock price volatility 23.80% - 53.17% 23.80% - 28.57% 28.57% - 30.02% Expected service period 2.7 - 3.0 years 2.4 - 3.0 years 2.5 - 3.0 years Expected dividend yield (assuming full reinvestment) — % — % — % During the years ended December 31, 2020, 2019 and 2018, the Company recognized $7.9 million, $9.8 million and $7.6 million, respectively, of stock-based compensation expense included in general and administrative expense in the consolidated statements of income. As of December 31, 2020, there was $20.8 million of total unrecognized stock-based compensation expense related to unvested awards, which is expected to be recognized over a weighted average period of 2.6 years. Employee Benefit Plan The Company maintains a 401(k) plan that allows for eligible participants to defer compensation, subject to certain limitations imposed by the Internal Revenue Code of 1986, as amended (the “Code”). The Company provides a discretionary matching contribution of up to 4% of each participant’s eligible compensation. During each of the years ended December 31, 2020, 2019 and 2018, the Company’s matching contributions were approximately $0.2 million.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. To qualify as a REIT, the Company must meet a number of organizational and operational requirements, including a requirement to distribute at least 90% of its taxable ordinary income. In addition, the Company is required to meet certain asset and income tests. As a REIT, the Company generally will not be subject to corporate level federal income tax on taxable income that it distributes to its stockholders. The Company also elected to treat certain of its consolidated subsidiaries as taxable REIT subsidiaries, which are subject to federal, state and foreign income taxes. As a result of acquisitions in Canada during 2015, the Company is subject to income taxes under the laws of Canada. The Company recorded a $0.6 million, $0.5 million and $0.6 million income tax benefit during the years ended December 31, 2020, 2019 and 2018, respectively, with respect to its Canadian operations. Due to uncertainty over the Company’s ability to utilize this income tax benefit in future periods, the Company recorded a valuation allowance of $0.8 million, $0.5 million and $0.7 million against the deferred tax benefit during the years ended December 31, 2020, 2019 and 2018, respectively.

EARNINGS PER COMMON SHARE

EARNINGS PER COMMON SHARE	12 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
EARNINGS PER COMMON SHARE	EARNINGS PER COMMON SHARE The following table illustrates the computation of basic and diluted earnings per share (in thousands, except share and per share amounts): Year Ended December 31, 2020 2019 2018 Numerator Net income attributable to common stockholders $ 138,417 $ 68,996 $ 269,314 Denominator Basic weighted average common shares and common equivalents 206,223,503 187,172,210 178,305,738 Dilutive stock options and restricted stock units 1,029,327 954,882 416,006 Diluted weighted average common shares 207,252,830 188,127,092 178,721,744 Net income attributable to common stockholders, per: Basic common share $ 0.67 $ 0.37 $ 1.51 Diluted common share $ 0.67 $ 0.37 $ 1.51 During the years ended December 31, 2020, 2019 and 2018, approximately 67,000, 1,000 and 121,000 restricted stock units, respectively, were not included in computing diluted earnings per share because they were considered anti-dilutive. No stock options were outstanding as of December 31, 2020 and 2019, and no stock options were considered anti-dilutive during the year ended December 31, 2018.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Environmental As an owner of real estate, the Company is subject to various environmental laws of federal, state and local governments. The Company is not aware of any environmental liability that could have a material adverse effect on its financial condition or results of operations. However, changes in applicable environmental laws and regulations, the uses and conditions of properties in the vicinity of the Company’s properties, the activities of its tenants and other environmental conditions of which the Company is unaware with respect to the properties could result in future environmental liabilities. As of December 31, 2020, the Company does not expect that compliance with existing environmental laws will have a material adverse effect on the Company’s financial condition and results of operations. Legal Matters From time to time, the Company is party to legal proceedings that arise in the ordinary course of its business. Management is not aware of any legal proceedings where the likelihood of a loss contingency is reasonably possible and the amount or range of reasonably possible losses is material to the Company’s results of operations, financial condition or cash flows.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS The Company evaluates subsequent events up until the date the consolidated financial statements are issued. Dividend Declaration On February 2, 2021, the Company’s board of directors declared a quarterly cash dividend of $0.30 per share of common stock. The dividend will be paid on February 26, 2021 to stockholders of record as of the close of business on February 12, 2021.

SCHEDULE II - VALUATION AND QUA

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
	Dec. 31, 2020
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS For the Years Ended December 31, 2020, 2019 and 2018 (dollars in thousands) Balance at Beginning of Year Charged to Earnings Recoveries Uncollectible Accounts Written-off Balance at End Year ended December 31, 2020 Allowance for loan losses (1) $ 542 $ 1,916 $ — $ — $ 2,458 Allowance for credit losses - sales-type lease (1) 189 (61) — — 128 $ 731 $ 1,855 $ — $ — $ 2,586 Year ended December 31, 2019 Allowance for doubtful accounts (2) $ 3,706 $ — $ — $ (3,706) $ — Straight-line rent receivable allowance (2) 35,778 — — (35,778) — Allowance for loan losses 1,258 1,238 — (1,932) 564 $ 40,742 $ 1,238 $ — $ (41,416) $ 564 Year ended December 31, 2018 Allowance for doubtful accounts $ 5,520 $ 986 $ (2,718) $ (82) $ 3,706 Straight-line rent receivable allowance 12,355 39,646 — (16,223) 35,778 Allowance for loan losses 97 1,161 — — 1,258 $ 17,972 $ 41,793 $ (2,718) $ (16,305) $ 40,742 (1) In conjunction with the adoption of Topic 326 on January 1, 2020, the Company recognized the cumulative effect through an adjustment to equity to increase (decrease) cumulative distributions in excess of net income by ($22,000) and $189,000 for loan loss reserves and allowance for credit losses - sales-type lease, respectively. These amounts are included in the balances at beginning of year for 2020 but are excluded from the balances at end of year for 2019. (2) Balances written-off in connection with the adoption of Topic 842 on January 1, 2019.

SCHEDULE III - REAL ESTATE ASSE

SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION	12 Months Ended
	Dec. 31, 2020
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation Disclosure [Abstract]
SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION	SCHEDULE III REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION As of December 31, 2020 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Skilled Nursing/Transitional Care Facilities Forest Hills (SNF) Broken Arrow, OK 100% (4) $ 1,653 $ 11,259 $ 12,912 $ — $ 1,653 $ 9,409 $ 11,062 $ (3,764) 1994/2008, 2009/2010, 2015 11/15/10 40 Seminole Estates Seminole, OK 100% — 655 3,527 4,182 — 655 3,134 3,789 (1,197) 1987/2020 11/15/10 32 Bedford Hills Bedford, NH 100% 5,595 1,911 12,245 14,156 — 1,911 10,687 12,598 (4,434) 1992/2010, 2019 11/15/10 36 The Elms Care Milford, NH 100% — 312 1,679 1,991 — 312 1,289 1,601 (918) 1890/2005 11/15/10 20 Lake Drive Henryetta, OK 100% — 160 549 709 — 160 40 200 (34) 1968 11/15/10 10 Mineral Springs North Conway, NH 100% 11,334 417 5,352 5,769 — 417 4,580 4,997 (1,890) 1988/2009 11/15/10 43 Wolfeboro Wolfeboro, NH 100% 9,547 454 4,531 4,985 — 454 3,747 4,201 (1,397) 1984/1986, 1987, 2009 11/15/10 41 Broadmeadow Healthcare Middletown, DE 100% — 1,650 21,730 23,380 — 1,650 21,730 23,380 (5,905) 2005 08/01/11 40 Capitol Healthcare Dover, DE 100% — 4,940 15,500 20,440 — 4,940 15,500 20,440 (4,405) 1996/2016 08/01/11 40 Pike Creek Healthcare Wilmington, DE 100% — 2,460 25,240 27,700 — 2,460 25,240 27,700 (6,934) 2009 08/01/11 40 Renaissance Healthcare Millsboro, DE 100% — 1,640 22,620 24,260 — 1,640 22,620 24,260 (6,336) 2008 08/01/11 40 Clara Burke Plymouth Meeting, PA 100% — 2,527 12,453 14,980 179 2,527 12,632 15,159 (3,470) 1927/1990, 2007/2016 03/30/12 40 Warrington Warrington, PA 100% — 2,617 11,662 14,279 106 2,617 11,768 14,385 (2,959) 1958/2009/ 03/30/12 40 Ridgecrest Duffield, VA 100% — 509 5,018 5,527 1,333 509 6,351 6,860 (1,975) 1981/2013 05/10/12 40 Arbrook Plaza Arlington, TX 100% — 3,783 14,219 18,002 — 3,783 14,219 18,002 (3,303) 2003/2012 11/30/12 40 Northgate Plaza Irving, TX 100% — 4,901 10,299 15,200 — 4,901 10,299 15,200 (2,465) 2003/2012, 2015 11/30/12 40 Gulf Pointe Plaza Rockport, TX 100% — 1,005 6,628 7,633 — 1,005 6,628 7,633 (1,667) 2002/2012, 2018 11/30/12 40 Gateway Senior Living Lincoln, NE 100% — 6,368 29,919 36,287 — 6,368 29,919 36,287 (5,824) 1962/1996, 2013 02/14/14 40 Legacy Fremont, NE 100% — 615 16,176 16,791 — 615 16,176 16,791 (3,454) 2008 02/14/14 40 Pointe Fremont, NE 100% — 615 2,943 3,558 — 615 2,943 3,558 (746) 1970/1979, 1983, 1994 02/14/14 40 Regency South Sioux City, NE 100% — 246 6,206 6,452 — 246 6,206 6,452 (1,614) 1962/1968, 1975, 2000, 2004 02/14/14 40 Parkmoor Village Colorado Springs, CO 100% — 430 13,703 14,133 — 430 13,703 14,133 (3,089) 1985/2017, 2018 03/05/14 40 Adams PARC Bartlesville, OK 100% — 1,332 6,904 8,236 115 1,332 7,019 8,351 (1,338) 1989/2019 10/29/14 40 PARCway Oklahoma City, OK 100% — 2,189 23,567 25,756 1,056 2,189 24,623 26,812 (4,405) 1963/1984, 2018, 2019 10/29/14 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Brookhaven Extensive Care Norman, OK 100% — 869 5,236 6,105 109 869 5,345 6,214 (1,134) 2001/2013, 2019 10/29/14 40 Cadia Healthcare of Hyattsville Hyattsville, MD 100% — 6,343 65,573 71,916 14 6,343 65,587 71,930 (10,867) 1950/1976, 2008 06/30/15 40 Cadia Healthcare of Annapolis Annapolis, MD 100% — 1,548 40,773 42,321 103 1,548 40,876 42,424 (6,314) 1964/1993, 2012 06/30/15 40 Cadia Healthcare of Wheaton Wheaton, MD 100% — 676 56,897 57,573 22 676 56,919 57,595 (8,618) 1966/1991, 2012 06/30/15 40 Cadia Healthcare of Hagerstown Hagerstown, MD 100% — 1,475 56,237 57,712 4,733 1,475 60,970 62,445 (8,200) 1950/1953, 1975, 2014, 2019, 2020 11/25/15 40 Cadia Healthcare of Spring Brook Silver Spring, MD 100% — 963 48,085 49,048 7 963 48,092 49,055 (5,945) 1965/2015 07/26/16 40 Andrew Residence Minneapolis, MN 100% — 2,931 6,943 9,874 565 2,931 7,462 10,393 (849) 1941/2014, 2019 08/17/17 40 Avamere Riverpark of Eugene Eugene, OR 100% — 2,205 28,700 30,905 2,252 2,205 30,952 33,157 (3,096) 1988/2016 08/17/17 40 Avamere Rehab of Lebanon Lebanon, OR 100% — 958 14,176 15,134 — 958 14,176 15,134 (1,277) 1974 08/17/17 40 Avamere Crestview of Portland Portland, OR 100% — 1,791 12,833 14,624 2,761 1,791 15,594 17,385 (1,824) 1964/2016 08/17/17 40 Avamere Rehabilitation of King City Tigard, OR 100% — 2,011 11,667 13,678 — 2,011 11,667 13,678 (1,086) 1975 08/17/17 40 Avamere Rehabilitation of Hillsboro Hillsboro, OR 100% — 1,387 14,028 15,415 — 1,387 14,028 15,415 (1,263) 1973 08/17/17 40 Avamere Rehab of Junction City Junction City, OR 100% — 584 7,901 8,485 — 584 7,901 8,485 (738) 1966/2015 08/17/17 40 Avamere Rehab of Eugene Eugene, OR 100% — 1,380 14,921 16,301 1,791 1,380 16,712 18,092 (1,801) 1966/2016 08/17/17 40 Avamere Rehab of Coos Bay Coos Bay, OR 100% — 829 8,518 9,347 — 829 8,518 9,347 (826) 1968 08/17/17 40 Avamere Rehab of Clackamas Gladstone, OR 100% — 792 5,000 5,792 — 792 5,000 5,792 (477) 1961 08/17/17 40 Avamere Rehab of Newport Newport, OR 100% — 406 5,001 5,407 — 406 5,001 5,407 (456) 1973/2014 08/17/17 40 Avamere Rehab of Oregon City Oregon City, OR 100% — 1,496 12,142 13,638 — 1,496 12,142 13,638 (1,093) 1974 08/17/17 40 Avamere Transitional Care of Puget Sound Tacoma, WA 100% — 1,771 11,595 13,366 15 1,771 11,610 13,381 (1,217) 2017 08/17/17 40 Richmond Beach Rehab Shoreline, WA 100% — 4,703 14,444 19,147 — 4,703 14,444 19,147 (1,347) 1993/2014 08/17/17 40 St. Francis of Bellingham Bellingham, WA 100% — — 15,330 15,330 — — 15,330 15,330 (1,442) 1984/2015 08/17/17 40 Avamere Olympic Rehabilitation of Sequim Sequim, WA 100% — 427 4,450 4,877 — 427 4,450 4,877 (502) 1974 08/17/17 40 Avamere Heritage Rehabilitation of Tacoma Tacoma, WA 100% — 1,705 4,952 6,657 — 1,705 4,952 6,657 (487) 1968 08/17/17 40 Avamere at Pacific Ridge Tacoma, WA 100% — 2,195 1,956 4,151 — 2,195 1,956 4,151 (255) 1972/2014 08/17/17 40 Avamere Rehabilitation of Cascade Park Vancouver, WA 100% — 1,782 15,116 16,898 — 1,782 15,116 16,898 (1,473) 1991 08/17/17 40 The Pearl at Kruse Way Lake Oswego, OR 100% — 5,947 13,401 19,348 — 5,947 13,401 19,348 (1,260) 2005/2016 08/17/17 40 Avamere at Medford Medford, OR 100% — 2,043 38,485 40,528 2,960 2,043 41,445 43,488 (4,091) 1974/2016 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Avamere Bellingham Healthcare and Rehab Services Bellingham, WA 100% — 2,908 2,058 4,966 — 2,908 2,058 4,966 (260) 1972/2015 08/17/17 40 Queen Anne Healthcare Seattle, WA 100% — 2,508 6,401 8,909 — 2,508 6,401 8,909 (609) 1970 08/17/17 40 Avamere Transitional Care and Rehab - Boise Boise, ID 100% — 681 9,348 10,029 — 681 9,348 10,029 (890) 1979 08/17/17 40 Avamere Transitional Care at Sunnyside Salem, OR 100% — 2,114 15,651 17,765 — 2,114 15,651 17,765 (1,451) 1981 08/17/17 40 Avamere Health Services of Rogue Valley Medford, OR 100% — 1,375 23,808 25,183 — 1,375 23,808 25,183 (2,227) 1961/2016 08/17/17 40 Avamere Transitional Care and Rehab - Malley Northglenn, CO 100% — 1,662 26,014 27,676 3,258 1,662 29,272 30,934 (3,114) 1972/2016 08/17/17 40 Avamere Transitional Care and Rehab - Brighton Brighton, CO 100% — 1,933 11,624 13,557 200 1,933 11,824 13,757 (1,124) 1971 08/17/17 40 Phoenix Rehabilitation Services Phoenix, AZ 100% — 1,270 11,502 12,772 — 1,270 11,502 12,772 (1,038) 2008 08/17/17 40 Tustin Subacute Care Facility Santa Ana, CA 100% — 1,889 11,682 13,571 — 1,889 11,682 13,571 (1,025) 2008 08/17/17 40 La Mesa Inpatient Rehabilitation Facility La Mesa, CA 100% — 1,276 8,177 9,453 — 1,276 8,177 9,453 (746) 2012 08/17/17 40 Golden Living Center - Westminster Westminster, MD 100% — 2,128 6,614 8,742 487 2,128 7,101 9,229 (913) 1973/2010, 2019 08/17/17 40 Maple Wood Care Center Kansas City, MO 100% — 1,142 3,226 4,368 653 1,142 3,879 5,021 (784) 1983 08/17/17 40 Garden Valley Nursing & Rehab Kansas City, MO 100% — 1,985 2,714 4,699 303 1,985 3,017 5,002 (711) 1983 08/17/17 40 Worthington Nursing & Rehab Parkersburg, WV 100% — 697 10,688 11,385 285 697 10,973 11,670 (1,293) 1974/1999, 2019 08/17/17 40 Burlington House Rehabilitative and Alzheimer’s Care Center Cincinnati, OH 100% — 2,686 10,062 12,748 — 2,686 10,062 12,748 (1,083) 1989/2015 08/17/17 40 Golden Living Center - Charlottesville Charlottesville, VA 100% — 2,840 8,450 11,290 1,176 2,840 9,626 12,466 (1,193) 1964/2009, 2019 08/17/17 40 Golden Living Center - Sleepy Hollow Annandale, VA 100% — 7,241 17,727 24,968 2,032 7,241 19,759 27,000 (2,190) 1963/2013, 2019 08/17/17 40 Golden Living Center - Petersburg Petersburg, VA 100% — 988 8,416 9,404 146 988 8,562 9,550 (922) 1970/2009 08/17/17 40 Golden Living Center - Battlefield Park Petersburg, VA 100% — 1,174 8,858 10,032 151 1,174 9,009 10,183 (955) 1976/2010 08/17/17 40 Golden Living Center - Hagerstown Hagerstown, MD 100% — 1,393 13,438 14,831 150 1,393 13,588 14,981 (1,376) 1971/2010 08/17/17 40 Golden Living Center - Cumberland Cumberland, MD 100% — 800 16,973 17,773 457 800 17,430 18,230 (1,760) 1968 08/17/17 40 Gilroy Healthcare and Rehabilitation Center Gilroy, CA 100% — 662 23,775 24,437 — 662 23,775 24,437 (2,117) 1968 08/17/17 40 North Cascades Health and Rehabilitation Center Bellingham, WA 100% — 1,437 14,196 15,633 — 1,437 14,196 15,633 (1,323) 1999 08/17/17 40 Granite Rehabilitation & Wellness Cheyenne, WY 100% — 387 13,613 14,000 2,246 387 15,859 16,246 (1,806) 1967/2017 08/17/17 40 Rawlins Rehabilitation & Wellness Rawlins, WY 100% — 281 6,007 6,288 — 281 6,007 6,288 (556) 1967 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Wind River Rehabilitation & Wellness Riverton, WY 100% — 199 11,398 11,597 — 199 11,398 11,597 (1,028) 1967 08/17/17 40 Sage View Care Center Rock Springs, WY 100% — 420 8,665 9,085 — 420 8,665 9,085 (815) 1964/2017 08/17/17 40 Shelton Health and Rehabilitation Center Shelton, WA 100% — 415 8,965 9,380 — 415 8,965 9,380 (899) 1998 08/17/17 40 Dundee Nursing Home Bennettsville, SC 100% — 1,437 4,631 6,068 — 1,437 4,631 6,068 (477) 1958 08/17/17 40 Mt. Pleasant Nursing Center Mount Pleasant, SC 100% — 2,689 3,942 6,631 — 2,689 3,942 6,631 (431) 1977/2015 08/17/17 40 Tri-State Comp Care Center Harrogate, TN 100% — 1,811 4,963 6,774 — 1,811 4,963 6,774 (554) 1990/2005 08/17/17 40 Epic-Conway Conway, SC 100% — 1,408 10,784 12,192 — 1,408 10,784 12,192 (1,083) 1975 08/17/17 40 Epic- Bayview Beaufort, SC 100% — 1,842 11,389 13,231 — 1,842 11,389 13,231 (1,110) 1970 08/17/17 40 Focused Care at Baytown Baytown, TX 100% — 479 6,351 6,830 209 479 6,457 6,936 (647) 1970/2019 08/17/17 40 Focused Care at Allenbrook Baytown, TX 100% — 426 3,236 3,662 173 426 3,372 3,798 (429) 1975/2019 08/17/17 40 Focused Care at Huntsville Huntsville, TX 100% — 302 3,153 3,455 75 302 3,201 3,503 (359) 1968/2019 08/17/17 40 Focused Care at Center Center, TX 100% — 231 1,335 1,566 312 231 1,556 1,787 (253) 1972/2019 08/17/17 40 Focused Care at Humble Humble, TX 100% — 2,114 1,643 3,757 596 2,114 2,100 4,214 (389) 1972/2019 08/17/17 40 Focused Care at Beechnut Houston, TX 100% — 1,019 5,734 6,753 318 1,019 5,876 6,895 (628) 1982/2019 08/17/17 40 Focused Care at Linden Linden, TX 100% — 112 256 368 133 112 331 443 (82) 1968/2019 08/17/17 40 Focused Care at Sherman Sherman, TX 100% — 469 6,310 6,779 255 469 6,400 6,869 (663) 1971/2019 08/17/17 40 Focused Care at Mount Pleasant Mount Pleasant, TX 100% — 250 6,913 7,163 345 250 7,249 7,499 (768) 1970/2019 08/17/17 40 Focused Care at Waxahachie Waxahachie, TX 100% — 416 7,259 7,675 582 416 7,789 8,205 (773) 1976/2019 08/17/17 40 Focused Care at Gilmer Gilmer, TX 100% — 707 4,552 5,259 93 707 4,605 5,312 (505) 1990/2019 08/17/17 40 Hearthstone of Northern Nevada Sparks, NV 100% — 1,986 9,004 10,990 — 1,986 9,004 10,990 (902) 1988 08/17/17 40 Golden Living Center - Richmond Richmond, IN 100% — 259 9,819 10,078 131 259 9,950 10,209 (936) 1975/2005 08/17/17 40 Golden Living Center - Petersburg Petersburg, IN 100% — 581 5,367 5,948 23 581 5,390 5,971 (547) 1970/2009 08/17/17 40 Beverly Health - Ft. Pierce Fort Pierce, FL 100% — 787 16,648 17,435 — 787 16,648 17,435 (1,525) 1960/2011 08/17/17 40 Maryville Maryville, MO 100% — 114 5,955 6,069 — 150 5,955 6,105 (625) 1972 08/17/17 40 Ashland Healthcare Ashland, MO 100% — 765 2,669 3,434 — 765 2,669 3,434 (300) 1993 08/17/17 40 Bellefontaine Gardens St. Louis, MO 100% — 2,071 5,739 7,810 — 2,071 5,739 7,810 (645) 1988/1991 08/17/17 40 Current River Nursing Center Doniphan, MO 100% — 657 8,251 8,908 — 657 8,251 8,908 (816) 1991 08/17/17 40 Dixon Nursing & Rehab Dixon, MO 100% — 521 3,358 3,879 — 521 3,358 3,879 (360) 1989/2011 08/17/17 40 Forsyth Nursing & Rehab Forsyth, MO 100% — 594 8,549 9,143 — 594 8,549 9,143 (858) 1993/2007 08/17/17 40 Glenwood Healthcare Seymour, MO 100% — 658 901 1,559 — 658 901 1,559 (126) 1990 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Silex Community Care Silex, MO 100% — 807 4,990 5,797 — 807 4,990 5,797 (508) 1991 08/17/17 40 South Hampton Place Columbia, MO 100% — 2,322 6,547 8,869 — 2,322 6,547 8,869 (677) 1994 08/17/17 40 Strafford Care Center Strafford, MO 100% — 1,634 6,518 8,152 — 1,634 6,518 8,152 (659) 1995 08/17/17 40 Windsor Healthcare & Rehab Windsor, MO 100% — 471 6,819 7,290 — 471 6,819 7,290 (625) 1996 08/17/17 40 Park Manor of Conroe Conroe, TX 100% — 1,222 19,099 20,321 — 1,222 19,099 20,321 (1,711) 2001 08/17/17 40 Park Manor of Cypress Station Houston, TX 100% — 1,334 11,615 12,949 — 1,334 11,615 12,949 (1,084) 2003/2013 08/17/17 40 Park Manor of Humble Humble, TX 100% — 1,541 12,332 13,873 645 1,541 12,977 14,518 (1,306) 2003/2019 08/17/17 40 Park Manor of Quail Valley Missouri City, TX 100% — 1,825 9,681 11,506 — 1,825 9,681 11,506 (939) 2005 08/17/17 40 Park Manor of Westchase Houston, TX 100% — 2,676 7,396 10,072 — 2,676 7,396 10,072 (734) 2005 08/17/17 40 Park Manor of CyFair Houston, TX 100% — 1,732 12,921 14,653 — 1,732 12,921 14,653 (1,197) 1999 08/17/17 40 Park Manor of McKinney McKinney, TX 100% — 1,441 9,017 10,458 — 1,441 9,017 10,458 (911) 1993/2012 08/17/17 40 Tanglewood Health and Rehabilitation Topeka, KS 100% — 176 2,340 2,516 — 176 2,340 2,516 (250) 1973/2013 08/17/17 40 Smoky Hill Health and Rehabilitation Salina, KS 100% — 301 4,201 4,502 — 301 4,201 4,502 (428) 1981 08/17/17 40 Belleville Health Center Belleville, KS 100% — 600 1,664 2,264 — 600 1,664 2,264 (213) 1977 08/17/17 40 Westridge Healthcare Center Terre Haute, IN 100% — 1,067 7,061 8,128 — 1,067 7,061 8,128 (677) 1965/1984 08/17/17 40 Willow Bend Living Center Muncie, IN 100% — 1,168 9,562 10,730 — 1,168 9,562 10,730 (874) 1976/1986 08/17/17 40 Twin City Healthcare Gas City, IN 100% — 345 8,852 9,197 — 345 8,852 9,197 (808) 1974 08/17/17 40 Pine Knoll Rehabilitation Center Winchester, IN 100% — 711 5,554 6,265 — 711 5,554 6,265 (535) 1986/1998 08/17/17 40 Willow Crossing Health & Rehab Center Columbus, IN 100% — 1,290 10,714 12,004 — 1,290 10,714 12,004 (983) 1988/2004 08/17/17 40 Persimmon Ridge Center Portland, IN 100% — 315 9,848 10,163 — 315 9,848 10,163 (917) 1964 08/17/17 40 Vermillion Convalescent Center Clinton, IN 100% — 884 9,839 10,723 — 884 9,839 10,723 (962) 1971 08/17/17 40 Las Vegas Post Acute & Rehabilitation Las Vegas, NV 100% — 509 18,216 18,725 — 509 18,216 18,725 (1,598) 1964 08/17/17 40 Torey Pines Rehabilitation Hospital Las Vegas, NV 100% — 3,169 7,863 11,032 — 3,169 7,863 11,032 (777) 1972/1997 08/17/17 40 Villa Campana Rehabilitation Hospital Tucson, AZ 100% — 1,800 4,387 6,187 1,131 1,800 5,518 7,318 (591) 1983/2011, 2020 08/17/17 40 Kachina Point Rehabilitation Hospital Sedona, AZ 100% — 2,035 10,981 13,016 714 2,035 11,695 13,730 (1,136) 1984/2011 08/17/17 40 Bay View Rehabilitation Hospital Alameda, CA 100% — 3,078 22,328 25,406 — 3,078 22,328 25,406 (2,003) 1967 08/17/17 40 Dover Center for Health & Rehabilitation Dover, NH 100% — 522 5,839 6,361 — 522 5,839 6,361 (729) 1969/1992, 2017 08/17/17 40 Augusta Center for Health & Rehabilitation Augusta, ME 100% — 135 6,470 6,605 — 135 6,470 6,605 (635) 1967 08/17/17 40 Eastside Center for Health & Rehabilitation Bangor, ME 100% — 302 1,811 2,113 2,112 302 3,923 4,225 (281) 1967/1993, 2019 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Winship Green Center for Health & Rehabilitation Bath, ME 100% — 250 1,934 2,184 — 250 1,934 2,184 (212) 1974 08/17/17 40 Brewer Center for Health & Rehabilitation Brewer, ME 100% — 177 14,497 14,674 2,436 177 16,933 17,110 (1,450) 1974/1990, 2019 08/17/17 40 Kennebunk Center for Health & Rehabilitation Kennebunk, ME 100% — 198 6,822 7,020 76 198 6,898 7,096 (659) 1977 08/17/17 40 Norway Center for Health & Rehabilitation Norway, ME 100% — 791 3,680 4,471 — 791 3,680 4,471 (384) 1976 08/17/17 40 Brentwood Center for Health & Rehabilitation Yarmouth, ME 100% — 134 2,072 2,206 — 134 2,072 2,206 (232) 1952 08/17/17 40 Country Center for Health & Rehabilitation Newburyport, MA 100% — 269 4,436 4,705 — 269 4,436 4,705 (575) 1968/2009 08/17/17 40 Sachem Center for Health & Rehabilitation E. Bridgewater, MA 100% — 447 1,357 1,804 — 447 1,357 1,804 (216) 1968 08/17/17 40 Eliot Center for Health & Rehabilitation Natick, MA 100% — 475 1,491 1,966 — 475 1,491 1,966 (204) 1964 08/17/17 40 The Reservoir Center for Health & Rehabilitation Marlborough, MA 100% — 942 1,541 2,483 8,727 942 10,268 11,210 (1,276) 1973/2018 08/17/17 40 Newton Wellesley Center for Alzheimer’s Care Wellesley, MA 100% — 1,186 13,917 15,103 — 1,186 13,917 15,103 (1,277) 1971 08/17/17 40 Colony Center for Health & Rehabilitation Abington, MA 100% — 1,727 2,103 3,830 — 1,727 2,103 3,830 (268) 1965 08/17/17 40 Westgate Center for Rehab & Alzheimer’s Care Bangor, ME 100% — 229 7,171 7,400 203 229 7,374 7,603 (716) 1969/1993 08/17/17 40 New Orange Hills Orange, CA 100% — 4,163 14,755 18,918 — 4,163 14,755 18,918 (1,390) 1987/2020 08/17/17 40 Millbrook Healthcare & Rehabilitation Center Lancaster, TX 100% — 548 5,794 6,342 — 548 5,794 6,342 (600) 2008 08/17/17 40 Pleasant Valley Health & Rehab Garland, TX 100% — 1,118 7,490 8,608 — 1,118 7,490 8,608 (739) 2008 08/17/17 40 Focused Care at Clarksville Clarksville, TX 100% — 279 4,269 4,548 100 279 4,369 4,648 (496) 1989/2019 08/17/17 40 McKinney Healthcare & Rehab McKinney, TX 100% — 1,272 6,047 7,319 — 1,272 6,047 7,319 (641) 2006 08/17/17 40 Golden Living Center - Hopkins Hopkins, MN 100% — 807 4,668 5,475 530 807 5,198 6,005 (672) 1961/2008, 2019 08/17/17 40 Golden Living Center - Florence Florence, WI 100% — 291 3,778 4,069 — 291 3,778 4,069 (418) 1970 08/17/17 40 Golden Living Center - South Shore St. Francis, WI 100% — 166 1,887 2,053 — 166 1,887 2,053 (217) 1960/1997 08/17/17 40 Golden Living Center - Rochester East Rochester, MN 100% — 645 7,067 7,712 178 645 7,245 7,890 (727) 1967/2011, 2019 08/17/17 40 Golden Living Center - Wisconsin Dells Wisconsin Dells, WI 100% — 1,640 1,599 3,239 — 1,640 1,599 3,239 (238) 1972/2006 08/17/17 40 Golden Living Center - Sheboygan Sheboygan, WI 100% — 1,038 2,839 3,877 — 1,038 2,839 3,877 (358) 1967/2012 08/17/17 40 Golden Living Center - Hendersonville Hendersonville, NC 100% — 1,611 3,503 5,114 — 1,611 3,503 5,114 (407) 1979 08/17/17 40 Focused Care at Corpus Corpus Christi, TX 100% — 366 6,961 7,327 127 51 1,061 1,112 (373) 1973/2010 08/17/17 40 Focused Care at Burnet Bay Baytown, TX 100% — 579 22,317 22,896 103 579 22,420 22,999 (2,022) 2000/2013 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Focused Care at Cedar Bayou Baytown, TX 100% — 589 20,475 21,064 328 589 20,803 21,392 (1,952) 2008 08/17/17 40 Focused Care at Westwood Houston, TX 100% — 1,300 13,353 14,653 31 1,300 13,384 14,684 (1,298) 2006 08/17/17 40 Focused Care at Pasadena Pasadena, TX 100% — 1,148 23,579 24,727 38 1,148 23,617 24,765 (2,170) 2004 08/17/17 40 Focused Care at Webster Webster, TX 100% — 904 10,315 11,219 24 904 10,339 11,243 (1,027) 2000/2009 08/17/17 40 Focused Care at Summer Place Beaumont, TX 100% — 945 20,424 21,369 253 945 20,677 21,622 (1,875) 2009 08/17/17 40 Focused Care at Orange Orange, TX 100% — 711 10,737 11,448 171 711 10,908 11,619 (1,034) 2006 08/17/17 40 Signature Healthcare of Whitesburg Gardens Huntsville, AL 100% — 634 28,071 28,705 — 634 28,071 28,705 (2,479) 1968/2012 08/17/17 40 Signature Healthcare of Terre Haute Terre Haute, IN 100% — 644 37,451 38,095 — 644 37,451 38,095 (3,716) 1996/2013 08/17/17 40 Signature Healthcare at Larkin Springs Madison, TN 100% — 902 3,850 4,752 — 902 3,850 4,752 (465) 1969/2016 08/17/17 40 Signature Healthcare of Savannah Savannah, GA 100% — 1,235 3,765 5,000 — 1,235 3,765 5,000 (476) 1970/2015 08/17/17 40 Signature Healthcare of Bluffton Bluffton, IN 100% — 254 5,105 5,359 — 254 5,105 5,359 (549) 1970/2015 08/17/17 40 Signature Healthcare of Bowling Green Bowling Green, KY 100% — 280 13,975 14,255 — 280 13,975 14,255 (1,364) 1970/2015 08/17/17 40 Oakview Nursing and Rehabilitation Center Calvert City, KY 100% — 1,176 7,012 8,188 — 1,176 7,012 8,188 (727) 1962/2015 08/17/17 40 Fountain Circle Care and Rehabilitation Center Winchester, KY 100% — 554 13,207 13,761 — 554 13,207 13,761 (1,316) 1967/2015 08/17/17 40 Riverside Care & Rehabilitation Center Calhoun, KY 100% — 613 7,643 8,256 — 613 7,643 8,256 (814) 1963/2015 08/17/17 40 Signature Healthcare of Bremen Bremen, IN 100% — 173 7,393 7,566 — 173 7,393 7,566 (720) 1982/2015 08/17/17 40 Signature Healthcare of Muncie Muncie, IN 100% — 374 27,429 27,803 — 374 27,429 27,803 (2,476) 1980/2013 08/17/17 40 Signature Healthcare at Parkwood Lebanon, IN 100% — 612 11,755 12,367 — 612 11,755 12,367 (1,124) 1977/2012 08/17/17 40 Signature Healthcare at Tower Road Marietta, GA 100% — 364 16,116 16,480 — 364 16,116 16,480 (1,580) 1969/2015 08/17/17 40 Danville Centre for Health and Rehabilitation Danville, KY 100% — 790 9,356 10,146 — 790 9,356 10,146 (1,075) 1962/2015 08/17/17 40 Signature Healthcare at Hillcrest Owensboro, KY 100% — 1,048 22,587 23,635 — 1,048 22,587 23,635 (2,118) 1963/2011 08/17/17 40 Signature Healthcare of Elizabethtown Elizabethtown, KY 100% — 239 4,853 5,092 — 239 4,853 5,092 (509) 1969 08/17/17 40 Signature Healthcare of Primacy Memphis, TN 100% — 1,633 9,371 11,004 — 1,633 9,371 11,004 (962) 1981/2015 08/17/17 40 Signature Healthcare of Harbour Pointe Norfolk, VA 100% — 705 16,451 17,156 — 705 16,451 17,156 (1,746) 1969/2015 08/17/17 40 Harrodsburg Health & Rehabilitation Center Harrodsburg, KY 100% — 1,049 9,851 10,900 — 1,049 9,851 10,900 (1,077) 1975/2016 08/17/17 40 Signature Healthcare of Putnam County Cookeville, TN 100% — 1,034 15,555 16,589 — 1,034 15,555 16,589 (1,493) 1979/2016 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Signature Healthcare of Fayette County Washington Court House, OH 100% — 405 4,839 5,244 — 405 4,839 5,244 (551) 1984/2015 08/17/17 40 Signature Healthcare of Galion Galion, OH 100% — 836 668 1,504 — 836 668 1,504 (124) 1967/1985 08/17/17 40 Signature Healthcare of Roanoke Rapids Roanoke Rapids, NC 100% — 373 10,308 10,681 — 373 10,308 10,681 (1,088) 1967/2015 08/17/17 40 Signature Healthcare of Kinston Kinston, NC 100% — 954 7,987 8,941 — 954 7,987 8,941 (945) 1960/2015 08/17/17 40 Signature Healthcare of Chapel Hill Chapel Hill, NC 100% — 809 2,703 3,512 302 809 3,005 3,814 (460) 1984/2015 08/17/17 40 Signature Healthcare of Chillicothe Chillicothe, OH 100% — 260 8,924 9,184 — 260 8,924 9,184 (972) 1974/2015 08/17/17 40 Signature Healthcare of Coshocton Coshocton, OH 100% — 374 2,530 2,904 — 374 2,530 2,904 (373) 1974/2015 08/17/17 40 McCreary Health & Rehabilitation Center Pine Knot, KY 100% — 208 7,665 7,873 — 208 7,665 7,873 (760) 1990 08/17/17 40 Colonial Health & Rehabilitation Center Bardstown, KY 100% — 634 4,094 4,728 — 634 4,094 4,728 (474) 1968/2010 08/17/17 40 Glasgow Health & Rehabilitation Center Glasgow, KY 100% — 83 2,057 2,140 — 83 2,057 2,140 (288) 1968 08/17/17 40 Green Valley Health & Rehabilitation Center Carrollton, KY 100% — 124 1,693 1,817 — 124 1,693 1,817 (249) 1978/2016 08/17/17 40 Hart County Health & Rehabilitation Horse Cave, KY 100% — 208 7,070 7,278 — 208 7,070 7,278 (765) 1993 08/17/17 40 Heritage Hall Health & Rehabilitation Center Lawrenceburg, KY 100% — 635 9,861 10,496 — 635 9,861 10,496 (992) 1973 08/17/17 40 Jackson Manor Annville, KY 100% — 479 6,078 6,557 — 479 6,078 6,557 (599) 1989 08/17/17 40 Jefferson Manor Louisville, KY 100% — 3,528 4,653 8,181 — 3,528 4,653 8,181 (574) 1982/2012 08/17/17 40 Jefferson Place Louisville, KY 100% — 2,207 20,733 22,940 — 2,207 20,733 22,940 (1,928) 1991/2010 08/17/17 40 Monroe Health & Rehabilitation Center Tompkinsville, KY 100% — 333 9,556 9,889 — 333 9,556 9,889 (950) 1969 08/17/17 40 North Hardin Health & Rehabilitation Center Radcliff, KY 100% — 1,815 7,470 9,285 — 1,815 7,470 9,285 (941) 1986 08/17/17 40 Professional Care Health & Rehabilitation Center Hartford, KY 100% — 312 8,189 8,501 — 312 8,189 8,501 (832) 1967 08/17/17 40 Rockford Health & Rehabilitation Center Louisville, KY 100% — 427 6,003 6,430 — 427 6,003 6,430 (650) 1975/2005 08/17/17 40 Summerfield Health & Rehabilitation Center Louisville, KY 100% — 1,134 9,166 10,300 — 1,134 9,166 10,300 (1,018) 1979/2013 08/17/17 40 Tanbark Senior Living Lexington, KY 100% — 2,558 4,311 6,869 — 2,558 4,311 6,869 (521) 1989 08/17/17 40 Summit Manor Health & Rehabilitation Center Columbia, KY 100% — 114 11,141 11,255 — 114 11,141 11,255 (1,084) 1965 08/17/17 40 Belle View Estates Rehabilitation and Care Center Monticello, AR 100% — 206 3,179 3,385 — 206 3,179 3,385 (371) 1995 08/17/17 40 River Chase Rehabilitation and Care Center Morrilton, AR 100% — 508 — 508 — 508 — 508 — 1988/2019 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Heartland Rehabilitation and Care Center Benton, AR 100% — 1,336 7,386 8,722 — 1,336 7,386 8,722 (786) 1992 08/17/17 40 River Ridge Rehabilitation and Care Center Wynne, AR 100% — 227 4,007 4,234 — 227 4,007 4,234 (431) 1990 08/17/17 40 Brookridge Cove Rehabilitation and Care Center Morrilton, AR 100% — 412 2,642 3,054 — 466 2,642 3,108 (349) 1996 08/17/17 40 Southern Trace Rehabilitation and Care Center Bryant, AR 100% — 819 8,938 9,757 — 819 8,938 9,757 (847) 1989/2015 08/17/17 40 Lake Village Rehabilitation and Care Center Lake Village, AR 100% — 507 4,838 5,345 — 507 4,838 5,345 (526) 1998 08/17/17 40 Savannah Specialty Care Center Savannah, GA 100% — 2,194 11,711 13,905 — 2,194 11,711 13,905 (1,095) 1972 08/17/17 40 Pettigrew Rehabilitation Center Durham, NC 100% — 470 9,633 10,103 — 470 9,633 10,103 (892) 1968/2006 08/17/17 40 Sunnybrook Rehabilitation Center Raleigh, NC 100% — 1,155 11,749 12,904 — 1,155 11,749 12,904 (1,114) 1971 08/17/17 40 Raleigh Rehabilitation Center Raleigh, NC 100% — 926 17,649 18,575 — 926 17,649 18,575 (1,645) 1967/2007 08/17/17 40 Cypress Pointe Rehabilitation Center Wilmington, NC 100% — 611 5,051 5,662 — 611 5,051 5,662 (534) 1966/2013 08/17/17 40 Silas Creek Rehabilitation Center Winston-Salem, NC 100% — 879 3,283 4,162 — 879 3,283 4,162 (396) 1965 08/17/17 40 Lincolnton Rehabilitation Center Lincolnton, NC 100% — — 9,967 9,967 — — 9,967 9,967 (949) 1976 08/17/17 40 Rehabilitation and Nursing Center of Monroe Monroe, NC 100% — 166 5,906 6,072 — 166 5,906 6,072 (626) 1963/2005 08/17/17 40 Guardian Care of Zebulon Zebulon, NC 100% — 594 8,559 9,153 — 594 8,559 9,153 (782) 1973/2010 08/17/17 40 Guardian Care of Rocky Mount Rocky Mount, NC 100% — — 18,314 18,314 — — 18,314 18,314 (1,644) 1975 08/17/17 40 San Pedro Manor San Antonio, TX 100% — 671 2,504 3,175 — 671 2,504 3,175 (302) 1986 08/17/17 40 Park Manor Health Care & Rehabilitation DeSoto, TX 100% — 942 6,033 6,975 — 942 6,033 6,975 (629) 1987 08/17/17 40 Avalon Place - Trinity Trinity, TX 100% — 363 3,852 4,215 — 363 3,852 4,215 (432) 1985/2019 08/17/17 40 Avalon Place - Kirbyville Kirbyville, TX 100% — 208 5,809 6,017 — 208 5,809 6,017 (624) 1987 08/17/17 40 Heritage House of Marshall Marshall, TX 100% — 732 4,288 5,020 — 732 4,288 5,020 (474) 2008 08/17/17 40 Autumn Woods Residential Health Care Facility Warren, MI 100% — 2,052 25,539 27,591 — 2,052 25,539 27,591 (2,636) 1961/2001 08/17/17 40 Autumn View Health Care Facility Hamburg, NY 100% — 1,026 54,086 55,112 — 1,026 54,086 55,112 (4,881) 1983/2014 08/17/17 40 Brookhaven Health Care Facility East Patchogue, NY 100% — 2,181 30,373 32,554 — 2,181 30,373 32,554 (2,883) 1988/2011 08/17/17 40 Harris Hill Nursing Facility Williamsville, NY 100% — 1,122 46,413 47,535 — 1,122 46,413 47,535 (4,112) 1992/2007 08/17/17 40 Garden Gate Health Care Facility Cheektowaga, NY 100% — 1,164 29,905 31,069 — 1,164 29,905 31,069 (2,808) 1979/2006 08/17/17 40 Initial Cost to Company Cost Capitalized Subsequent to Acquisition Gross Amount at which Carried at Close of Period Life on Which Depreciation in Latest Income Statement is Computed Description Location Ownership Percentage Encum- brances (1) Land Building and Improve- ments (2)(3) Total Land Building and Improve- ments (2)(3) Total Accumulated Depreciation and Amortization Original Date of Construction/ Renovation Date Acquired Northgate Health Care Facility North Tonawanda, NY 100% — 830 29,488 30,318 — 830 29,488 30,318 (2,768) 1982/2007 08/17/17 40 Seneca Health Care Center West Seneca, NY 100% — 1,325 26,839 28,164 — 1,325 26,839 28,164 (2,473) 1974/2008 08/17/17 40 Blueberry Hill Rehab and Healthcare Center Beverly, MA 100% — 2,410 13,588 15,998 — 2,410 13,588 15,998 (1,684) 1965/2015 08/17/17 40 River Terrace Rehabilitation and Healthcare Center Lancaster, MA 100% — 343 7,733 8,076 — 343 7,73

SCHEDULE IV - MORTGAGE LOANS ON

SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE	12 Months Ended
	Dec. 31, 2020
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract]
SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE	SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE As of December 31, 2020 (dollars in thousands) Description Contractual Interest Rate Maturity Date Periodic Payment Terms Prior Liens Principal Balance Book Value (1) Principal Amount of Loans Subject to Delinquent Principal or Interest Mortgages: River Vista 10.0 % 2027 (2) $ — $ 19,000 $ 19,000 N/A Construction Mortgages: Arlington 8.0 2022 (3) — 3,343 3,352 N/A $ — $ 22,343 $ 22,352 (1) The aggregate cost for federal income tax purposes was $22.5 million as of December 31, 2020. (2) Interest is due monthly, and principal is due at the maturity date. (3) Interest and principal for the first 36 months is deferred and due at the maturity date. Interest after the first 36 months is due monthly. Changes in mortgage loans are summarized as follows: Year Ended December 31, 2020 2019 2018 Balance at the beginning of the year $ 21,468 $ 23,146 $ 16,033 Additions during period: Draws 706 1,689 10,943 Interest income added to principal 169 194 1,528 Deductions during period: Paydowns/repayments — (3,561) (5,358) Balance at the end of the year $ 22,343 $ 21,468 $ 23,146

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	The accompanying consolidated financial statements include the accounts of Sabra and its wholly owned subsidiaries as of December 31, 2020 and 2019 and for the years ended December 31, 2020, 2019 and 2018. All significant intercompany transactions and balances have been eliminated in consolidation. The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
Variable Interest Entities	GAAP requires the Company to identify entities for which control is achieved through voting rights or other means and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity’s activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity’s activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity’s activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. If the Company were determined to be the primary beneficiary of the VIE, the Company would consolidate investments in the VIE. The Company may change its original assessment of a VIE due to events such as modifications of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk and the disposal of all or a portion of an interest held by the primary beneficiary. The Company identifies the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company performs this analysis on an ongoing basis. As of December 31, 2020, the Company determined that it was not the primary beneficiary of any VIEs. As it relates to investments in loans, in addition to the Company’s assessment of VIEs and whether the Company is the primary beneficiary of those VIEs, the Company evaluates the loan terms and other pertinent facts to determine whether the loan investment should be accounted for as a loan or as a real estate joint venture. If an investment has the characteristics of a real estate joint venture, including if the Company participates in the majority of the borrower’s expected residual profit, the Company would account for the investment as an investment in a real estate joint venture and not as a loan investment. Expected residual profit is defined as the amount of profit, whether called interest or another name, such as an equity kicker, above a reasonable amount of interest and fees expected to be earned by a lender. At December 31, 2020 and 2019, none of the Company’s investments in loans were accounted for as real estate joint ventures. As it relates to investments in joint ventures, the Company assesses any limited partners’ rights and their impact on the presumption of control of the limited partnership by any single partner. The Company also applies this guidance to managing member interests in limited liability companies. The Company reassesses its determination of which entity controls the joint venture if: there is a change to the terms or in the exercisability of the rights of any partners or members, the sole general partner or managing member increases or decreases its ownership interests, or there is an increase or decrease in the number of outstanding ownership interests. As of December 31, 2020, the Company’s determination of which entity controls its investments in joint ventures has not changed as a result of any reassessment.
Use of Estimates	The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
Reclassifications	Certain amounts in the Company’s consolidated statements of income for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations.
Real Estate Investments	Real Estate Acquisition Valuation All assets acquired and liabilities assumed in an acquisition of real estate accounted for as a business combination are measured at their acquisition date fair values. For acquisitions of real estate accounted for as an asset acquisition, the fair value of consideration transferred by the Company (including transaction costs) is allocated to all assets acquired and liabilities assumed on a relative fair value basis. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of above market lease, tenant origination and absorption costs and tenant relationship intangible assets is included in lease intangible assets, net on the accompanying consolidated balance sheets. The acquisition value of below market lease intangible liabilities is included in lease intangible liabilities, net on the accompanying consolidated balance sheets. Acquisition costs associated with real estate acquisitions deemed asset acquisitions are capitalized, and costs associated with real estate acquisitions deemed business combinations are expensed as incurred. Restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the Company’s evaluation of the specific characteristics of each tenant’s lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income. Depreciation and Amortization Real estate costs related to the acquisition and improvement of properties are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term of any property subject to a ground lease. Tenant improvements are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of tenant origination and absorption costs and tenant relationship lease intangibles are included in depreciation and amortization on the accompanying consolidated statements of income. Amortization of above and below market lease intangibles is included in rental income on the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, five five 40 years; and furniture and equipment, three Impairment of Real Estate Investments The Company regularly monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate investments may not be recoverable or realized. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through the future cash flows and the eventual disposition of the investment. In some instances, there may be various potential outcomes for an investment and its potential future cash flows. In these instances, the future cash flows used to assess recoverability are based on several assumptions and are probability-weighted based on the Company’s best estimates as of the date of evaluation. These assumptions include, among others, cash flow projections, holding period, market capitalization rates, and letters of intent, purchase and sale agreements and recent sales data for comparable properties. When necessary, a discount rate assumption may be used to determine fair value. The assumptions are generally based on management’s experience in its local real estate markets, and the effects of current market conditions, which are subject to economic and market uncertainties. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments.
Real Estate Investments, Inventory	Real Estate Acquisition Valuation All assets acquired and liabilities assumed in an acquisition of real estate accounted for as a business combination are measured at their acquisition date fair values. For acquisitions of real estate accounted for as an asset acquisition, the fair value of consideration transferred by the Company (including transaction costs) is allocated to all assets acquired and liabilities assumed on a relative fair value basis. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of above market lease, tenant origination and absorption costs and tenant relationship intangible assets is included in lease intangible assets, net on the accompanying consolidated balance sheets. The acquisition value of below market lease intangible liabilities is included in lease intangible liabilities, net on the accompanying consolidated balance sheets. Acquisition costs associated with real estate acquisitions deemed asset acquisitions are capitalized, and costs associated with real estate acquisitions deemed business combinations are expensed as incurred. Restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the Company’s evaluation of the specific characteristics of each tenant’s lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income. Depreciation and Amortization Real estate costs related to the acquisition and improvement of properties are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term of any property subject to a ground lease. Tenant improvements are capitalized and amortized on a straight-line basis over the lesser of the expected useful life of the asset and the remaining lease term. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of tenant origination and absorption costs and tenant relationship lease intangibles are included in depreciation and amortization on the accompanying consolidated statements of income. Amortization of above and below market lease intangibles is included in rental income on the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, five five 40 years; and furniture and equipment, three Impairment of Real Estate Investments The Company regularly monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate investments may not be recoverable or realized. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through the future cash flows and the eventual disposition of the investment. In some instances, there may be various potential outcomes for an investment and its potential future cash flows. In these instances, the future cash flows used to assess recoverability are based on several assumptions and are probability-weighted based on the Company’s best estimates as of the date of evaluation. These assumptions include, among others, cash flow projections, holding period, market capitalization rates, and letters of intent, purchase and sale agreements and recent sales data for comparable properties. When necessary, a discount rate assumption may be used to determine fair value. The assumptions are generally based on management’s experience in its local real estate markets, and the effects of current market conditions, which are subject to economic and market uncertainties. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments.
Revenue Recognition	Revenue Recognition The Company recognizes rental revenue from tenants, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, on a straight-line basis over the term of the related leases when it is probable that substantially all rents over the life of a lease are collectible. Certain of the Company’s leases provide for contingent rents equal to a percentage of the facility’s revenue in excess of specified base amounts or other thresholds. Such revenue is recognized when actual results reported by the tenant, or estimates of tenant results, exceed the applicable base amount or other threshold. The Company assesses the collectability of rents on a lease-by-lease basis, and in doing so, considers such things as historical bad debts, tenant creditworthiness, current economic trends, facility operating performance, lease structure, credit enhancements (including guarantees), current developments relevant to a tenant’s business specifically and to its business category generally, and changes in tenants’ payment patterns. The Company’s assessment includes an estimation of a tenant’s ability to fulfill all of its rental obligations over the remaining lease term. In addition, with respect to tenants in bankruptcy, management makes estimates of the expected recovery of pre-petition and post-petition claims in assessing the estimated collectability of the related receivable. If at any time the Company cannot determine that it is probable that substantially all rents over the life of a lease are collectible, rental revenue will be recognized only to the extent of payments received, and all receivables associated with the lease will be written off irrespective of amounts expected to be collectible. Any recoveries of these amounts will be recorded in future periods upon receipt of payment. Write-offs of receivables and any recoveries of previously written-off receivables are recorded as adjustments to rental revenue.
Government Grants	Government assistance provided to the Company in the form of an income grant, which is not related to long-lived assets and is not required to be repaid, is recognized as grant income when there is reasonable assurance that the grant will be received and the Company will comply with any conditions associated with the grant. Additionally, grants are recognized over the periods in which the Company recognizes the qualifying expenses and/or lost income for which the grants are intended to compensate.
Assets Held for Sale, DIspositions and Discontinued Operations	The Company generally considers real estate to be “held for sale” when the following criteria are met: (i) management commits to a plan to sell the property, (ii) the property is available for sale immediately, (iii) the property is actively being marketed for sale at a price that is reasonable in relation to its current fair value, (iv) the sale of the property within one year is considered probable and (v) significant changes to the plan to sell are not expected. Real estate that is held for sale and its related assets are classified as assets held for sale and are included in accounts receivable, prepaid expenses and other assets, net on the accompanying consolidated balance sheets. Secured indebtedness and other liabilities related to real estate held for sale are classified as liabilities related to assets held for sale and are included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets. Real estate classified as held for sale is no longer depreciated and is reported at the lower of its carrying value or its estimated fair value less estimated costs to sell. As of December 31, 2020 and 2019, the Company did not have any assets held for sale. For sales of real estate where the Company has collected the consideration to which it is entitled in exchange for transferring the real estate, the related assets and liabilities are removed from the balance sheet and the resultant gain or loss is recorded in the period in which the transaction closes. Any post-sale involvement is accounted for as separate performance obligations, and when the separate performance obligations are satisfied, the portion of the sales price allocated to each such obligation is recognized.
Investment in Unconsolidated Joint Venture and Preferred Equity Investments and Preferred Return	The Company reports investments in unconsolidated entities over whose operating and financial policies it has the ability to exercise significant influence under the equity method of accounting. Under this method of accounting, the Company’s share of the investee’s earnings or losses is included in the Company’s consolidated statements of income. The initial carrying value of the investment is based on the amount paid to purchase the joint venture interest. Differences between the Company’s cost basis and the basis reflected at the joint venture level are generally amortized over the lives of the related assets and liabilities, and such amortization is included in the Company’s share of earnings of the joint venture. In addition, distributions received from unconsolidated entities are classified based on the nature of the activity or activities that generated the distribution. The Company regularly monitors events and changes in circumstances that could indicate that the carrying amounts of its equity method investments may not be recoverable or realized. When indicators of potential impairment are identified, the Company evaluates its equity method investments for impairment based on a comparison of the fair value of the investment to its carrying value. The fair value is estimated based on discounted cash flows that include all estimated cash inflows and outflows over a specified holding period and any estimated debt premiums or discounts. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its equity method investment, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its equity method investment. Preferred equity investments are accounted for at unreturned capital contributions, plus accrued and unpaid preferred returns. The Company recognizes preferred return income on a monthly basis based on the outstanding investment including any previously accrued and unpaid return. As a preferred member of the preferred equity joint ventures in which the Company participates, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to currently pay the accrued preferred return. The Company regularly monitors events and changes in circumstances that could indicate that the carrying amounts of its preferred equity investments may not be recoverable or realized. On a quarterly basis, the Company evaluates its preferred equity investments for impairment based on a comparison of the fair value of the investment to its carrying value. The fair value is estimated based on discounted cash flows that include all estimated cash inflows and outflows over a specified holding period. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its preferred equity investment, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its preferred equity investment.
Loans Receivable and Interest Income	Loans Receivable The Company’s loans receivable are reflected at amortized cost on the accompanying consolidated balance sheets. The amortized cost of a loan receivable is the outstanding unpaid principal balance, net of unamortized discounts, costs and fees directly associated with the origination of the loan. Loans acquired in connection with a business combination are recorded at their acquisition date fair value. The Company determines the fair value of loans receivable based on estimates of expected discounted cash flows, collateral, credit risk and other factors. The Company does not establish a valuation allowance at the acquisition date, as the amount of estimated future cash flows reflects its judgment regarding their uncertainty. The Company recognizes the difference between the acquisition date fair value and the total expected cash flows as interest income using the effective interest method over the life of the applicable loan. The Company immediately recognizes in income any unamortized balances if the loan is repaid before its contractual maturity. On a quarterly basis, the Company evaluates the collectability of its loan portfolio, including the portion of unfunded loan commitments expected to be funded, and establishes an allowance for credit losses. The allowance for credit losses is calculated using the related amortization schedules, payment histories and loan-to-value ratios. The following rates are applied to determine the aggregate expected losses, which is recorded as the allowance for credit losses: (i) a default rate, (ii) a liquidation cost rate and (iii) a distressed property reduction rate. If no loan-to-value ratio is available, a loss severity rate is applied in place of the liquidation cost rate and the distressed property reduction rate. The default rate is based on average charge-off and delinquency rates from the Federal Reserve, and the other rates are based on industry research and historical performance of a similar portfolio of financial assets. The allowance for credit losses is a valuation allowance that reflects management’s estimate of losses inherent in the loan portfolio as of the balance sheet date. The reserve is adjusted through provision for loan losses and other reserves on the Company’s consolidated statements of income and is decreased by charge-offs to specific loans when losses are confirmed. Interest Income Interest income on the Company’s loans receivable is recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination costs are amortized over the term of the loan as an adjustment to interest income. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on nonaccrual status, and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines that the collection of interest according to the contractual terms of the loan or through the receipts of assets in satisfaction of contractual amounts due is probable, the Company will resume the accrual of interest. In instances where borrowers are in default under the terms of their loans, the Company may continue recognizing interest income provided that all amounts owed under the contractual terms of the loan, including accrued and unpaid interest, do not exceed the estimated fair value of the collateral, less costs to sell. On a quarterly basis, the Company evaluates the collectability of its interest income receivable and establishes a reserve for amounts not expected to be collected. The Company’s evaluation includes reviewing credit quality indicators such as payment status, changes affecting the operations of the facilities securing the loans, and national and regional economic factors. The reserve is a valuation allowance that reflects management’s estimate of losses inherent in the interest income receivable balance as of the balance sheet date. The reserve is adjusted through provision for loan losses and other reserves on the Company’s consolidated statements of income and is decreased by charge-offs to specific receivables when losses are confirmed.
Cash and Cash Equivalents	The Company considers all short-term (with an original maturity of three months or less), highly-liquid investments utilized as part of the Company’s cash-management activities to be cash equivalents. Cash equivalents may include cash and short-term investments. Short-term investments are stated at cost, which approximates fair value. The Company’s cash and cash equivalents balance exceeded federally insurable limits as of December 31, 2020. To date, the Company has experienced no loss or lack of access to cash in its operating accounts. The Company has a corporate banking relationship with Bank of America, N.A. in which it deposits the majority of its cash.
Restricted Cash	Restricted cash primarily consists of amounts held by an exchange accommodation titleholder or by secured debt lenders to provide for future real estate tax expenditures, tenant improvements and capital expenditures. Pursuant to the terms of the Company’s leases with certain tenants, the Company has assigned its interests in certain of these restricted cash accounts with secured debt lenders to the tenants, and this amount is included in accounts payable and accrued liabilities on the Company’s consolidated balance sheets.
Stock-Based Compensation	Stock-based compensation expense for stock-based awards granted to Sabra’s employees (team members) and its non-employee directors is recognized in the statements of income based on the estimated grant date fair value, as adjusted. Compensation expense for awards with graded vesting schedules is generally recognized ratably over the period from the grant date to the date when the award is no longer contingent on the recipient providing additional services. Compensation expense for awards with performance-based vesting conditions is recognized based on the Company’s estimate of the ultimate value of such award after considering the Company’s expectations of future performance. Forfeitures of stock-based awards are recognized as they occur.
Deferred Financing Costs	Deferred financing costs representing fees paid to third parties are amortized over the terms of the respective financing agreements using the interest method. Deferred financing costs related to secured debt, term loans and senior unsecured notes are recorded as a reduction of the related debt liability, and deferred financing costs related to the revolving credit facility are recorded in accounts receivable, prepaid expenses and other assets, net. Unamortized deferred financing costs are generally expensed when the associated debt is refinanced or repaid before maturity. Costs incurred in seeking financings that do not close are expensed in the period in which it is determined that the financing will not close.
Income Taxes	The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. The Company believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute at least 90% of the Company’s annual REIT taxable income to stockholders (which is computed without regard to the dividends-paid deduction or net capital gains and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax on income that it distributes as dividends to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to U.S. federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the Internal Revenue Service grants the Company relief under certain statutory provisions. Such an event could materially and adversely affect the Company’s net income and net cash available for distribution to stockholders. However, the Company believes that it is organized and operates in such a manner as to qualify for treatment as a REIT. As a result of certain investments, the Company now records income tax expense or benefit with respect to certain of its entities that are taxed as taxable REIT subsidiaries under provisions similar to those applicable to regular corporations and not under the REIT provisions. The Company accounts for deferred income taxes using the asset and liability method and recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the Company’s financial statements or tax returns. Under this method, the Company determines deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes a change in the Company’s judgment about expected future tax consequences of events, is included in the tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss and tax credit carryforwards. A valuation allowance is provided if the Company believes it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes a change in the Company’s judgment about the realizability of the related deferred tax asset, is included in the tax provision when such changes occur.
Foreign Currency	Certain of the Company’s subsidiaries’ functional currencies are the local currencies of their respective foreign jurisdictions. The Company translates the results of operations of its foreign subsidiaries into U.S. dollars using average rates of exchange in effect during the period presented, and it translates balance sheet accounts using exchange rates in effect at the end of the period presented. The Company records resulting currency translation adjustments in accumulated other comprehensive loss, a component of stockholders’ equity, on its consolidated balance sheets, and it records foreign currency transaction gains and losses as a component of interest and other income on its consolidated statements of income.
Derivative Instruments	The Company uses certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at inception, the Company must make an assessment that the transaction that the Company intends to hedge is probable of occurring, and this assessment must be updated each reporting period. The Company recognizes all derivative instruments as assets or liabilities on the consolidated balance sheets at their fair value. For derivatives designated and qualified as a hedge, the change in fair value of the effective portion of the derivatives is recognized in accumulated other comprehensive loss. Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria for hedge accounting would be recognized in earnings. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific transactions, as well as recognizing obligations or assets on the consolidated balance sheets. The Company also assesses and documents, both at inception of the hedging relationship and on a quarterly basis thereafter, whether the derivatives are highly effective in offsetting the designated risks associated with the respective hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, or that it is probable the underlying transaction will not occur, the Company would discontinue hedge accounting prospectively and record the appropriate adjustment to earnings based on the then-current fair value of the derivative.
Fair Value Measurements	Under GAAP, the Company is required to measure certain financial instruments at fair value on a recurring basis. In addition, the Company is required to measure other financial instruments and balances at fair value on a non-recurring basis (e.g., carrying value of impaired loans receivable and long-lived assets). Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The GAAP fair value framework uses a three-tiered approach. Fair value measurements are classified and disclosed in one of the following three categories: • Level 1: unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities; • Level 2: quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and • Level 3: prices or valuation techniques where little or no market data is available that requires inputs that are both significant to the fair value measurement and unobservable. When available, the Company utilizes quoted market prices from an independent third-party source to determine fair value and classifies such items as Level 1 or Level 2. In instances where the market for a financial instrument is not active, regardless of the availability of a nonbinding quoted market price, observable inputs might not be relevant and could require the Company to make a significant adjustment to derive a fair value measurement. Additionally, in an inactive market, a market price quoted from an independent third party may rely more on models with inputs based on information available only to that independent third party. When the Company determines the market for a financial instrument owned by the Company to be illiquid or when market transactions for similar instruments do not appear orderly, the Company may use several valuation sources (including internal valuations, discounted cash flow analysis and quoted market prices) to establish a fair value. If more than one valuation source is used, the Company will assign weights to the various valuation sources. Additionally, when determining the fair value of liabilities in circumstances in which a quoted price in an active market for an identical liability is not available, the Company measures fair value using (i) a valuation technique that uses the quoted price of the identical liability when traded as an asset or quoted prices for similar liabilities or similar liabilities when traded as assets or (ii) another valuation technique that is consistent with the principles of fair value measurement, such as the income approach or the market approach. Changes in assumptions or estimation methodologies can have a material effect on these estimated fair values. In this regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, may not be realized in an immediate settlement of the instrument. The Company considers the following factors to be indicators of an inactive market: (i) there are few recent transactions, (ii) price quotations are not based on current information, (iii) price quotations vary substantially either over time or among market makers (for example, some brokered markets), (iv) indexes that previously were highly correlated with the fair values of the asset or liability are demonstrably uncorrelated with recent indications of fair value for that asset or liability, (v) there is a The fair value for certain financial instruments is derived using a combination of market quotes, pricing models and other valuation techniques that involve significant management judgment. The price transparency of financial instruments is a key determinant of the degree of judgment involved in determining the fair value of the Company’s financial instruments. Financial instruments for which actively quoted prices or pricing parameters are available and whose markets contain orderly transactions will generally have a higher degree of price transparency than financial instruments whose markets are inactive or consist of non-orderly trades. The Company evaluates several factors when determining if a market is inactive or when market transactions are not orderly. The carrying values of cash and cash equivalents, restricted cash, accounts payable, accrued liabilities and the Credit Agreement are reasonable estimates of fair value because of the short-term maturities of these instruments. Fair values for other financial instruments are derived as follows: Loans receivable : These instruments are presented on the accompanying consolidated balance sheets at their amortized cost and not at fair value. The fair values of the loans receivable were estimated using an internal valuation model that considered the expected cash flows for the loans receivable, as well as the underlying collateral value and other credit enhancements as applicable. The Company utilized discount rates ranging from 6% to 12% with a weighted average rate of 9% in its fair value calculation. As such, the Company classifies these instruments as Level 3. Preferred equity investments : These instruments are presented on the accompanying consolidated balance sheets at their cost and not at fair value. The fair values of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows for the preferred equity investments, the underlying collateral value and other credit enhancements. The Company utilized discount rates ranging from 10% to 15% with a weighted average rate of 11% in its fair value calculation. As such, the Company classifies these instruments as Level 3. Derivative instruments : The Company’s derivative instruments are presented at fair value on the accompanying consolidated balance sheets. The Company estimates the fair value of derivative instruments, including its interest rate swaps and cross currency swaps, using the assistance of a third party using inputs that are observable in the market, which include forward yield curves and other relevant information. Although the Company has determined that the majority of the inputs used to value its derivative financial instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivative financial instruments utilize Level 3 inputs, such as estimates of current credit spreads, to evaluate the likelihood of default by itself and its counterparties. The Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of its derivative financial instruments. As a result, the Company has determined that its derivative financial instruments valuations in their entirety are classified in Level 2 of the fair value hierarchy. Senior Notes : These instruments are presented on the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums/discounts and not at fair value. The fair values of the Senior Notes were determined using third-party market quotes derived from orderly trades. As such, the Company classifies these instruments as Level 2. Secured indebtedness : These instruments are presented on the accompanying consolidated balance sheets at their outstanding principal balance, net of unamortized deferred financing costs and premiums/discounts and not at fair value. The fair values of the Company’s secured debt were estimated using a discounted cash flow analysis based on management’s estimates of current market interest rates for instruments with similar characteristics, including remaining loan term, loan-to-value ratio, type of collateral and other credit enhancements. The Company utilized rates ranging from 2% to 3% with a weighted average rate of 3% in its fair value calculation. As such, the Company classifies these instruments as Level 3.
Per Share Data	Basic earnings per common share is computed by dividing net income applicable to common stockholders by the weighted average number of shares of common stock and common equivalents outstanding during the period. Diluted earnings per common share is calculated by including the effect of dilutive securities.
Industry Segments	The Company has one reportable segment consisting of investments in healthcare-related real estate properties.
Recently Issued Accounting Standards Update	Adopted Effective January 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2016-02, Leases, as amended by subsequent ASUs (“Topic 842”) using the modified retrospective transition method. Topic 842 supersedes guidance related to accounting for leases and provides for the recognition of lease assets and lease liabilities by lessees for those leases previously classified as operating leases under GAAP. In addition, the Company elected to use the available practical expedients, and therefore did not reassess classification of its existing leases and did not separate lease and nonlease components (such as services rendered). As a result of electing these practical expedients, the Company, beginning January 1, 2019, recognizes revenue from its leased skilled nursing/transitional care facilities, Senior Housing - Leased communities, and specialty hospitals and other facilities under Topic 842 and recognizes revenue from its Senior Housing - Managed communities under the Revenue ASUs (codified under Topic 606). Upon adoption of Topic 842, the Company recognized its operating leases for which it is the lessee, mainly its corporate office lease and ground leases, as a lease liability of $10.0 million, included in accounts payable and accrued liabilities on the consolidated balance sheets, and a corresponding right-of-use asset, included in accounts receivable, prepaid expenses and other assets, net on the consolidated balance sheets. Upon adoption of Topic 842 and as of the adoption date, the Company recorded a $32.5 million reduction in equity and accounts receivable due to the cumulative effect of this change. This reduction consisted of $17.5 million of straight-line rental income receivables and $15.0 million of cash rent receivables, although management believes the $15.0 million of cash rent receivables are collectible. In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires that a financial asset (or a group of financial assets) measured at amortized cost basis be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. The amendments in ASU 2016-13 are an improvement because they eliminate the probable initial recognition threshold under current GAAP and, instead, reflect an entity’s current estimate of all expected credit losses. Previously, when credit losses were measured under GAAP, an entity generally only considered past events and current conditions in measuring the incurred loss. In November 2018, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments—Credit Losses (“ASU 2018-19”), which amends ASU 2016-13 to clarify that receivables arising from operating leases are not within the scope of Subtopic 326-20, and instead, impairment of such receivables should be accounted for in accordance with Topic 842. In November 2019, the FASB issued ASU 2019-11, Codification Improvements to Topic 326, Financial Instruments—Credit Losses (“ASU 2019-11”), which amends ASU 2016-13 to clarify or address stakeholders’ specific issues about certain aspects of ASU 2016-13. ASU 2016-13, ASU 2018-19 and ASU 2019-11 are effective for fiscal years and interim periods within those years beginning after December 15, 2019, with early adoption permitted as of the fiscal years beginning after December 15, 2018. An entity will apply the amendments in these updates through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective (that is, a modified-retrospective approach). The Company adopted ASU 2016-13, ASU 2018-19 and ASU 2019-11 (collectively, “Topic 326”) on January 1, 2020. The financial assets within the scope of Topic 326 are the Company’s investments in a sales-type lease and loans receivable, including the portion of unfunded loan commitments expected to be funded. The allowance for credit losses is calculated using the related amortization schedules, payment histories and loan-to-value ratios. The following rates are applied to determine the aggregate expected losses, which is recorded as the allowance for credit losses: (i) a default rate, (ii) a liquidation cost rate and (iii) a distressed property reduction rate. If no loan-to-value ratio is available, a loss severity rate is applied in place of the liquidation cost rate and the distressed property reduction rate. The default rate is based on average charge-off and delinquency rates from the Federal Reserve, and the other rates are based on industry research and historical performance of a similar portfolio of financial assets. Related interest income receivable balances are evaluated separately for collectability, and reserves are established based on management’s estimate of losses. Upon adoption of these standards, the Company recognized the cumulative effect on the opening balance of the allowance for credit losses in the condensed consolidated balance sheets, which resulted in an increase to cumulative distributions in excess of net income and a decrease to total assets of $0.2 million. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”). ASU 2018-13 updates the fair value measurement disclosure requirements by (i) eliminating certain requirements, including disclosure of the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels and the valuation processes for Level 3 fair value measurements, (ii) modifying certain requirements, including clarifying that the measurement uncertainty disclosure is to communicate information about the uncertainty in measurement as of the reporting date and (iii) adding certain requirements, including disclosure of the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for fiscal years and interim periods within those years beginning after December 15, 2019, with early adoption permitted for any eliminated or modified disclosures. The Company adopted ASU 2018-13 on January 1, 2020. The adoption of ASU 2018-13 did not have a material impact on the Company’s consolidated financial statements. In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”). ASU 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes the liability and equity separation models for convertible instruments. Instead, entities will account for convertible debt instruments wholly as debt unless convertible instruments contain features that require bifurcation as a derivative or that result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, with early adoption permitted for fiscal years beginning after December 15, 2020, and can be adopted on either a retrospective or modified retrospective basis. The Company adopted ASU 2020-06 on January 1, 2021. The adoption of ASU 2020-06 did not have an impact on the Company’s consolidated financial statements. Issued but Not Yet Adopted In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). ASU 2020-04 provides temporary optional guidance that provides transition relief for reference rate reform, including optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions that reference LIBOR or a reference rate that is expected to be discontinued as a result of reference rate reform if certain criteria are met. ASU 2020-04 is effective upon issuance, and the provisions generally can be applied prospectively as of January 1, 2020 through December 31, 2022. During the first quarter of 2020, the Company elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848), which refines the

RECENT REAL ESTATE ACQUISITIO_2

RECENT REAL ESTATE ACQUISITIONS (Tables)	12 Months Ended
	Dec. 31, 2020
Business Combinations [Abstract]
Purchase Price Allocation	The consideration was allocated as follows (in thousands): Year Ended December 31, 2020 2019 Land $ 5,800 $ 10,049 Building and improvements 104,952 39,434 Tenant origination and absorption costs intangible assets 2,578 1,438 Tenant relationship intangible assets 347 215 Total consideration $ 113,677 $ 51,136

REAL ESTATE PROPERTIES HELD F_2

REAL ESTATE PROPERTIES HELD FOR INVESTMENT (Tables)	12 Months Ended
	Dec. 31, 2020
Real Estate Investments, Net [Abstract]
Real Estate Properties Held for Investment	The Company’s real estate properties held for investment consisted of the following (dollars in thousands): As of December 31, 2020 Property Type Number of Number of Total Accumulated Total Skilled Nursing/Transitional Care 287 31,761 $ 3,644,470 $ (385,094) $ 3,259,376 Senior Housing - Leased 65 4,282 707,634 (87,600) 620,034 Senior Housing - Managed 47 4,924 942,996 (142,538) 800,458 Specialty Hospitals and Other 27 1,092 670,793 (66,021) 604,772 426 42,059 5,965,893 (681,253) 5,284,640 Corporate Level 802 (404) 398 $ 5,966,695 $ (681,657) $ 5,285,038 As of December 31, 2019 Property Type Number of Number of Total Accumulated Total Skilled Nursing/Transitional Care 296 33,290 $ 3,701,666 $ (306,565) $ 3,395,101 Senior Housing - Leased 62 3,820 630,688 (72,278) 558,410 Senior Housing - Managed 46 4,809 907,771 (112,893) 794,878 Specialty Hospitals and Other 25 1,193 639,721 (47,124) 592,597 429 43,112 5,879,846 (538,860) 5,340,986 Corporate Level 737 (353) 384 $ 5,880,583 $ (539,213) $ 5,341,370 December 31, 2020 December 31, 2019 Building and improvements $ 5,120,598 $ 5,042,435 Furniture and equipment 249,034 239,229 Land improvements 2,220 1,534 Land 594,843 597,385 5,966,695 5,880,583 Accumulated depreciation (681,657) (539,213) $ 5,285,038 $ 5,341,370
Future Minimum Rental Payments from Non-Cancelable Operating Leases	As of December 31, 2020, the future minimum rental payments from the Company’s properties held for investment under non-cancelable operating leases were as follows and may materially differ from actual future rental payments received (in thousands): 2021 $ 434,074 2022 418,547 2023 408,367 2024 409,357 2025 399,984 Thereafter 1,561,535 $ 3,631,864
Summarized Financial Information for the Enlivant Joint Venture	The following tables present summarized financial information for the Enlivant Joint Venture and, except for basis adjustments and loss from unconsolidated joint venture, reflect the historical cost basis of the assets which pre-dated the Company’s investment in the Enlivant Joint Venture (in thousands): As of December 31, 2020 2019 Total assets $ 490,541 $ 504,920 Total liabilities 824,410 815,299 Member’s deficit (333,869) (310,379) Year Ended December 31, 2020 2019 2018 Total revenues $ 299,031 $ 312,055 $ 303,486 Operating expenses 240,331 231,659 228,458 Net income 5,196 13,161 10,378 Company’s share of net income $ 2,546 $ 6,449 $ 5,085 Basis adjustments 19,145 13,245 10,516 Loss from unconsolidated joint venture $ (16,599) $ (6,796) $ (5,431) The Enlivant Joint Venture has experienced decreased occupancy and increased operating costs as a result of the impact from the COVID-19 pandemic that, if they continue to negatively impact the operating results of the Enlivant Joint Venture for a prolonged period, could result in the determination that the full amount of the Company’s investment is not recoverable, resulting in a possible impairment charge.

INTANGIBLE ASSETS AND LIABILI_2

INTANGIBLE ASSETS AND LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Intangible Assets and Liabilities	The following table summarizes the Company’s intangible assets and liabilities as of December 31, 2020 and 2019 (in thousands): December 31, 2020 2019 Lease Intangible Assets: Above market leases $ 35,695 $ 51,040 Tenant origination and absorption costs 60,413 65,234 Tenant relationship 23,289 23,150 Gross lease intangible assets 119,397 139,424 Accumulated amortization (36,601) (37,915) Lease intangible assets, net $ 82,796 $ 101,509 Lease Intangible Liabilities: Below market leases $ 89,389 $ 99,133 Accumulated amortization (31,664) (29,187) Lease intangible liabilities, net $ 57,725 $ 69,946
Summary of Real Estate Intangible Amortization	The following is a summary of real estate intangible amortization income (expense) for the years ended December 31, 2020, 2019 and 2018 (in thousands): Year Ended December 31, 2020 2019 2018 Increase (decrease) to rental income related to above/below market leases, net $ 849 $ 508 $ (7,701) Depreciation and amortization related to tenant origination and absorption costs and tenant relationship (10,620) (17,674) (16,118)
Remaining Unamortized Balance for Outstanding Intangible Assets and Liabilities	The remaining unamortized balance for these outstanding intangible assets and liabilities as of December 31, 2020 will be amortized for the years ending December 31 as follows (dollars in thousands): Lease Intangible Lease Intangible 2021 $ 10,277 $ 8,012 2022 9,936 7,269 2023 8,895 7,269 2024 8,480 7,168 2025 8,012 6,228 Thereafter 37,196 21,779 $ 82,796 $ 57,725 Weighted-average remaining amortization period 10.3 years 8.5 years

LOANS RECEIVABLE AND OTHER IN_2

LOANS RECEIVABLE AND OTHER INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2020
Receivables [Abstract]
Composition of Loans Receivable and Other Investments	As of December 31, 2020 and 2019, the Company’s loans receivable and other investments consisted of the following (dollars in thousands): December 31, 2020 Investment Quantity Property Type Principal Balance as of December 31, 2020 (1) Book Value Book Value Weighted Average Contractual Interest Rate / Rate of Return Weighted Average Annualized Effective Interest Rate / Rate of Return Maturity Date Loans Receivable: Mortgage 1 Specialty Hospital $ 19,000 $ 19,000 $ 19,000 10.0 % 10.0 % 01/31/27 Construction 1 Senior Housing 3,343 3,352 2,487 8.0 % 7.8 % 09/30/22 Other 16 Multiple 42,977 39,005 42,147 6.8 % 6.9 % 03/01/21- 08/31/28 18 65,320 61,357 63,634 7.8 % 7.9 % Allowance for loan losses — (2,458) (564) $ 65,320 $ 58,899 $ 63,070 Other Investments: Preferred Equity 6 Skilled Nursing / Senior Housing 43,724 43,940 44,304 11.3 % 11.3 % N/A Total 24 $ 109,044 $ 102,839 $ 107,374 9.2 % 9.3 %
Changes in Accretable Yield	The following table presents changes in the accretable yield for the years ended December 31, 2020 and 2019 (in thousands): Year Ended December 31, 2020 2019 2018 Accretable yield, beginning of period $ 39 $ 449 $ 2,483 Accretion recognized in earnings (27) (377) (2,761) Reduction due to payoff — (33) — Net reclassification from nonaccretable difference — — 727 Accretable yield, end of period $ 12 $ 39 $ 449

DEBT (Tables)

DEBT (Tables)	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Debt	The Company’s secured debt consists of the following (dollars in thousands): Interest Rate Type Principal Balance as of (1) Principal Balance as of (1) Weighted Average Interest Rate at (2) Maturity Date Fixed Rate $ 80,199 $ 114,777 3.39 % December 2021 - (1) Principal balance does not include deferred financing costs, net of $1.1 million and $1.7 million as of December 31, 2020 and 2019, respectively. (2) Weighted average interest rate includes private mortgage insurance. The Company’s senior unsecured notes consist of the following (dollars in thousands): Principal Balance as of December 31, Title Maturity Date 2020 (1) 2019 (1) 4.80% senior unsecured notes due 2024 (“2024 Notes”) June 1, 2024 $ 300,000 $ 300,000 5.125% senior unsecured notes due 2026 (“2026 Notes”) August 15, 2026 500,000 500,000 5.38% senior unsecured notes due 2027 (“2027 Notes”) May 17, 2027 100,000 100,000 3.90% senior unsecured notes due 2029 (“2029 Notes”) October 15, 2029 350,000 350,000 $ 1,250,000 $ 1,250,000
Schedule of Maturities for Outstanding Debt	The following is a schedule of maturities for the Company’s outstanding debt as of December 31, 2020 (in thousands): Secured Term Loans Senior Notes Total 2021 $ 18,419 $ — $ — $ 18,419 2022 2,412 105,000 — 107,412 2023 2,478 350,000 — 352,478 2024 2,545 598,100 300,000 900,645 2025 2,615 — — 2,615 Thereafter 51,730 — 950,000 1,001,730 Total Debt 80,199 1,053,100 1,250,000 2,383,299 Premium, net — — 6,442 6,442 Deferred financing costs, net (1,134) (8,184) (8,049) (17,367) Total Debt, Net $ 79,065 $ 1,044,916 $ 1,248,393 $ 2,372,374

DERIVATIVE AND HEDGING INSTRU_2

DERIVATIVE AND HEDGING INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Notional Amounts of Derivative Instruments	The following presents the notional amount of derivative instruments as of the dates indicated (in thousands): December 31, 2020 December 31, 2019 Derivatives designated as cash flow hedges: Denominated in U.S. Dollars (1) $ 1,340,000 $ 1,490,000 Denominated in Canadian Dollars (2) $ 250,000 $ 125,000 Derivatives designated as net investment hedges: Denominated in Canadian Dollars $ 52,778 $ 54,489 Financial instrument designated as net investment hedge: Denominated in Canadian Dollars $ 125,000 $ 125,000 Derivatives not designated as net investment hedges: Denominated in Canadian Dollars $ 3,522 $ 1,811 (1) Balance includes swaps with an aggregate notional amount of $400.0 million, which accretes to $600.0 million in January 2023, and two forward starting interest rate swaps and one forward starting interest rate collar with an effective date of January 2021. The forward starting interest rate swaps and forward starting interest rate collar have an aggregate notional amount of $245.0 million. Balance as of December 31, 2020 also includes six forward starting interest rate swaps with an effective date of May 2024 and an aggregate notional amount of $250.0 million. (2) Balance as of December 31, 2020 includes two forward starting interest rate swaps with an effective date of January 2021 and an aggregate notional amount of CAD $125.0 million.
Summary of Derivative and Financial Instruments Designated as Hedging Instruments	The following is a summary of the derivative and financial instruments designated as hedging instruments held by the Company at December 31, 2020 and 2019 (dollars in thousands): Count as of December 31, 2020 Fair Value Maturity Dates December 31, Type Designation 2020 2019 Balance Sheet Location Assets: Interest rate swaps Cash flow — $ — $ 4,239 N/A Accounts receivable, prepaid expenses and other assets, net Forward starting interest rate swaps Cash flow 6 10,652 — 2034 Accounts receivable, prepaid expenses and other assets, net Cross currency interest rate swaps Net investment 2 2,150 3,238 2025 Accounts receivable, prepaid expenses and other assets, net $ 12,802 $ 7,477 Liabilities: Interest rate swaps Cash flow 10 $ 23,849 $ — 2021-2024 Accounts payable and accrued liabilities Interest rate collar Cash flow 1 1,626 — 2024 Accounts payable and accrued liabilities Forward starting interest rate swaps Cash flow 4 10,723 494 2024 Accounts payable and accrued liabilities Forward starting interest rate collar Cash flow 1 820 132 2024 Accounts payable and accrued liabilities CAD term loan Net investment 1 98,100 96,025 2024 Term loans, net $ 135,118 $ 96,651
Effect of Derivatives and Financial Instruments Designated as Hedging Instruments on Income and Equity	The following presents the effect of the Company’s derivative and financial instruments designated as hedging instruments on the consolidated statements of income and the consolidated statements of equity for the years ended December 31, 2020, 2019 and 2018: (Loss) Gain Recognized in Other Comprehensive Income (Loss) Gain Reclassified from Accumulated Other Comprehensive Income Into Income Income Statement Location For the year ended December 31, 2020 2019 2018 2020 2019 2018 Cash Flow Hedges: Interest rate products $ (35,320) $ (19,932) $ 2,707 $ (8,072) $ 5,545 $ 3,099 Interest expense Net Investment Hedges: Foreign currency products (758) (772) 3,554 — — — N/A CAD term loan (2,075) (4,325) 7,888 — — — N/A $ (38,153) $ (25,029) $ 14,149 $ (8,072) $ 5,545 $ 3,099
Gross Presentation, Effects of Offsetting, and a Net Presentation of Derivatives, Assets	The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of December 31, 2020 and 2019 (in thousands): As of December 31, 2020 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 12,802 $ — $ 12,802 $ (7,420) $ — $ 5,382 Offsetting Liabilities: Derivatives $ 37,018 $ — $ 37,018 $ (7,420) $ — $ 29,598 As of December 31, 2019 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 7,477 $ — $ 7,477 $ (544) $ — $ 6,933 Offsetting Liabilities: Derivatives $ 626 $ — $ 626 $ (544) $ — $ 82
Gross Presentation, Effects of Offsetting, and a Net Presentation of Derivatives, Liabilities	The table below presents a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of December 31, 2020 and 2019 (in thousands): As of December 31, 2020 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 12,802 $ — $ 12,802 $ (7,420) $ — $ 5,382 Offsetting Liabilities: Derivatives $ 37,018 $ — $ 37,018 $ (7,420) $ — $ 29,598 As of December 31, 2019 Gross Amounts Not Offset in the Balance Sheet Gross Amounts of Recognized Assets / Liabilities Gross Amounts Offset in the Balance Sheet Net Amounts of Assets / Liabilities presented in the Balance Sheet Financial Instruments Cash Collateral Received Net Amount Offsetting Assets: Derivatives $ 7,477 $ — $ 7,477 $ (544) $ — $ 6,933 Offsetting Liabilities: Derivatives $ 626 $ — $ 626 $ (544) $ — $ 82

FAIR VALUE DISCLOSURES (Tables)

FAIR VALUE DISCLOSURES (Tables)	12 Months Ended
	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Face Values, Carrying Amounts and Fair Values of Financial Instruments	The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2020 and 2019 whose carrying amounts do not approximate their fair value (in thousands): December 31, 2020 December 31, 2019 Face Value (1) Carrying Amount (2) Fair Face Value (1) Carrying Amount (2) Fair Financial assets: Loans receivable $ 65,320 $ 58,899 $ 60,421 $ 67,527 $ 63,070 $ 59,832 Preferred equity investments 43,724 43,940 44,597 43,893 44,304 44,493 Financial liabilities: Senior Notes 1,250,000 1,248,393 1,362,678 1,250,000 1,248,773 1,328,714 Secured indebtedness 80,199 79,065 79,326 114,777 113,070 105,510 (1) Face value represents amounts contractually due under the terms of the respective agreements. (2) Carrying amount represents the book value of financial instruments, including unamortized premiums/discounts and deferred financing costs.
Inputs Used for Valuation of Financial Instruments	The Company determined the fair value of financial instruments as of December 31, 2020 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands): Fair Value Measurements Using Total Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Financial assets: Loans receivable $ 60,421 $ — $ — $ 60,421 Preferred equity investments 44,597 — — 44,597 Financial liabilities: Senior Notes 1,362,678 — 1,362,678 — Secured indebtedness 79,326 — — 79,326
Amounts Measured at Fair Value	During the year ended December 31, 2020, the Company recorded the following amounts measured at fair value (in thousands): Fair Value Measurements Using Total Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Recurring Basis: Financial assets: Forward starting interest rate swaps $ 10,652 $ — $ 10,652 $ — Cross currency interest rate swaps 2,150 — 2,150 — Financial liabilities: Interest rate swaps 23,849 — 23,849 — Interest rate collar 1,626 — 1,626 — Forward starting interest rate swaps 10,723 — 10,723 — Forward starting interest rate collars 820 — 820 —

EQUITY (Tables)

EQUITY (Tables)	12 Months Ended
	Dec. 31, 2020
Equity [Abstract]
Summary of Accumulated Other Comprehensive Income	The following is a summary of the Company’s accumulated other comprehensive loss (in thousands): Year Ended December 31, 2020 2019 Foreign currency translation loss $ (1,831) $ (1,516) Unrealized loss on cash flow hedges (38,080) (10,872) Total accumulated other comprehensive loss $ (39,911) $ (12,388)

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	12 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Summary of Additional Information Concerning Restricted Stock Units	The following table summarizes additional information concerning restricted stock units at December 31, 2020: Restricted Stock Units Weighted Average Grant Date Fair Value Per Unit Unvested as of December 31, 2019 1,737,862 $ 18.35 Granted 623,523 17.13 Vested (540,751) 17.84 Dividends reinvested 157,905 18.44 Cancelled/forfeited (163,124) 20.70 Unvested as of December 31, 2020 1,815,415 $ 17.88
Summary of Assumptions Used in Total Stockholder Return-Based Stock Units Valuation	The following are the key assumptions used in this valuation: 2020 2019 2018 Risk free interest rate 0.17% - 1.63% 1.57% - 2.54% 2.36% - 2.59% Expected stock price volatility 23.80% - 53.17% 23.80% - 28.57% 28.57% - 30.02% Expected service period 2.7 - 3.0 years 2.4 - 3.0 years 2.5 - 3.0 years Expected dividend yield (assuming full reinvestment) — % — % — %

EARNINGS PER COMMON SHARE (Tabl

EARNINGS PER COMMON SHARE (Tables)	12 Months Ended
	Dec. 31, 2020
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	The following table illustrates the computation of basic and diluted earnings per share (in thousands, except share and per share amounts): Year Ended December 31, 2020 2019 2018 Numerator Net income attributable to common stockholders $ 138,417 $ 68,996 $ 269,314 Denominator Basic weighted average common shares and common equivalents 206,223,503 187,172,210 178,305,738 Dilutive stock options and restricted stock units 1,029,327 954,882 416,006 Diluted weighted average common shares 207,252,830 188,127,092 178,721,744 Net income attributable to common stockholders, per: Basic common share $ 0.67 $ 0.37 $ 1.51 Diluted common share $ 0.67 $ 0.37 $ 1.51

BUSINESS (Details)

BUSINESS (Details) $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)
Schedule of Equity Method Investments [Line Items]
Government grants received under the CARES Act	$ 5.3
Enlivant Joint Venture
Schedule of Equity Method Investments [Line Items]
Equity interest in joint venture	49.00%

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	12 Months Ended
	Dec. 31, 2020USD ($)variableInterestEntityInvestmentSegment	Dec. 31, 2019USD ($)Investment	Dec. 31, 2018USD ($)	Jan. 01, 2020USD ($)	Jan. 01, 2019USD ($)	Dec. 31, 2017USD ($)
Accounting Policies [Line Items]
Number of investments in loans accounted for as real estate joint ventures | Investment	0	0
Income (loss) from unconsolidated joint venture	$ (16,599,000)	$ (6,796,000)	$ (5,431,000)
Net income (loss)	$ 138,417,000	69,018,000	279,115,000
Extension period for tenant relationship intangible assets	10 years
Assets held for sale	$ 0	0
Restricted cash	$ 6,447,000	10,046,000
Number of reportable segments | Segment	1
Equity	$ 3,409,228,000	3,488,460,000	3,254,747,000			$ 3,437,249,000
Total assets	5,985,603,000	6,069,299,000
Cumulative Distributions in Excess of Net Income
Accounting Policies [Line Items]
Net income (loss)	138,417,000	68,996,000	279,082,000
Equity	(716,195,000)	(573,283,000)	(271,595,000)			(217,236,000)
Cumulative Effect
Accounting Policies [Line Items]
Equity		(167,000)	(32,502,000)			0
Operating lease liability					$ 10,000,000
Operating lease right-of-use asset					10,000,000
Straight-line rental income receivables					(17,500,000)
Cash rent receivables					(15,000,000)
Total assets				$ (200,000)
Cumulative Effect | Cumulative Distributions in Excess of Net Income
Accounting Policies [Line Items]
Equity		(167,000)	(32,502,000)	$ 200,000	$ (32,500,000)	$ (795,000)
Restricted Cash Obligations
Accounting Policies [Line Items]
Restricted cash	3,500,000	5,600,000
Resident Fee and Services Fee
Accounting Policies [Line Items]
Grant income	1,800,000
Loss from Unconsolidated Joint Venture
Accounting Policies [Line Items]
Grant income	$ 3,500,000
Minimum | Land Improvements
Accounting Policies [Line Items]
Estimated useful lives of assets	5 years
Minimum | Buildings and Building Improvements
Accounting Policies [Line Items]
Estimated useful lives of assets	5 years
Minimum | Furniture and Equipment
Accounting Policies [Line Items]
Estimated useful lives of assets	3 years
Maximum | Land Improvements
Accounting Policies [Line Items]
Estimated useful lives of assets	20 years
Maximum | Buildings and Building Improvements
Accounting Policies [Line Items]
Estimated useful lives of assets	40 years
Maximum | Furniture and Equipment
Accounting Policies [Line Items]
Estimated useful lives of assets	10 years
Out of Period Adjustment | Correction of Depreciation and Amortization Expense Errors
Accounting Policies [Line Items]
Income (loss) from unconsolidated joint venture	$ 1,600,000	(100,000)	1,700,000
Net income (loss)	$ 1,600,000	$ (100,000)	$ 1,700,000
Primary Beneficiary
Accounting Policies [Line Items]
Number of variable interest entities | variableInterestEntity	0

RECENT REAL ESTATE ACQUISITIO_3

RECENT REAL ESTATE ACQUISITIONS - Narrative (Details) - Recent Real Estate Acquisitions $ in Millions	12 Months Ended
	Dec. 31, 2020USD ($)property	Dec. 31, 2019USD ($)Property
Business Acquisition [Line Items]
Revenues from the properties acquired	$ 12.5	$ 0.8
Net income attributable to common stockholders from the properties acquired	$ 4.8	$ 0.4
Tenant Origination and Absorption Costs
Business Acquisition [Line Items]
Finite-lived intangible assets, weighted average amortization period as of date of acquisition	7 years	6 years
Tenant Relationship
Business Acquisition [Line Items]
Finite-lived intangible assets, weighted average amortization period as of date of acquisition	25 years	21 years
Senior Housing Facilities
Business Acquisition [Line Items]
Amount previously funded through preferred equity investments	$ 20.7
Senior Housing - Leased
Business Acquisition [Line Items]
Number of acquired properties	3	1
Senior Housing - Managed
Business Acquisition [Line Items]
Number of acquired properties	1	1
Specialty Hospitals and Other
Business Acquisition [Line Items]
Number of acquired properties | Property		3

RECENT REAL ESTATE ACQUISITIO_4

RECENT REAL ESTATE ACQUISITIONS - Recent Real Estate Acquisitions Purchase Price Allocation (Details) - Recent Real Estate Acquisitions - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Business Acquisition [Line Items]
Land	$ 5,800	$ 10,049
Building and improvements	104,952	39,434
Total consideration	113,677	51,136
Tenant origination and absorption costs intangible assets
Business Acquisition [Line Items]
Lease intangible assets, net	2,578	1,438
Tenant relationship intangible assets
Business Acquisition [Line Items]
Lease intangible assets, net	$ 347	$ 215

REAL ESTATE PROPERTIES HELD F_3

REAL ESTATE PROPERTIES HELD FOR INVESTMENT - Real Estate Properties Held for Investment (Details) $ in Thousands	Dec. 31, 2020USD ($)facilityBed	Dec. 31, 2019USD ($)facilityBed
Real Estate Properties [Line Items]
Building and improvements	$ 5,120,598	$ 5,042,435
Furniture and equipment	249,034	239,229
Land improvements	2,220	1,534
Land	594,843	597,385
Total Real Estate at Cost	5,966,695	5,880,583
Accumulated Depreciation	(681,657)	(539,213)
Total Real Estate Investments, Net	$ 5,285,038	$ 5,341,370
Operating Segments
Real Estate Properties [Line Items]
Number of Properties | facility	426	429
Number of Beds/Units | Bed	42,059	43,112
Total Real Estate at Cost	$ 5,965,893	$ 5,879,846
Accumulated Depreciation	(681,253)	(538,860)
Total Real Estate Investments, Net	$ 5,284,640	$ 5,340,986
Operating Segments | Skilled Nursing/Transitional Care
Real Estate Properties [Line Items]
Number of Properties | facility	287	296
Number of Beds/Units | Bed	31,761	33,290
Total Real Estate at Cost	$ 3,644,470	$ 3,701,666
Accumulated Depreciation	(385,094)	(306,565)
Total Real Estate Investments, Net	$ 3,259,376	$ 3,395,101
Operating Segments | Senior Housing - Leased
Real Estate Properties [Line Items]
Number of Properties | facility	65	62
Number of Beds/Units | Bed	4,282	3,820
Total Real Estate at Cost	$ 707,634	$ 630,688
Accumulated Depreciation	(87,600)	(72,278)
Total Real Estate Investments, Net	$ 620,034	$ 558,410
Operating Segments | Senior Housing - Managed
Real Estate Properties [Line Items]
Number of Properties | facility	47	46
Number of Beds/Units | Bed	4,924	4,809
Total Real Estate at Cost	$ 942,996	$ 907,771
Accumulated Depreciation	(142,538)	(112,893)
Total Real Estate Investments, Net	$ 800,458	$ 794,878
Operating Segments | Specialty Hospitals and Other
Real Estate Properties [Line Items]
Number of Properties | facility	27	25
Number of Beds/Units | Bed	1,092	1,193
Total Real Estate at Cost	$ 670,793	$ 639,721
Accumulated Depreciation	(66,021)	(47,124)
Total Real Estate Investments, Net	604,772	592,597
Corporate Level
Real Estate Properties [Line Items]
Total Real Estate at Cost	802	737
Accumulated Depreciation	(404)	(353)
Total Real Estate Investments, Net	$ 398	$ 384

REAL ESTATE PROPERTIES HELD F_4

REAL ESTATE PROPERTIES HELD FOR INVESTMENT - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)propertyfacilityProperty	Dec. 31, 2019USD ($)Propertyfacility	Dec. 31, 2018USD ($)	Jan. 01, 2020USD ($)	Dec. 31, 2017USD ($)
Real Estate Properties [Line Items]
Weighted average expiration period	8 years
Security deposit liability	$ 17,500	$ 10,500
Letters of credit deposited	85,000	83,000
Deposits held for future real estate taxes, insurance expenditures and tenant improvement	16,900	14,300
Variable lease, income	20,900	17,600
Write off of non-cash rent receivable balances and lease intangibles	14,300
Resident fees and services	156,045	128,058	$ 70,137
Investment in unconsolidated joint venture	288,761	319,460
Equity	3,409,228	3,488,460	3,254,747		$ 3,437,249
Cumulative Effect
Real Estate Properties [Line Items]
Equity		(167)	(32,502)		$ 0
Skilled Nursing/Transitional Care
Real Estate Properties [Line Items]
Net investment in sales type lease	$ 24,200
Properties in sales-type | Property	1
Total rental payments	$ 2,300
Estimated purchase price	24,800
Unearned lease income	2,800
Allowance for credit losses related to sales-type lease	100
Lease income	2,700	2,700
Lease income			2,600
Reduction in the allowance for credit losses related to sales-type lease	100
Future minimum lease payments contractually due under the sales-type lease due for next year	2,300
Future minimum lease payments contractually due under the sales-type lease due for year two	2,400
Future minimum lease payments contractually due under the sales-type lease due for year three	800
Skilled Nursing/Transitional Care | Cumulative Effect | Sales-Type Lease
Real Estate Properties [Line Items]
Equity				$ (200)
Enlivant Joint Venture
Real Estate Properties [Line Items]
Equity	$ (333,869)	$ (310,379)
Enlivant Joint Venture | Senior Housing Facilities
Real Estate Properties [Line Items]
Number of properties | property	158
Number of properties sold	12	2
Proceeds from sale of real estate	$ 18,200	$ 6,300
Aggregate net loss on sale of real estate		1,700
Enlivant Joint Venture
Real Estate Properties [Line Items]
Equity interest in joint venture	49.00%
Investment in unconsolidated joint venture	$ 288,800
Enlivant Joint Venture | Senior Housing Facilities
Real Estate Properties [Line Items]
Aggregate net loss on sale of real estate	3,300
Ancillary Services
Real Estate Properties [Line Items]
Resident fees and services	$ 900	$ 800	$ 500
Minimum
Real Estate Properties [Line Items]
Operating lease expiration period	1 year
Maximum
Real Estate Properties [Line Items]
Operating lease expiration period	16 years
Operating Segments
Real Estate Properties [Line Items]
Number of properties | facility	426	429
Operating Segments | Senior Housing - Managed
Real Estate Properties [Line Items]
Number of properties | facility	47	46

REAL ESTATE PROPERTIES HELD F_5

REAL ESTATE PROPERTIES HELD FOR INVESTMENT - Future Minimum Rental Payments from Non-Cancelable Operating Leases (Details) $ in Thousands	Dec. 31, 2020USD ($)
Future minimum rental payments from the Company’s properties held for investment under non-cancelable operating leases:
2021	$ 434,074
2022	418,547
2023	408,367
2024	409,357
2025	399,984
Thereafter	1,561,535
Total	$ 3,631,864

REAL ESTATE PROPERTIES HELD F_6

REAL ESTATE PROPERTIES HELD FOR INVESTMENT - Summarized Financial Information for the Enlivant Joint Venture (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Balance Sheet Amounts
Total assets	$ 5,985,603	$ 6,069,299
Total liabilities	2,576,375	2,580,839
Member’s deficit	3,409,228	3,488,460	$ 3,254,747	$ 3,437,249
Income Statement Amounts
Total revenues	598,569	661,736	623,409
Net income	138,417	69,018	279,115
Loss from unconsolidated joint venture	(16,599)	(6,796)	(5,431)
Enlivant Joint Venture
Income Statement Amounts
Company’s share of net income	2,546	6,449	5,085
Basis adjustments	19,145	13,245	10,516
Loss from unconsolidated joint venture	(16,599)	(6,796)	(5,431)
Enlivant Joint Venture
Balance Sheet Amounts
Total assets	490,541	504,920
Total liabilities	824,410	815,299
Member’s deficit	(333,869)	(310,379)
Income Statement Amounts
Total revenues	299,031	312,055	303,486
Operating expenses	240,331	231,659	228,458
Net income	$ 5,196	$ 13,161	$ 10,378

IMPAIRMENT OF REAL ESTATE AND_2

IMPAIRMENT OF REAL ESTATE AND DISPOSITIONS (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2020USD ($)facility	Dec. 31, 2019USD ($)facility	Dec. 31, 2018USD ($)facility
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Real estate impairment	$ 4,003	$ 121,819	$ 1,413
Skilled Nursing Transitional Care Facilities and Senior Housing Facilities
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Real estate impairment		$ 26,600
Skilled Nursing/Transitional Care Facilities
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Real estate impairment			$ 900
Number of real estate properties impaired | facility	1	6	1
Senior Housing Communities
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Real estate impairment			$ 500
Number of real estate properties impaired | facility	3	4	1
Senior Care Centers Facilities
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Real estate impairment		$ 95,200
Senior Care Centers Facilities - Subsequently Sold
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of real estate properties impaired | facility		30
Senior Care Centers Facilities - Not Subsequently Sold
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of real estate properties impaired | facility		1
2020 Dispositions | Skilled Nursing/Transitional Care Facilities | Dispositions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Real estate impairment	$ 600	$ 15,500
Number of facilities sold | facility	8
Aggregate sale price of facility	$ 50,000
Carrying value of assets and liabilities of facility	47,100
Net gain (loss) on sale	2,900
Net income (loss) from facilities sold	$ 4,000	(12,600)	$ 5,400
2019 Dispositions | Skilled Nursing Transitional Care Facilities and Senior Housing Facilities | Dispositions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Real estate impairment		89,400	900
Aggregate sale price of facility		323,600
Carrying value of assets and liabilities of facility		321,300
Net gain (loss) on sale		2,300
Net income (loss) from facilities sold		$ (84,900)	19,100
2019 Dispositions | Skilled Nursing/Transitional Care Facilities | Dispositions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of facilities sold | facility		39
2019 Dispositions | Senior Housing Communities | Dispositions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of facilities sold | facility		7
2018 Dispositions | Skilled Nursing Transitional Care Facilities, Senior Housing Facilities, And Senior Housing - Managed Portfolio [Member] | Dispositions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Real estate impairment			500
Aggregate sale price of facility			382,600
Carrying value of assets and liabilities of facility			254,400
Net gain (loss) on sale			128,200
Net income (loss) from facilities sold			$ (151,300)
2018 Dispositions | Skilled Nursing/Transitional Care Facilities | Dispositions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of facilities sold | facility			51
2018 Dispositions | Senior Housing Communities | Dispositions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of facilities sold | facility			6
2018 Dispositions | Senior Housing - Managed | Dispositions
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Number of facilities sold | facility			1

INTANGIBLE ASSETS AND LIABILI_3

INTANGIBLE ASSETS AND LIABILITIES - Summary of Intangible Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Lease Intangible Assets:
Gross lease intangible assets	$ 119,397	$ 139,424
Accumulated amortization	(36,601)	(37,915)
Lease intangible assets, net	82,796	101,509
Lease Intangible Liabilities:
Below market leases	89,389	99,133
Accumulated amortization	(31,664)	(29,187)
Lease intangible liabilities, net	57,725	69,946
Above market leases
Lease Intangible Assets:
Gross lease intangible assets	35,695	51,040
Tenant origination and absorption costs
Lease Intangible Assets:
Gross lease intangible assets	60,413	65,234
Tenant relationship
Lease Intangible Assets:
Gross lease intangible assets	$ 23,289	$ 23,150

INTANGIBLE ASSETS AND LIABILI_4

INTANGIBLE ASSETS AND LIABILITIES - Summary of Real Estate Intangible Amortization (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Increase (decrease) to rental income related to above/below market leases, net
Finite-Lived Intangible Assets
Increase (decrease) to rental income related to above/below market leases, net	$ 849	$ 508	$ (7,701)
Depreciation and amortization related to tenant origination and absorption costs and tenant relationship
Finite-Lived Intangible Assets
Depreciation and amortization related to tenant origination and absorption costs and tenant relationship	$ (10,620)	$ (17,674)	$ (16,118)

INTANGIBLE ASSETS AND LIABILI_5

INTANGIBLE ASSETS AND LIABILITIES - Remaining Unamortized Balance for Outstanding Intangible Assets and Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets
Lease intangible assets, net	$ 82,796	$ 101,509
Lease Intangible Assets
Finite-Lived Intangible Assets
2021	10,277
2022	9,936
2023	8,895
2024	8,480
2025	8,012
Thereafter	37,196
Lease intangible assets, net	$ 82,796
Lease Intangible Assets | Weighted Average
Finite-Lived Intangible Assets
Weighted-average remaining amortization period	10 years 3 months 18 days
Lease Intangible Liabilities
Finite-Lived Intangible Assets
2021	$ 8,012
2022	7,269
2023	7,269
2024	7,168
2025	6,228
Thereafter	21,779
Lease intangible assets, net	$ 57,725
Lease Intangible Liabilities | Weighted Average
Finite-Lived Intangible Assets
Weighted-average remaining amortization period	8 years 6 months

LOANS RECEIVABLE AND OTHER IN_3

LOANS RECEIVABLE AND OTHER INVESTMENTS - Composition of Loans Receivable and Other Investments (Details) $ in Thousands	Dec. 31, 2020USD ($)loaninvestmentpreferredEquityInvestment	Dec. 31, 2019USD ($)
Loans Receivable:
Quantity | loan	18
Principal balance	$ 65,320	$ 67,527
Book Value	61,357	63,634
Allowance for loan losses	(2,458)	(564)
Book Value	$ 58,899	63,070
Weighted Average Contractual Interest Rate / Rate of Return	7.80%
Weighted Average Annualized Effective Interest Rate / Rate of Return	7.90%
Preferred Equity
Quantity | preferredEquityInvestment	6
Principal Balance	$ 43,724	43,893
Book Value	$ 43,940	44,304
Weighted Average Contractual Interest Rate / Rate of Return	11.30%
Weighted Average Annualized Effective Interest Rate / Rate of Return	11.30%
Total Quantity | investment	24
Total Principal Balance	$ 109,044
Total Book Value	$ 102,839	107,374
Total Weighted Average Contractual Interest Rate / Rate of Return	9.20%
Total Weighted Average Annualized Effective Interest Rate / Rate of Return	9.30%
Mortgage
Loans Receivable:
Quantity | loan	1
Principal balance	$ 19,000
Book Value	$ 19,000	19,000
Weighted Average Contractual Interest Rate / Rate of Return	10.00%
Weighted Average Annualized Effective Interest Rate / Rate of Return	10.00%
Construction
Loans Receivable:
Quantity | loan	1
Principal balance	$ 3,343
Book Value	$ 3,352	2,487
Weighted Average Contractual Interest Rate / Rate of Return	8.00%
Weighted Average Annualized Effective Interest Rate / Rate of Return	7.80%
Other
Loans Receivable:
Quantity | loan	16
Principal balance	$ 42,977
Book Value	$ 39,005	$ 42,147
Weighted Average Contractual Interest Rate / Rate of Return	6.80%
Weighted Average Annualized Effective Interest Rate / Rate of Return	6.90%

LOANS RECEIVABLE AND OTHER IN_4

LOANS RECEIVABLE AND OTHER INVESTMENTS - Narrative (Details)	12 Months Ended
	Dec. 31, 2020USD ($)loan	Dec. 31, 2019USD ($)loan
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal balance	$ 65,320,000	$ 67,527,000
Book value	61,357,000	63,634,000
Increase (decrease) in the allowance for loan losses	1,900,000
Allowance for loan losses	$ 2,458,000	$ 564,000
Nonperforming Financial Instruments
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of loans receivable considered to be impaired | loan		0
Number of loans receivable on nonaccrual status | loan	2	2
Book value of loans receivable on nonaccrual status	$ 0	$ 0
Portfolio-Based Loan Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Increase (decrease) in the allowance for loan losses		4,000
Allowance for loan losses		600,000
Specific Loans | Nonperforming Financial Instruments
Accounts, Notes, Loans and Financing Receivable [Line Items]
Allowance for loan losses		0
Provision recorded for specific loan losses		1,200,000
Receivables Acquired with Deteriorated Credit Quality
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of loans receivable considered to be impaired | loan	4
Principal balance	$ 2,100,000	27,700,000
Book value	$ 500,000	$ 4,200,000

LOANS RECEIVABLE AND OTHER IN_5

LOANS RECEIVABLE AND OTHER INVESTMENTS - Changes in the Accretable Yield (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Accretable Yield Movement Schedule [Roll Forward]
Accretable yield, beginning of period	$ 39	$ 449	$ 2,483
Accretion recognized in earnings	(27)	(377)	(2,761)
Reduction due to payoff	0	(33)	0
Net reclassification from nonaccretable difference	0	0	727
Accretable yield, end of period	$ 12	$ 39	$ 449

DEBT - Secured Debt (Details)

DEBT - Secured Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Deferred financing costs, net	$ 17,367
Secured Debt
Debt Instrument [Line Items]
Deferred financing costs, net	1,134	$ 1,700
Secured Debt | Fixed Rate
Debt Instrument [Line Items]
Principal, fixed rate	$ 80,199	$ 114,777
Weighted average interest rate	3.39%

DEBT - Narrative (Details)

DEBT - Narrative (Details)

Oct. 27, 2019USD ($)

Oct. 07, 2019USD ($)

Sep. 09, 2019USD ($)extension_option

Jun. 29, 2019USD ($)

May 29, 2019USD ($)

Aug. 17, 2017USD ($)

Dec. 31, 2020USD ($)property

Dec. 31, 2019USD ($)

Dec. 31, 2018USD ($)

Sep. 09, 2019CAD ($)extension_option

Oct. 10, 2014USD ($)

Jan. 23, 2014USD ($)

May 23, 2013USD ($)

Debt Instrument [Line Items]

Number of properties sold securing debt | property

3

Aggregate amount of secured debt assumed by buyer

$ 31,800,000

Loss on extinguishment of debt

531,000

$ 16,340,000

$ 2,917,000

Repayments of fixed rate secured debt

3,072,000

3,436,000

140,338,000

Payments made to noteholders and legal fees for early redemption

0

10,502,000

2,043,000

Proceeds from issuance of senior unsecured notes

0

638,779,000

0

Interest expense

100,424,000

126,610,000

147,106,000

Non-cash interest expense

8,418,000

10,080,000

10,137,000

Accrued interest

16,100,000

16,700,000

Secured Indebtedness

Debt Instrument [Line Items]

Loss on extinguishment of debt

900,000

Repayments of fixed rate secured debt

37,600,000

Aggregate principal amount of debt oustanding

80,199,000

114,777,000

Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount of debt oustanding

$ 1,250,000,000

1,250,000,000

Variable Rate Secured Term Loan | Secured Indebtedness

Debt Instrument [Line Items]

Loss on extinguishment of debt

2,000,000

Aggregate principal amount of debt oustanding

$ 98,500,000

5.5% Senior Unsecured Notes due 2021 | Senior Notes

Debt Instrument [Line Items]

Loss on extinguishment of debt

10,100,000

Interest rate

5.50%

Aggregate principal amount of debt redeemed

$ 500,000,000

Cash redemption price as a percent of principal amount redeemed

101.375%

Payments made to noteholders and legal fees for early redemption

6,900,000

Write-offs associated with unamortized deferred financing and premium costs

3,200,000

5.5% Senior Unsecured Notes due 2021 (Issued January 2014) | Senior Notes

Debt Instrument [Line Items]

Interest rate

5.50%

Aggregate principal amount of debt oustanding

$ 350,000,000

5.5% Senior Unsecured Notes due 2021 (Issued October 2014) | Senior Notes

Debt Instrument [Line Items]

Interest rate

5.50%

Aggregate principal amount of debt oustanding

$ 150,000,000

5.375% Senior Unsecured Notes due 2023 | Senior Notes

Debt Instrument [Line Items]

Loss on extinguishment of debt

5,600,000

Interest rate

5.375%

Aggregate principal amount of debt oustanding

$ 200,000,000

Aggregate principal amount of debt redeemed

$ 200,000,000

Cash redemption price as a percent of principal amount redeemed

101.792%

Payments made to noteholders and legal fees for early redemption

3,600,000

Write-offs associated with unamortized deferred financing and premium costs

$ 2,000,000

4.80% Senior Unsecured Notes due 2024

Debt Instrument [Line Items]

Required ratio of total unencumbered assets to unsecured debt

150.00%

4.80% Senior Unsecured Notes due 2024 | Senior Notes

Debt Instrument [Line Items]

Interest rate

4.80%

Aggregate principal amount of debt oustanding

$ 300,000,000

Proceeds from issuance of senior unsecured notes

$ 295,300,000

4.80% Senior Unsecured Notes due 2024 | Senior Notes | Redemption Period One

Debt Instrument [Line Items]

Redemption price percentage

100.00%

4.80% Senior Unsecured Notes due 2024 | Senior Notes | Redemption Period Two

Debt Instrument [Line Items]

Redemption price percentage

100.00%

5.125% Senior Unsecured Notes due 2026

Debt Instrument [Line Items]

Required ratio of total unencumbered assets to unsecured debt

150.00%

5.125% Senior Unsecured Notes due 2026 | Senior Notes

Debt Instrument [Line Items]

Interest rate

5.125%

Aggregate principal amount of debt oustanding

$ 500,000,000

Redemption price percentage

100.00%

5.38% Senior Unsecured Notes due 2027 | Senior Notes

Debt Instrument [Line Items]

Interest rate

5.38%

Aggregate principal amount of debt oustanding

$ 100,000,000

Redemption price percentage

100.00%

3.90% Senior Unsecured Notes due 2029

Debt Instrument [Line Items]

Required ratio of total unencumbered assets to unsecured debt

150.00%

3.90% Senior Unsecured Notes due 2029 | Senior Notes

Debt Instrument [Line Items]

Interest rate

3.90%

Aggregate principal amount of debt oustanding

$ 350,000,000

Proceeds from issuance of senior unsecured notes

$ 340,500,000

3.90% Senior Unsecured Notes due 2029 | Senior Notes | Redemption Period One

Debt Instrument [Line Items]

Redemption price percentage

100.00%

3.90% Senior Unsecured Notes due 2029 | Senior Notes | Redemption Period Two

Debt Instrument [Line Items]

Redemption price percentage

100.00%

Fifth Amended and Restated Credit Agreement | U.S. Dollar Term Loan

Debt Instrument [Line Items]

Aggregate principal amount of debt oustanding

$ 955,000,000

Interest rate

1.39%

Fifth Amended and Restated Credit Agreement | U.S. Dollar Term Loan | Redemption Period One

Debt Instrument [Line Items]

Aggregate principal amount of debt oustanding

105,000,000

Fifth Amended and Restated Credit Agreement | U.S. Dollar Term Loan | Redemption Period Two

Debt Instrument [Line Items]

Aggregate principal amount of debt oustanding

$ 350,000,000

Fifth Amended and Restated Credit Agreement | U.S. Dollar Term Loan | Base Rate | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

0.00%

Fifth Amended and Restated Credit Agreement | U.S. Dollar Term Loan | Base Rate | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

0.65%

Fifth Amended and Restated Credit Agreement | U.S. Dollar Term Loan | LIBOR | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

0.85%

Fifth Amended and Restated Credit Agreement | U.S. Dollar Term Loan | LIBOR | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

1.65%

Fifth Amended and Restated Credit Agreement | Canadian Dollar Term Loan

Debt Instrument [Line Items]

Aggregate principal amount of debt oustanding

$ 125,000,000

Interest rate

1.71%

Fixed interest rate under swap

0.93%

0.93%

Fifth Amended and Restated Credit Agreement | Canadian Dollar Term Loan | CDOR | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

0.85%

Fifth Amended and Restated Credit Agreement | Canadian Dollar Term Loan | CDOR | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

1.65%

Fifth Amended and Restated Credit Agreement | Revolving Credit Facility

Debt Instrument [Line Items]

Borrowing capacity (up to)

$ 1,000,000,000

Borrowing capacity in certain foreign currencies (up to)

$ 175,000,000

Number of optional extensions | extension_option

2

2

Optional extension period

6 months

Amount outstanding under credit facility

$ 0

Available borrowing capacity

$ 1,000,000,000

Interest rate

1.24%

Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | Minimum

Debt Instrument [Line Items]

Annum percent unused borrowing fee

0.125%

Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | Maximum

Debt Instrument [Line Items]

Annum percent unused borrowing fee

0.30%

Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | Federal Funds Rate

Debt Instrument [Line Items]

Basis spread on variable rate

0.50%

Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | Base Rate

Debt Instrument [Line Items]

Basis spread on variable rate

1.00%

Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | Base Rate | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

0.00%

Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | Base Rate | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

0.45%

Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | LIBOR | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

0.775%

Fifth Amended and Restated Credit Agreement | Revolving Credit Facility | LIBOR | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

1.45%

Fifth Amended and Restated Credit Agreement | Line of Credit

Debt Instrument [Line Items]

Borrowing capacity (up to)

$ 2,750,000,000

Fifth Amended and Restated Credit Agreement | Interest Rate Swap | U.S. Dollar Term Loan

Debt Instrument [Line Items]

Aggregate principal amount of debt oustanding

$ 845,000,000

Fixed interest rate under swap

1.24%

1.24%

DEBT - Senior Unsecured Notes (

DEBT - Senior Unsecured Notes (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Oct. 07, 2019	May 29, 2019	Aug. 17, 2017
Debt Instrument [Line Items]
Deferred financing costs, net	$ 17,367,000
Senior Notes
Debt Instrument [Line Items]
Principal balance	1,250,000,000	$ 1,250,000,000
Premium, net	6,400,000	7,600,000
Deferred financing costs, net	8,049,000	8,800,000
Senior Notes | 4.80% senior unsecured notes due 2024 (“2024 Notes”)
Debt Instrument [Line Items]
Principal balance	300,000,000	300,000,000
Interest rate				4.80%
Senior Notes | 5.125% senior unsecured notes due 2026 (“2026 Notes”)
Debt Instrument [Line Items]
Principal balance	500,000,000	500,000,000
Interest rate					5.125%
Senior Notes | 5.38% senior unsecured notes due 2027 (“2027 Notes”)
Debt Instrument [Line Items]
Principal balance	100,000,000	100,000,000
Interest rate					5.38%
Senior Notes | 3.90% senior unsecured notes due 2029 (“2029 Notes”)
Debt Instrument [Line Items]
Principal balance	$ 350,000,000	$ 350,000,000
Interest rate			3.90%

DEBT - Schedule of Maturities o

DEBT - Schedule of Maturities of Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
2020	$ 18,419
2021	107,412
2022	352,478
2023	900,645
2024	2,615
Thereafter	1,001,730
Total debt	2,383,299
Premium, net	6,442
Deferred financing costs, net	(17,367)
Total Debt, Net	2,372,374
Secured Indebtedness
Debt Instrument [Line Items]
2020	18,419
2021	2,412
2022	2,478
2023	2,545
2024	2,615
Thereafter	51,730
Total debt	80,199
Premium, net	0
Deferred financing costs, net	(1,134)	$ (1,700)
Total Debt, Net	79,065
Term Loans
Debt Instrument [Line Items]
2020	0
2021	105,000
2022	350,000
2023	598,100
2024	0
Thereafter	0
Total debt	1,053,100
Premium, net	0
Deferred financing costs, net	(8,184)
Total Debt, Net	1,044,916
Senior Notes
Debt Instrument [Line Items]
2020	0
2021	0
2022	0
2023	300,000
2024	0
Thereafter	950,000
Total debt	1,250,000
Premium, net	6,442
Deferred financing costs, net	(8,049)	$ (8,800)
Total Debt, Net	$ 1,248,393

DERIVATIVE AND HEDGING INSTRU_3

DERIVATIVE AND HEDGING INSTRUMENTS - Narrative (Details)	1 Months Ended	12 Months Ended
	May 31, 2019USD ($)derivative	Dec. 31, 2020USD ($)derivative	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Derivative [Line Items]
Fair value of derivatives in a net liability position		$ 37,018,000	$ 626,000
Forward Starting Interest Rate Swaps
Derivative [Line Items]
Number of derivative contracts terminated | derivative	3
Payments for termination of derivative instruments	$ 12,600,000
Credit-Risk-Related Contingent Features
Derivative [Line Items]
Fair value of derivatives in a net liability position		30,500,000
Termination value		29,600,000
Cash Flow Hedges | Interest Rate Swap
Derivative [Line Items]
Hedge ineffectiveness recorded in earnings		0	0	$ 0
Designated as Hedging Instrument
Derivative [Line Items]
Fair value of derivatives in a net liability position		135,118,000	96,651,000
Designated as Hedging Instrument | Cash Flow Hedges
Derivative [Line Items]
Losses included in accumulated other comprehensive loss		$ 13,000,000
Not Designated as Hedging Instrument | Cross Currency Interest Rate Swaps
Derivative [Line Items]
Number of derivative instruments held | derivative		1
Fair value of derivative asset		$ 100,000
Other income (expense)		$ (100,000)	$ 5,000	$ 34,000

DERIVATIVE AND HEDGING INSTRU_4

DERIVATIVE AND HEDGING INSTRUMENTS - Notional Amounts of Derivative Instruments (Details)	Jan. 31, 2023USD ($)	Dec. 31, 2020USD ($)derivative	Dec. 31, 2020CAD ($)derivative	Dec. 31, 2019USD ($)	Dec. 31, 2019CAD ($)
Not Designated as Hedging Instrument | Cross Currency Interest Rate Swaps
Derivative [Line Items]
Number of derivative instruments held | derivative		1	1
Cash Flow Hedges | Designated as Hedging Instrument
Derivative [Line Items]
Notional amount		$ 1,340,000,000		$ 1,490,000,000
Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swaps
Derivative [Line Items]
Notional amount			$ 250,000,000		$ 125,000,000
Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Contract with Accreting Balance
Derivative [Line Items]
Notional amount		$ 400,000,000
Cash Flow Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Contract with Accreting Balance | Forecast
Derivative [Line Items]
Notional amount	$ 600,000,000
Cash Flow Hedges | Designated as Hedging Instrument | Forward Starting Interest Rate Swaps - Effective January 2021
Derivative [Line Items]
Notional amount			$ 125,000,000
Number of derivative instruments held | derivative		2	2
Cash Flow Hedges | Designated as Hedging Instrument | Forward Starting Interest Rate Collar - Effective January 2021
Derivative [Line Items]
Number of derivative instruments held | derivative		1	1
Cash Flow Hedges | Designated as Hedging Instrument | Forward Starting Interest Rate Swaps And Forward Starting Interest Rate Collars
Derivative [Line Items]
Notional amount		$ 245,000,000
Cash Flow Hedges | Designated as Hedging Instrument | Forward Starting Interest Rate Swaps - Effective May 2024
Derivative [Line Items]
Notional amount		$ 250,000,000
Number of derivative instruments held | derivative		6	6
Net Investment Hedges | Designated as Hedging Instrument
Derivative [Line Items]
Notional amount			$ 125,000,000		125,000,000
Net Investment Hedges | Designated as Hedging Instrument | Cross Currency Interest Rate Swaps
Derivative [Line Items]
Notional amount			52,778,000		54,489,000
Net Investment Hedges | Not Designated as Hedging Instrument | Cross Currency Interest Rate Swaps
Derivative [Line Items]
Notional amount			$ 3,522,000		$ 1,811,000

DERIVATIVE AND HEDGING INSTRU_5

DERIVATIVE AND HEDGING INSTRUMENTS - Summary of Derivative and Financial Instruments Designated as Hedging Instruments (Details) $ in Thousands	Dec. 31, 2020USD ($)instrument	Dec. 31, 2019USD ($)
Assets:
Fair Value	$ 12,802	$ 7,477
Liabilities:
Fair Value	37,018	626
Designated as Hedging Instrument
Assets:
Fair Value	12,802	7,477
Liabilities:
Fair Value	$ 135,118	96,651
Designated as Hedging Instrument | Interest rate swaps | Cash flow | Accounts receivable, prepaid expenses and other assets, net
Assets:
Count | instrument	0
Fair Value	$ 0	4,239
Designated as Hedging Instrument | Interest rate swaps | Cash flow | Accounts payable and accrued liabilities
Liabilities:
Count | instrument	10
Fair Value	$ 23,849	0
Designated as Hedging Instrument | Interest rate collar | Cash flow | Accounts payable and accrued liabilities
Liabilities:
Count | instrument	1
Fair Value	$ 1,626	0
Designated as Hedging Instrument | Forward starting interest rate swaps | Cash flow | Accounts receivable, prepaid expenses and other assets, net
Assets:
Count | instrument	6
Fair Value	$ 10,652	0
Designated as Hedging Instrument | Forward starting interest rate swaps | Cash flow | Accounts payable and accrued liabilities
Liabilities:
Count | instrument	4
Fair Value	$ 10,723	494
Designated as Hedging Instrument | Cross currency interest rate swaps | Net investment | Accounts receivable, prepaid expenses and other assets, net
Assets:
Count | instrument	2
Fair Value	$ 2,150	3,238
Designated as Hedging Instrument | Forward starting interest rate collar | Cash flow | Accounts payable and accrued liabilities
Liabilities:
Count | instrument	1
Fair Value	$ 820	132
Designated as Hedging Instrument | CAD term loan | Net investment | Term loans, net
Liabilities:
Count | instrument	1
Fair Value	$ 98,100	$ 96,025

DERIVATIVE AND HEDGING INSTRU_6

DERIVATIVE AND HEDGING INSTRUMENTS - Effect of Derivative Financial Instruments on the Condensed Consolidated Statements of Income and Condensed Consolidated Statements of Equity (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Derivative Instruments, Gain (Loss) [Line Items]
(Loss) gain recognized in other comprehensive income	$ (38,153)	$ (25,029)	$ 14,149
(Loss) gain reclassified from accumulated other comprehensive income into income	(8,072)	5,545	3,099
Interest rate products | Interest expense
Derivative Instruments, Gain (Loss) [Line Items]
(Loss) gain recognized in other comprehensive income, cash flow hedges	(35,320)	(19,932)	2,707
(Loss) gain reclassified from accumulated other comprehensive income into income, cash flow hedges	(8,072)	5,545	3,099
Foreign currency products
Derivative Instruments, Gain (Loss) [Line Items]
(Loss) gain recognized in other comprehensive income, net investment hedges	(758)	(772)	3,554
(Loss) gain reclassified from accumulated other comprehensive income into income, net investment hedges	0	0	0
CAD term loan
Derivative Instruments, Gain (Loss) [Line Items]
(Loss) gain recognized in other comprehensive income, net investment hedges	(2,075)	(4,325)	7,888
(Loss) gain reclassified from accumulated other comprehensive income into income, net investment hedges	$ 0	$ 0	$ 0

DERIVATIVE AND HEDGING INSTRU_7

DERIVATIVE AND HEDGING INSTRUMENTS - Gross Presentation, Effects of Offsetting, and a Net Presentation of Derivatives (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Offsetting Assets:
Gross Amounts of Recognized Assets	$ 12,802	$ 7,477
Gross Amounts Offset in the Balance Sheet	0	0
Net Amounts of Assets presented in the Balance Sheet	12,802	7,477
Financial Instruments	(7,420)	(544)
Cash Collateral Received	0	0
Net Amount	5,382	6,933
Offsetting Liabilities:
Gross Amounts of Recognized Liabilities	37,018	626
Gross Amounts Offset in the Balance Sheet	0	0
Net Amounts of Liabilities presented in the Balance Sheet	37,018	626
Financial Instruments	(7,420)	(544)
Cash Collateral Received	0	0
Net Amount	$ 29,598	$ 82

FAIR VALUE DISCLOSURES - Narrat

FAIR VALUE DISCLOSURES - Narrative (Details) - Discount Rate	Dec. 31, 2020
Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Loans receivable, measurement input	0.06
Preferred equity investments, measurement input	0.10
Minimum | Secured Debt
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt, measurement input	0.02
Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Loans receivable, measurement input	0.12
Preferred equity investments, measurement input	0.15
Maximum | Secured Debt
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt, measurement input	0.03
Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Loans receivable, measurement input	0.09
Preferred equity investments, measurement input	0.11
Weighted Average | Secured Debt
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt, measurement input	0.03

FAIR VALUE DISCLOSURES - Face V

FAIR VALUE DISCLOSURES - Face Values, Carrying Amounts and Fair Values of Financial Instruments (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable, face value	$ 65,320,000	$ 67,527,000
Preferred equity investments, face value	43,724,000	43,893,000
Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities, face value	1,250,000,000	1,250,000,000
Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities, face value	80,199,000	114,777,000
Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	58,899,000	63,070,000
Preferred equity investments	43,940,000	44,304,000
Carrying Amount | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	1,248,393,000	1,248,773,000
Carrying Amount | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	79,065,000	113,070,000
Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	60,421,000	59,832,000
Preferred equity investments	44,597,000	44,493,000
Fair Value | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	1,362,678,000	1,328,714,000
Fair Value | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	$ 79,326,000	$ 105,510,000

FAIR VALUE DISCLOSURES - Inputs

FAIR VALUE DISCLOSURES - Inputs Used for Valuation of Financial Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Total
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	$ 60,421	$ 59,832
Preferred equity investments	44,597	44,493
Total | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	1,362,678	1,328,714
Total | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	79,326	$ 105,510
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	0
Preferred equity investments	0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	0
Preferred equity investments	0
Recurring | Significant Other Observable Inputs (Level 2) | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	1,362,678
Recurring | Significant Other Observable Inputs (Level 2) | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	60,421
Preferred equity investments	44,597
Recurring | Significant Unobservable Inputs (Level 3) | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Significant Unobservable Inputs (Level 3) | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	79,326
Recurring | Total
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans receivable	60,421
Preferred equity investments	44,597
Recurring | Total | Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	1,362,678
Recurring | Total | Secured Indebtedness
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	$ 79,326

FAIR VALUE DISCLOSURES - Amount

FAIR VALUE DISCLOSURES - Amounts Measured at Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	$ 12,802	$ 7,477
Financial liabilities	37,018	$ 626
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Interest rate collar
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Forward starting interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Financial liabilities	0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Cross currency interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Forward starting interest rate collar
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Significant Other Observable Inputs (Level 2) | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	23,849
Recurring | Significant Other Observable Inputs (Level 2) | Interest rate collar
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	1,626
Recurring | Significant Other Observable Inputs (Level 2) | Forward starting interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	10,652
Financial liabilities	10,723
Recurring | Significant Other Observable Inputs (Level 2) | Cross currency interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	2,150
Recurring | Significant Other Observable Inputs (Level 2) | Forward starting interest rate collar
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	820
Recurring | Significant Unobservable Inputs (Level 3) | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Significant Unobservable Inputs (Level 3) | Interest rate collar
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Significant Unobservable Inputs (Level 3) | Forward starting interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Financial liabilities	0
Recurring | Significant Unobservable Inputs (Level 3) | Cross currency interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	0
Recurring | Significant Unobservable Inputs (Level 3) | Forward starting interest rate collar
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	0
Recurring | Total | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	23,849
Recurring | Total | Interest rate collar
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	1,626
Recurring | Total | Forward starting interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	10,652
Financial liabilities	10,723
Recurring | Total | Cross currency interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial assets	2,150
Recurring | Total | Forward starting interest rate collar
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities	$ 820

EQUITY - Narrative (Details)

EQUITY - Narrative (Details) - USD ($)	Dec. 11, 2019	Feb. 25, 2019	Jun. 01, 2018	Mar. 21, 2013	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Class of Stock [Line Items]
Preferred stock dividend rate				7.125%
Redemption price per share (in dollars per share)			$ 25
Accrued and unpaid dividends (in dollars per share)			0.4453125
Redemption price per share (in dollars per share)			$ 25.4453125
Vesting of common stock units (in shares)					200,000	100,000
Tax withholding obligations					$ 3,200,000	$ 1,500,000	$ 400,000
ATM Program and Prior ATM Program
Class of Stock [Line Items]
Shares of common stock issued (in shares)						26,800,000
Proceeds from issuance of common stock						$ 560,000,000
Payments for stock issuance commissions						$ 7,700,000
ATM Program and Prior ATM Program | Average
Class of Stock [Line Items]
Price per share (in dollars per share)						$ 20.92
Prior ATM Program
Class of Stock [Line Items]
Maximum proceeds from common stock issuances (up to)		$ 500,000,000
ATM Program
Class of Stock [Line Items]
Maximum proceeds from common stock issuances (up to)	$ 400,000,000
Shares of common stock issued (in shares)					3,700,000
Proceeds from issuance of common stock					$ 60,000,000
Payments for stock issuance commissions					900,000
Amount available for issuance					$ 234,700,000
ATM Program | Average
Class of Stock [Line Items]
Price per share (in dollars per share)					$ 16.23
ATM Program - Forward Feature
Class of Stock [Line Items]
Maximum proceeds from common stock issuances (up to)					$ 45,300,000
Shares of common stock issued (in shares)					1,400,000
Proceeds from issuance of common stock					$ 25,000,000
Initial weighted average price (in dollars per share)					$ 17.44
Forward sale agreements term					1 year
Shares outstanding under forward sale agreement (in shares)					1,100,000
ATM Program - Forward Feature | Average
Class of Stock [Line Items]
Price per share (in dollars per share)					$ 17.45
Preferred Stock Dividends
Class of Stock [Line Items]
Charge related to original issuance costs							$ 5,500,000
Preferred Stock
Class of Stock [Line Items]
Shares redeemed (in shares)			5,750,000				5,750,000

EQUITY - Summary of Accumulated

EQUITY - Summary of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]
Equity	$ 3,409,228	$ 3,488,460	$ 3,254,747	$ 3,437,249
Total accumulated other comprehensive loss
Accumulated Other Comprehensive Income (Loss) [Line Items]
Equity	(39,911)	(12,388)	$ 12,301	$ 11,289
Foreign currency translation loss
Accumulated Other Comprehensive Income (Loss) [Line Items]
Equity	(1,831)	(1,516)
Unrealized loss on cash flow hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Equity	$ (38,080)	$ (10,872)

STOCK-BASED COMPENSATION - Narr

STOCK-BASED COMPENSATION - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total fair value of units vested	$ 10,700	$ 7,900	$ 3,600
Stock-based compensation expense	7,907	9,819	7,648
Total unrecognized stock-based compensation expense	$ 20,800
Weighted average period to recognized stock-based compensation expense	2 years 7 months 6 days
Discretionary matching contribution percent	4.00%
Matching contributions	$ 200	200	200
General and Administrative Expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 7,900	$ 9,800	$ 7,600
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares of common stock convertible upon each performance-based restricted stock unit vesting (in shares)	1
Weighted average remaining vesting period	2 years 7 months 6 days
Weighted average fair value per share (in dollars per share)	$ 17.13	$ 20.59	$ 16.02
Restricted Stock Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Restricted Stock Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	5 years
FFO Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	0.00%
FFO Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	200.00%
TSR Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Historical volatility rate period	3 years
TSR Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	0.00%
TSR Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	200.00%

STOCK-BASED COMPENSATION - Summ

STOCK-BASED COMPENSATION - Summary of Additional Information Concerning Restricted Stock Units (Details) - Restricted Stock Units - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Restricted Stock Units
Unvested beginning balance (in shares)	1,737,862
Granted (in shares)	623,523
Vested (in shares)	(540,751)
Dividends reinvested (in shares)	157,905
Cancelled (in shares)	(163,124)
Unvested ending balance (in shares)	1,815,415	1,737,862
Weighted Average Grant Date Fair Value Per Unit
Unvested beginning balance (in dollars per share)	$ 18.35
Granted (in dollars per share)	17.13	$ 20.59	$ 16.02
Vested (in dollars per share)	17.84
Dividends reinvested (in dollars per share)	18.44
Cancelled (in dollars per share)	20.70
Unvested ending balance (in dollars per share)	$ 17.88	$ 18.35

STOCK-BASED COMPENSATION - Su_2

STOCK-BASED COMPENSATION - Summary of Assumptions Used in Total Stockholder Return-Based Stock Units Valuation (Details) - TSR Units	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Assumptions used in fair value valuation
Expected dividend yield (assuming full reinvestment)	0.00%	0.00%	0.00%
Minimum
Assumptions used in fair value valuation
Risk free interest rate	0.17%	1.57%	2.36%
Expected stock price volatility	23.80%	23.80%	28.57%
Expected service period	2 years 8 months 12 days	2 years 4 months 24 days	2 years 6 months
Maximum
Assumptions used in fair value valuation
Risk free interest rate	1.63%	2.54%	2.59%
Expected stock price volatility	53.17%	28.57%	30.02%
Expected service period	3 years	3 years	3 years

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Business Acquisition [Line Items]
Income tax benefit	$ (710)	$ (3,402)	$ (3,011)
Acquisitions in Canada | Foreign Tax Authority | Canada Revenue Agency
Business Acquisition [Line Items]
Income tax benefit	600	500	600
Valuation allowance	$ 800	$ 500	$ 700

EARNINGS PER COMMON SHARE - Com

EARNINGS PER COMMON SHARE - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Numerator
Net income attributable to common stockholders	$ 138,417	$ 68,996	$ 269,314
Denominator
Basic weighted average common shares and common equivalents (in shares)	206,223,503	187,172,210	178,305,738
Dilutive stock options and restricted stock units (in shares)	1,029,327	954,882	416,006
Dilutive weighted average common shares (in shares)	207,252,830	188,127,092	178,721,744
Net income attributable to common stockholders, per:
Basic common share (in dollars per share)	$ 0.67	$ 0.37	$ 1.51
Diluted common share (in dollars per share)	$ 0.67	$ 0.37	$ 1.51

EARNINGS PER COMMON SHARE - Nar

EARNINGS PER COMMON SHARE - Narrative (Details) - shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share
Stock options outstanding (in shares)	0	0
Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share
Anti-dilutive shares excluded from the computation of earnings per share (in shares)	67,000	1,000	121,000
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share
Anti-dilutive shares excluded from the computation of earnings per share (in shares)			0

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - $ / shares	Feb. 02, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Subsequent Event
Common stock dividends declared (in dollars per share)		$ 1.35	$ 1.80	$ 1.80
Dividend Declared | Subsequent Event
Subsequent Event
Common stock dividends declared (in dollars per share)	$ 0.30

SCHEDULE II - VALUATION AND Q_2

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Jan. 01, 2020	Jan. 01, 2019	Dec. 31, 2017
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	$ 564	$ 40,742	$ 17,972
Charged to Earnings	1,855	1,238	41,793
Recoveries	0	0	(2,718)
Uncollectible Accounts Written-off	0	(41,416)	(16,305)
Balance at End of Year	2,586	564	40,742
Equity	3,409,228	3,488,460	3,254,747			$ 3,437,249
Cumulative Distributions in Excess of Net Income
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Equity	(716,195)	(573,283)	(271,595)			(217,236)
Cumulative Effect
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Equity		(167)	(32,502)			0
Cumulative Effect | Cumulative Distributions in Excess of Net Income
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Equity		(167)	(32,502)	$ 200	$ (32,500)	$ (795)
Adjusted Balance
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	731
Balance at End of Year		731
Allowance for doubtful accounts
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	0	3,706	5,520
Charged to Earnings		0	986
Recoveries		0	(2,718)
Uncollectible Accounts Written-off		(3,706)	(82)
Balance at End of Year		0	3,706
Straight-line rent receivable allowance
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	0	35,778	12,355
Charged to Earnings		0	39,646
Recoveries		0	0
Uncollectible Accounts Written-off		(35,778)	(16,223)
Balance at End of Year		0	35,778
Allowance for loan losses
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	564	1,258	97
Charged to Earnings	1,916	1,238	1,161
Recoveries	0	0	0
Uncollectible Accounts Written-off	0	(1,932)	0
Balance at End of Year	2,458	564	$ 1,258
Allowance for loan losses | Cumulative Effect | Cumulative Distributions in Excess of Net Income
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Equity				(22)
Allowance for loan losses | Adjusted Balance
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	542
Balance at End of Year		542
Allowance for credit losses - sales-type lease
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Charged to Earnings	(61)
Recoveries	0
Uncollectible Accounts Written-off	0
Balance at End of Year	128
Allowance for credit losses - sales-type lease | Cumulative Effect | Cumulative Distributions in Excess of Net Income
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Equity				$ 189
Allowance for credit losses - sales-type lease | Adjusted Balance
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Year	$ 189
Balance at End of Year		$ 189

SCHEDULE III - REAL ESTATE AS_2

SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION - Summary of Real Estate Properties (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Real Estate and Accumulated Depreciation
Encumbrances	$ 80,199
Initial Cost to Company
Land	595,791
Buildings and Improvements	5,258,376
Total	5,854,167
Cost Capitalized Subsequent to Acquisition	121,128
Gross Amount at which Carried at Close of Period
Land	594,843
Building and Improvements	5,371,852
Total	5,966,695	$ 5,880,583	$ 6,255,883	$ 6,334,855
Accumulated Depreciation and Amortization	(681,657)	(539,213)	$ (402,338)	$ (340,423)
Deferred financing costs, net	17,367
Aggregate cost of real estate for federal income tax purposes	5,000,000
Secured Debt
Gross Amount at which Carried at Close of Period
Deferred financing costs, net	1,134	$ 1,700
Operating Segments
Real Estate and Accumulated Depreciation
Encumbrances	80,199
Initial Cost to Company
Land	595,791
Buildings and Improvements	5,258,240
Total	5,854,031
Cost Capitalized Subsequent to Acquisition	120,462
Gross Amount at which Carried at Close of Period
Land	594,843
Building and Improvements	5,371,050
Total	5,965,893
Accumulated Depreciation and Amortization	(681,253)
Corporate Assets
Real Estate and Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	0
Buildings and Improvements	136
Total	136
Cost Capitalized Subsequent to Acquisition	666
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	802
Total	802
Accumulated Depreciation and Amortization	(404)
Multi-property Indebtedness
Real Estate and Accumulated Depreciation
Encumbrances	10,224
Initial Cost to Company
Land	0
Buildings and Improvements	0
Total	0
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	0
Total	0
Accumulated Depreciation and Amortization	0
Various Skilled Nursing/Transitional Care and Leased Senior Housing Facilities | Multi-property Indebtedness | Real Estate
Gross Amount at which Carried at Close of Period
Collateral amount	10,200
Skilled Nursing/Transitional Care Facilities
Real Estate and Accumulated Depreciation
Encumbrances	26,476
Initial Cost to Company
Land	376,386
Buildings and Improvements	3,218,616
Total	3,595,002
Cost Capitalized Subsequent to Acquisition	63,018
Gross Amount at which Carried at Close of Period
Land	376,164
Building and Improvements	3,268,306
Total	3,644,470
Accumulated Depreciation and Amortization	(385,094)
Skilled Nursing/Transitional Care Facilities | Forest Hills (SNF)
Initial Cost to Company
Land	1,653
Buildings and Improvements	11,259
Total	12,912
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,653
Building and Improvements	9,409
Total	11,062
Accumulated Depreciation and Amortization	$ (3,764)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Seminole Estates
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	655
Buildings and Improvements	3,527
Total	4,182
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	655
Building and Improvements	3,134
Total	3,789
Accumulated Depreciation and Amortization	$ (1,197)
Life on Which Depreciation in Latest Income Statement is Computed	32 years
Skilled Nursing/Transitional Care Facilities | Bedford Hills
Real Estate and Accumulated Depreciation
Encumbrances	$ 5,595
Initial Cost to Company
Land	1,911
Buildings and Improvements	12,245
Total	14,156
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,911
Building and Improvements	10,687
Total	12,598
Accumulated Depreciation and Amortization	$ (4,434)
Life on Which Depreciation in Latest Income Statement is Computed	36 years
Skilled Nursing/Transitional Care Facilities | The Elms Care
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	312
Buildings and Improvements	1,679
Total	1,991
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	312
Building and Improvements	1,289
Total	1,601
Accumulated Depreciation and Amortization	$ (918)
Life on Which Depreciation in Latest Income Statement is Computed	20 years
Skilled Nursing/Transitional Care Facilities | Lake Drive
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	160
Buildings and Improvements	549
Total	709
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	160
Building and Improvements	40
Total	200
Accumulated Depreciation and Amortization	$ (34)
Life on Which Depreciation in Latest Income Statement is Computed	10 years
Skilled Nursing/Transitional Care Facilities | Mineral Springs
Real Estate and Accumulated Depreciation
Encumbrances	$ 11,334
Initial Cost to Company
Land	417
Buildings and Improvements	5,352
Total	5,769
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	417
Building and Improvements	4,580
Total	4,997
Accumulated Depreciation and Amortization	$ (1,890)
Life on Which Depreciation in Latest Income Statement is Computed	43 years
Skilled Nursing/Transitional Care Facilities | Wolfeboro
Real Estate and Accumulated Depreciation
Encumbrances	$ 9,547
Initial Cost to Company
Land	454
Buildings and Improvements	4,531
Total	4,985
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	454
Building and Improvements	3,747
Total	4,201
Accumulated Depreciation and Amortization	$ (1,397)
Life on Which Depreciation in Latest Income Statement is Computed	41 years
Skilled Nursing/Transitional Care Facilities | Broadmeadow Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,650
Buildings and Improvements	21,730
Total	23,380
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,650
Building and Improvements	21,730
Total	23,380
Accumulated Depreciation and Amortization	$ (5,905)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Capitol Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,940
Buildings and Improvements	15,500
Total	20,440
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,940
Building and Improvements	15,500
Total	20,440
Accumulated Depreciation and Amortization	$ (4,405)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pike Creek Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,460
Buildings and Improvements	25,240
Total	27,700
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,460
Building and Improvements	25,240
Total	27,700
Accumulated Depreciation and Amortization	$ (6,934)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Renaissance Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,640
Buildings and Improvements	22,620
Total	24,260
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,640
Building and Improvements	22,620
Total	24,260
Accumulated Depreciation and Amortization	$ (6,336)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Clara Burke
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,527
Buildings and Improvements	12,453
Total	14,980
Cost Capitalized Subsequent to Acquisition	179
Gross Amount at which Carried at Close of Period
Land	2,527
Building and Improvements	12,632
Total	15,159
Accumulated Depreciation and Amortization	$ (3,470)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Warrington
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,617
Buildings and Improvements	11,662
Total	14,279
Cost Capitalized Subsequent to Acquisition	106
Gross Amount at which Carried at Close of Period
Land	2,617
Building and Improvements	11,768
Total	14,385
Accumulated Depreciation and Amortization	$ (2,959)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Ridgecrest
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	509
Buildings and Improvements	5,018
Total	5,527
Cost Capitalized Subsequent to Acquisition	1,333
Gross Amount at which Carried at Close of Period
Land	509
Building and Improvements	6,351
Total	6,860
Accumulated Depreciation and Amortization	$ (1,975)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Arbrook Plaza
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,783
Buildings and Improvements	14,219
Total	18,002
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,783
Building and Improvements	14,219
Total	18,002
Accumulated Depreciation and Amortization	$ (3,303)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Northgate Plaza
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,901
Buildings and Improvements	10,299
Total	15,200
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,901
Building and Improvements	10,299
Total	15,200
Accumulated Depreciation and Amortization	$ (2,465)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Gulf Pointe Plaza
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,005
Buildings and Improvements	6,628
Total	7,633
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,005
Building and Improvements	6,628
Total	7,633
Accumulated Depreciation and Amortization	$ (1,667)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Gateway Senior Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	6,368
Buildings and Improvements	29,919
Total	36,287
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	6,368
Building and Improvements	29,919
Total	36,287
Accumulated Depreciation and Amortization	$ (5,824)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Legacy
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	615
Buildings and Improvements	16,176
Total	16,791
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	615
Building and Improvements	16,176
Total	16,791
Accumulated Depreciation and Amortization	$ (3,454)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pointe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	615
Buildings and Improvements	2,943
Total	3,558
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	615
Building and Improvements	2,943
Total	3,558
Accumulated Depreciation and Amortization	$ (746)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Regency
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	246
Buildings and Improvements	6,206
Total	6,452
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	246
Building and Improvements	6,206
Total	6,452
Accumulated Depreciation and Amortization	$ (1,614)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Parkmoor Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	430
Buildings and Improvements	13,703
Total	14,133
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	430
Building and Improvements	13,703
Total	14,133
Accumulated Depreciation and Amortization	$ (3,089)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Adams PARC
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,332
Buildings and Improvements	6,904
Total	8,236
Cost Capitalized Subsequent to Acquisition	115
Gross Amount at which Carried at Close of Period
Land	1,332
Building and Improvements	7,019
Total	8,351
Accumulated Depreciation and Amortization	$ (1,338)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | PARCway
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,189
Buildings and Improvements	23,567
Total	25,756
Cost Capitalized Subsequent to Acquisition	1,056
Gross Amount at which Carried at Close of Period
Land	2,189
Building and Improvements	24,623
Total	26,812
Accumulated Depreciation and Amortization	$ (4,405)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Brookhaven Extensive Care
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	869
Buildings and Improvements	5,236
Total	6,105
Cost Capitalized Subsequent to Acquisition	109
Gross Amount at which Carried at Close of Period
Land	869
Building and Improvements	5,345
Total	6,214
Accumulated Depreciation and Amortization	$ (1,134)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cadia Healthcare of Hyattsville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	6,343
Buildings and Improvements	65,573
Total	71,916
Cost Capitalized Subsequent to Acquisition	14
Gross Amount at which Carried at Close of Period
Land	6,343
Building and Improvements	65,587
Total	71,930
Accumulated Depreciation and Amortization	$ (10,867)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cadia Healthcare of Annapolis
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,548
Buildings and Improvements	40,773
Total	42,321
Cost Capitalized Subsequent to Acquisition	103
Gross Amount at which Carried at Close of Period
Land	1,548
Building and Improvements	40,876
Total	42,424
Accumulated Depreciation and Amortization	$ (6,314)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cadia Healthcare of Wheaton
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	676
Buildings and Improvements	56,897
Total	57,573
Cost Capitalized Subsequent to Acquisition	22
Gross Amount at which Carried at Close of Period
Land	676
Building and Improvements	56,919
Total	57,595
Accumulated Depreciation and Amortization	$ (8,618)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cadia Healthcare of Hagerstown
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,475
Buildings and Improvements	56,237
Total	57,712
Cost Capitalized Subsequent to Acquisition	4,733
Gross Amount at which Carried at Close of Period
Land	1,475
Building and Improvements	60,970
Total	62,445
Accumulated Depreciation and Amortization	$ (8,200)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cadia Healthcare of Spring Brook
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	963
Buildings and Improvements	48,085
Total	49,048
Cost Capitalized Subsequent to Acquisition	7
Gross Amount at which Carried at Close of Period
Land	963
Building and Improvements	48,092
Total	49,055
Accumulated Depreciation and Amortization	$ (5,945)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Andrew Residence
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,931
Buildings and Improvements	6,943
Total	9,874
Cost Capitalized Subsequent to Acquisition	565
Gross Amount at which Carried at Close of Period
Land	2,931
Building and Improvements	7,462
Total	10,393
Accumulated Depreciation and Amortization	$ (849)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Riverpark of Eugene
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,205
Buildings and Improvements	28,700
Total	30,905
Cost Capitalized Subsequent to Acquisition	2,252
Gross Amount at which Carried at Close of Period
Land	2,205
Building and Improvements	30,952
Total	33,157
Accumulated Depreciation and Amortization	$ (3,096)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Lebanon
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	958
Buildings and Improvements	14,176
Total	15,134
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	958
Building and Improvements	14,176
Total	15,134
Accumulated Depreciation and Amortization	$ (1,277)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Crestview of Portland
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,791
Buildings and Improvements	12,833
Total	14,624
Cost Capitalized Subsequent to Acquisition	2,761
Gross Amount at which Carried at Close of Period
Land	1,791
Building and Improvements	15,594
Total	17,385
Accumulated Depreciation and Amortization	$ (1,824)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehabilitation of King City
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,011
Buildings and Improvements	11,667
Total	13,678
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,011
Building and Improvements	11,667
Total	13,678
Accumulated Depreciation and Amortization	$ (1,086)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehabilitation of Hillsboro
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,387
Buildings and Improvements	14,028
Total	15,415
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,387
Building and Improvements	14,028
Total	15,415
Accumulated Depreciation and Amortization	$ (1,263)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Junction City
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	584
Buildings and Improvements	7,901
Total	8,485
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	584
Building and Improvements	7,901
Total	8,485
Accumulated Depreciation and Amortization	$ (738)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Eugene
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,380
Buildings and Improvements	14,921
Total	16,301
Cost Capitalized Subsequent to Acquisition	1,791
Gross Amount at which Carried at Close of Period
Land	1,380
Building and Improvements	16,712
Total	18,092
Accumulated Depreciation and Amortization	$ (1,801)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Coos Bay
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	829
Buildings and Improvements	8,518
Total	9,347
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	829
Building and Improvements	8,518
Total	9,347
Accumulated Depreciation and Amortization	$ (826)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Clackamas
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	792
Buildings and Improvements	5,000
Total	5,792
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	792
Building and Improvements	5,000
Total	5,792
Accumulated Depreciation and Amortization	$ (477)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Newport
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	406
Buildings and Improvements	5,001
Total	5,407
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	406
Building and Improvements	5,001
Total	5,407
Accumulated Depreciation and Amortization	$ (456)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehab of Oregon City
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,496
Buildings and Improvements	12,142
Total	13,638
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,496
Building and Improvements	12,142
Total	13,638
Accumulated Depreciation and Amortization	$ (1,093)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Transitional Care of Puget Sound
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,771
Buildings and Improvements	11,595
Total	13,366
Cost Capitalized Subsequent to Acquisition	15
Gross Amount at which Carried at Close of Period
Land	1,771
Building and Improvements	11,610
Total	13,381
Accumulated Depreciation and Amortization	$ (1,217)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Richmond Beach Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,703
Buildings and Improvements	14,444
Total	19,147
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,703
Building and Improvements	14,444
Total	19,147
Accumulated Depreciation and Amortization	$ (1,347)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | St. Francis of Bellingham
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	15,330
Total	15,330
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	15,330
Total	15,330
Accumulated Depreciation and Amortization	$ (1,442)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Olympic Rehabilitation of Sequim
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	427
Buildings and Improvements	4,450
Total	4,877
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	427
Building and Improvements	4,450
Total	4,877
Accumulated Depreciation and Amortization	$ (502)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Heritage Rehabilitation of Tacoma
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,705
Buildings and Improvements	4,952
Total	6,657
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,705
Building and Improvements	4,952
Total	6,657
Accumulated Depreciation and Amortization	$ (487)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere at Pacific Ridge
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,195
Buildings and Improvements	1,956
Total	4,151
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,195
Building and Improvements	1,956
Total	4,151
Accumulated Depreciation and Amortization	$ (255)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Rehabilitation of Cascade Park
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,782
Buildings and Improvements	15,116
Total	16,898
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,782
Building and Improvements	15,116
Total	16,898
Accumulated Depreciation and Amortization	$ (1,473)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | The Pearl at Kruse Way
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	5,947
Buildings and Improvements	13,401
Total	19,348
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	5,947
Building and Improvements	13,401
Total	19,348
Accumulated Depreciation and Amortization	$ (1,260)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere at Medford
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,043
Buildings and Improvements	38,485
Total	40,528
Cost Capitalized Subsequent to Acquisition	2,960
Gross Amount at which Carried at Close of Period
Land	2,043
Building and Improvements	41,445
Total	43,488
Accumulated Depreciation and Amortization	$ (4,091)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Bellingham Healthcare and Rehab Services
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,908
Buildings and Improvements	2,058
Total	4,966
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,908
Building and Improvements	2,058
Total	4,966
Accumulated Depreciation and Amortization	$ (260)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Queen Anne Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,508
Buildings and Improvements	6,401
Total	8,909
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,508
Building and Improvements	6,401
Total	8,909
Accumulated Depreciation and Amortization	$ (609)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Transitional Care and Rehab - Boise
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	681
Buildings and Improvements	9,348
Total	10,029
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	681
Building and Improvements	9,348
Total	10,029
Accumulated Depreciation and Amortization	$ (890)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Transitional Care at Sunnyside
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,114
Buildings and Improvements	15,651
Total	17,765
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,114
Building and Improvements	15,651
Total	17,765
Accumulated Depreciation and Amortization	$ (1,451)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Health Services of Rogue Valley
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,375
Buildings and Improvements	23,808
Total	25,183
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,375
Building and Improvements	23,808
Total	25,183
Accumulated Depreciation and Amortization	$ (2,227)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Transitional Care and Rehab - Malley
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,662
Buildings and Improvements	26,014
Total	27,676
Cost Capitalized Subsequent to Acquisition	3,258
Gross Amount at which Carried at Close of Period
Land	1,662
Building and Improvements	29,272
Total	30,934
Accumulated Depreciation and Amortization	$ (3,114)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avamere Transitional Care and Rehab - Brighton
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,933
Buildings and Improvements	11,624
Total	13,557
Cost Capitalized Subsequent to Acquisition	200
Gross Amount at which Carried at Close of Period
Land	1,933
Building and Improvements	11,824
Total	13,757
Accumulated Depreciation and Amortization	$ (1,124)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Phoenix Rehabilitation Services
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,270
Buildings and Improvements	11,502
Total	12,772
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,270
Building and Improvements	11,502
Total	12,772
Accumulated Depreciation and Amortization	$ (1,038)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Tustin Subacute Care Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,889
Buildings and Improvements	11,682
Total	13,571
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,889
Building and Improvements	11,682
Total	13,571
Accumulated Depreciation and Amortization	$ (1,025)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | La Mesa Inpatient Rehabilitation Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,276
Buildings and Improvements	8,177
Total	9,453
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,276
Building and Improvements	8,177
Total	9,453
Accumulated Depreciation and Amortization	$ (746)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Westminster
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,128
Buildings and Improvements	6,614
Total	8,742
Cost Capitalized Subsequent to Acquisition	487
Gross Amount at which Carried at Close of Period
Land	2,128
Building and Improvements	7,101
Total	9,229
Accumulated Depreciation and Amortization	$ (913)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Maple Wood Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,142
Buildings and Improvements	3,226
Total	4,368
Cost Capitalized Subsequent to Acquisition	653
Gross Amount at which Carried at Close of Period
Land	1,142
Building and Improvements	3,879
Total	5,021
Accumulated Depreciation and Amortization	$ (784)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Garden Valley Nursing & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,985
Buildings and Improvements	2,714
Total	4,699
Cost Capitalized Subsequent to Acquisition	303
Gross Amount at which Carried at Close of Period
Land	1,985
Building and Improvements	3,017
Total	5,002
Accumulated Depreciation and Amortization	$ (711)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Worthington Nursing & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	697
Buildings and Improvements	10,688
Total	11,385
Cost Capitalized Subsequent to Acquisition	285
Gross Amount at which Carried at Close of Period
Land	697
Building and Improvements	10,973
Total	11,670
Accumulated Depreciation and Amortization	$ (1,293)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Burlington House Rehabilitative and Alzheimer’s Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,686
Buildings and Improvements	10,062
Total	12,748
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,686
Building and Improvements	10,062
Total	12,748
Accumulated Depreciation and Amortization	$ (1,083)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Charlottesville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,840
Buildings and Improvements	8,450
Total	11,290
Cost Capitalized Subsequent to Acquisition	1,176
Gross Amount at which Carried at Close of Period
Land	2,840
Building and Improvements	9,626
Total	12,466
Accumulated Depreciation and Amortization	$ (1,193)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Sleepy Hollow
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	7,241
Buildings and Improvements	17,727
Total	24,968
Cost Capitalized Subsequent to Acquisition	2,032
Gross Amount at which Carried at Close of Period
Land	7,241
Building and Improvements	19,759
Total	27,000
Accumulated Depreciation and Amortization	$ (2,190)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Petersburg
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	988
Buildings and Improvements	8,416
Total	9,404
Cost Capitalized Subsequent to Acquisition	146
Gross Amount at which Carried at Close of Period
Land	988
Building and Improvements	8,562
Total	9,550
Accumulated Depreciation and Amortization	$ (922)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Battlefield Park
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,174
Buildings and Improvements	8,858
Total	10,032
Cost Capitalized Subsequent to Acquisition	151
Gross Amount at which Carried at Close of Period
Land	1,174
Building and Improvements	9,009
Total	10,183
Accumulated Depreciation and Amortization	$ (955)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Hagerstown
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,393
Buildings and Improvements	13,438
Total	14,831
Cost Capitalized Subsequent to Acquisition	150
Gross Amount at which Carried at Close of Period
Land	1,393
Building and Improvements	13,588
Total	14,981
Accumulated Depreciation and Amortization	$ (1,376)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Cumberland
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	800
Buildings and Improvements	16,973
Total	17,773
Cost Capitalized Subsequent to Acquisition	457
Gross Amount at which Carried at Close of Period
Land	800
Building and Improvements	17,430
Total	18,230
Accumulated Depreciation and Amortization	$ (1,760)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Gilroy Healthcare and Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	662
Buildings and Improvements	23,775
Total	24,437
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	662
Building and Improvements	23,775
Total	24,437
Accumulated Depreciation and Amortization	$ (2,117)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | North Cascades Health and Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,437
Buildings and Improvements	14,196
Total	15,633
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,437
Building and Improvements	14,196
Total	15,633
Accumulated Depreciation and Amortization	$ (1,323)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Granite Rehabilitation & Wellness
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	387
Buildings and Improvements	13,613
Total	14,000
Cost Capitalized Subsequent to Acquisition	2,246
Gross Amount at which Carried at Close of Period
Land	387
Building and Improvements	15,859
Total	16,246
Accumulated Depreciation and Amortization	$ (1,806)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Rawlins Rehabilitation & Wellness
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	281
Buildings and Improvements	6,007
Total	6,288
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	281
Building and Improvements	6,007
Total	6,288
Accumulated Depreciation and Amortization	$ (556)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wind River Rehabilitation & Wellness
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	199
Buildings and Improvements	11,398
Total	11,597
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	199
Building and Improvements	11,398
Total	11,597
Accumulated Depreciation and Amortization	$ (1,028)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Sage View Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	420
Buildings and Improvements	8,665
Total	9,085
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	420
Building and Improvements	8,665
Total	9,085
Accumulated Depreciation and Amortization	$ (815)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Shelton Health and Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	415
Buildings and Improvements	8,965
Total	9,380
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	415
Building and Improvements	8,965
Total	9,380
Accumulated Depreciation and Amortization	$ (899)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Dundee Nursing Home
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,437
Buildings and Improvements	4,631
Total	6,068
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,437
Building and Improvements	4,631
Total	6,068
Accumulated Depreciation and Amortization	$ (477)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Mt. Pleasant Nursing Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,689
Buildings and Improvements	3,942
Total	6,631
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,689
Building and Improvements	3,942
Total	6,631
Accumulated Depreciation and Amortization	$ (431)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Tri-State Comp Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,811
Buildings and Improvements	4,963
Total	6,774
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,811
Building and Improvements	4,963
Total	6,774
Accumulated Depreciation and Amortization	$ (554)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Epic-Conway
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,408
Buildings and Improvements	10,784
Total	12,192
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,408
Building and Improvements	10,784
Total	12,192
Accumulated Depreciation and Amortization	$ (1,083)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Epic- Bayview
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,842
Buildings and Improvements	11,389
Total	13,231
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,842
Building and Improvements	11,389
Total	13,231
Accumulated Depreciation and Amortization	$ (1,110)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Baytown
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	479
Buildings and Improvements	6,351
Total	6,830
Cost Capitalized Subsequent to Acquisition	209
Gross Amount at which Carried at Close of Period
Land	479
Building and Improvements	6,457
Total	6,936
Accumulated Depreciation and Amortization	$ (647)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Allenbrook
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	426
Buildings and Improvements	3,236
Total	3,662
Cost Capitalized Subsequent to Acquisition	173
Gross Amount at which Carried at Close of Period
Land	426
Building and Improvements	3,372
Total	3,798
Accumulated Depreciation and Amortization	$ (429)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Huntsville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	302
Buildings and Improvements	3,153
Total	3,455
Cost Capitalized Subsequent to Acquisition	75
Gross Amount at which Carried at Close of Period
Land	302
Building and Improvements	3,201
Total	3,503
Accumulated Depreciation and Amortization	$ (359)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	231
Buildings and Improvements	1,335
Total	1,566
Cost Capitalized Subsequent to Acquisition	312
Gross Amount at which Carried at Close of Period
Land	231
Building and Improvements	1,556
Total	1,787
Accumulated Depreciation and Amortization	$ (253)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Humble
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,114
Buildings and Improvements	1,643
Total	3,757
Cost Capitalized Subsequent to Acquisition	596
Gross Amount at which Carried at Close of Period
Land	2,114
Building and Improvements	2,100
Total	4,214
Accumulated Depreciation and Amortization	$ (389)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Beechnut
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,019
Buildings and Improvements	5,734
Total	6,753
Cost Capitalized Subsequent to Acquisition	318
Gross Amount at which Carried at Close of Period
Land	1,019
Building and Improvements	5,876
Total	6,895
Accumulated Depreciation and Amortization	$ (628)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Linden
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	112
Buildings and Improvements	256
Total	368
Cost Capitalized Subsequent to Acquisition	133
Gross Amount at which Carried at Close of Period
Land	112
Building and Improvements	331
Total	443
Accumulated Depreciation and Amortization	$ (82)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Sherman
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	469
Buildings and Improvements	6,310
Total	6,779
Cost Capitalized Subsequent to Acquisition	255
Gross Amount at which Carried at Close of Period
Land	469
Building and Improvements	6,400
Total	6,869
Accumulated Depreciation and Amortization	$ (663)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Mount Pleasant
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	250
Buildings and Improvements	6,913
Total	7,163
Cost Capitalized Subsequent to Acquisition	345
Gross Amount at which Carried at Close of Period
Land	250
Building and Improvements	7,249
Total	7,499
Accumulated Depreciation and Amortization	$ (768)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Waxahachie
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	416
Buildings and Improvements	7,259
Total	7,675
Cost Capitalized Subsequent to Acquisition	582
Gross Amount at which Carried at Close of Period
Land	416
Building and Improvements	7,789
Total	8,205
Accumulated Depreciation and Amortization	$ (773)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Gilmer
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	707
Buildings and Improvements	4,552
Total	5,259
Cost Capitalized Subsequent to Acquisition	93
Gross Amount at which Carried at Close of Period
Land	707
Building and Improvements	4,605
Total	5,312
Accumulated Depreciation and Amortization	$ (505)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Hearthstone of Northern Nevada
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,986
Buildings and Improvements	9,004
Total	10,990
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,986
Building and Improvements	9,004
Total	10,990
Accumulated Depreciation and Amortization	$ (902)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Richmond
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	259
Buildings and Improvements	9,819
Total	10,078
Cost Capitalized Subsequent to Acquisition	131
Gross Amount at which Carried at Close of Period
Land	259
Building and Improvements	9,950
Total	10,209
Accumulated Depreciation and Amortization	$ (936)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Petersburg
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	581
Buildings and Improvements	5,367
Total	5,948
Cost Capitalized Subsequent to Acquisition	23
Gross Amount at which Carried at Close of Period
Land	581
Building and Improvements	5,390
Total	5,971
Accumulated Depreciation and Amortization	$ (547)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Beverly Health - Ft. Pierce
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	787
Buildings and Improvements	16,648
Total	17,435
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	787
Building and Improvements	16,648
Total	17,435
Accumulated Depreciation and Amortization	$ (1,525)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Maryville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	114
Buildings and Improvements	5,955
Total	6,069
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	150
Building and Improvements	5,955
Total	6,105
Accumulated Depreciation and Amortization	$ (625)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Ashland Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	765
Buildings and Improvements	2,669
Total	3,434
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	765
Building and Improvements	2,669
Total	3,434
Accumulated Depreciation and Amortization	$ (300)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Bellefontaine Gardens
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,071
Buildings and Improvements	5,739
Total	7,810
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,071
Building and Improvements	5,739
Total	7,810
Accumulated Depreciation and Amortization	$ (645)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Current River Nursing Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	657
Buildings and Improvements	8,251
Total	8,908
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	657
Building and Improvements	8,251
Total	8,908
Accumulated Depreciation and Amortization	$ (816)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Dixon Nursing & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	521
Buildings and Improvements	3,358
Total	3,879
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	521
Building and Improvements	3,358
Total	3,879
Accumulated Depreciation and Amortization	$ (360)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Forsyth Nursing & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	594
Buildings and Improvements	8,549
Total	9,143
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	594
Building and Improvements	8,549
Total	9,143
Accumulated Depreciation and Amortization	$ (858)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Glenwood Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	658
Buildings and Improvements	901
Total	1,559
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	658
Building and Improvements	901
Total	1,559
Accumulated Depreciation and Amortization	$ (126)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Silex Community Care
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	807
Buildings and Improvements	4,990
Total	5,797
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	807
Building and Improvements	4,990
Total	5,797
Accumulated Depreciation and Amortization	$ (508)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | South Hampton Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,322
Buildings and Improvements	6,547
Total	8,869
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,322
Building and Improvements	6,547
Total	8,869
Accumulated Depreciation and Amortization	$ (677)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Strafford Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,634
Buildings and Improvements	6,518
Total	8,152
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,634
Building and Improvements	6,518
Total	8,152
Accumulated Depreciation and Amortization	$ (659)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Windsor Healthcare & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	471
Buildings and Improvements	6,819
Total	7,290
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	471
Building and Improvements	6,819
Total	7,290
Accumulated Depreciation and Amortization	$ (625)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of Conroe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,222
Buildings and Improvements	19,099
Total	20,321
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,222
Building and Improvements	19,099
Total	20,321
Accumulated Depreciation and Amortization	$ (1,711)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of Cypress Station
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,334
Buildings and Improvements	11,615
Total	12,949
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,334
Building and Improvements	11,615
Total	12,949
Accumulated Depreciation and Amortization	$ (1,084)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of Humble
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,541
Buildings and Improvements	12,332
Total	13,873
Cost Capitalized Subsequent to Acquisition	645
Gross Amount at which Carried at Close of Period
Land	1,541
Building and Improvements	12,977
Total	14,518
Accumulated Depreciation and Amortization	$ (1,306)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of Quail Valley
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,825
Buildings and Improvements	9,681
Total	11,506
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,825
Building and Improvements	9,681
Total	11,506
Accumulated Depreciation and Amortization	$ (939)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of Westchase
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,676
Buildings and Improvements	7,396
Total	10,072
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,676
Building and Improvements	7,396
Total	10,072
Accumulated Depreciation and Amortization	$ (734)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of CyFair
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,732
Buildings and Improvements	12,921
Total	14,653
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,732
Building and Improvements	12,921
Total	14,653
Accumulated Depreciation and Amortization	$ (1,197)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor of McKinney
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,441
Buildings and Improvements	9,017
Total	10,458
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,441
Building and Improvements	9,017
Total	10,458
Accumulated Depreciation and Amortization	$ (911)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Tanglewood Health and Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	176
Buildings and Improvements	2,340
Total	2,516
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	176
Building and Improvements	2,340
Total	2,516
Accumulated Depreciation and Amortization	$ (250)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Smoky Hill Health and Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	301
Buildings and Improvements	4,201
Total	4,502
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	301
Building and Improvements	4,201
Total	4,502
Accumulated Depreciation and Amortization	$ (428)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Belleville Health Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	600
Buildings and Improvements	1,664
Total	2,264
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	600
Building and Improvements	1,664
Total	2,264
Accumulated Depreciation and Amortization	$ (213)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Westridge Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,067
Buildings and Improvements	7,061
Total	8,128
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,067
Building and Improvements	7,061
Total	8,128
Accumulated Depreciation and Amortization	$ (677)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Willow Bend Living Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,168
Buildings and Improvements	9,562
Total	10,730
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,168
Building and Improvements	9,562
Total	10,730
Accumulated Depreciation and Amortization	$ (874)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Twin City Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	345
Buildings and Improvements	8,852
Total	9,197
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	345
Building and Improvements	8,852
Total	9,197
Accumulated Depreciation and Amortization	$ (808)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pine Knoll Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	711
Buildings and Improvements	5,554
Total	6,265
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	711
Building and Improvements	5,554
Total	6,265
Accumulated Depreciation and Amortization	$ (535)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Willow Crossing Health & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,290
Buildings and Improvements	10,714
Total	12,004
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,290
Building and Improvements	10,714
Total	12,004
Accumulated Depreciation and Amortization	$ (983)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Persimmon Ridge Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	315
Buildings and Improvements	9,848
Total	10,163
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	315
Building and Improvements	9,848
Total	10,163
Accumulated Depreciation and Amortization	$ (917)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Vermillion Convalescent Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	884
Buildings and Improvements	9,839
Total	10,723
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	884
Building and Improvements	9,839
Total	10,723
Accumulated Depreciation and Amortization	$ (962)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Las Vegas Post Acute & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	509
Buildings and Improvements	18,216
Total	18,725
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	509
Building and Improvements	18,216
Total	18,725
Accumulated Depreciation and Amortization	$ (1,598)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Torey Pines Rehabilitation Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,169
Buildings and Improvements	7,863
Total	11,032
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,169
Building and Improvements	7,863
Total	11,032
Accumulated Depreciation and Amortization	$ (777)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Villa Campana Rehabilitation Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,800
Buildings and Improvements	4,387
Total	6,187
Cost Capitalized Subsequent to Acquisition	1,131
Gross Amount at which Carried at Close of Period
Land	1,800
Building and Improvements	5,518
Total	7,318
Accumulated Depreciation and Amortization	$ (591)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Kachina Point Rehabilitation Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,035
Buildings and Improvements	10,981
Total	13,016
Cost Capitalized Subsequent to Acquisition	714
Gross Amount at which Carried at Close of Period
Land	2,035
Building and Improvements	11,695
Total	13,730
Accumulated Depreciation and Amortization	$ (1,136)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Bay View Rehabilitation Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,078
Buildings and Improvements	22,328
Total	25,406
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,078
Building and Improvements	22,328
Total	25,406
Accumulated Depreciation and Amortization	$ (2,003)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Dover Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	522
Buildings and Improvements	5,839
Total	6,361
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	522
Building and Improvements	5,839
Total	6,361
Accumulated Depreciation and Amortization	$ (729)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Augusta Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	135
Buildings and Improvements	6,470
Total	6,605
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	135
Building and Improvements	6,470
Total	6,605
Accumulated Depreciation and Amortization	$ (635)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Eastside Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	302
Buildings and Improvements	1,811
Total	2,113
Cost Capitalized Subsequent to Acquisition	2,112
Gross Amount at which Carried at Close of Period
Land	302
Building and Improvements	3,923
Total	4,225
Accumulated Depreciation and Amortization	$ (281)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Winship Green Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	250
Buildings and Improvements	1,934
Total	2,184
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	250
Building and Improvements	1,934
Total	2,184
Accumulated Depreciation and Amortization	$ (212)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Brewer Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	177
Buildings and Improvements	14,497
Total	14,674
Cost Capitalized Subsequent to Acquisition	2,436
Gross Amount at which Carried at Close of Period
Land	177
Building and Improvements	16,933
Total	17,110
Accumulated Depreciation and Amortization	$ (1,450)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Kennebunk Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	198
Buildings and Improvements	6,822
Total	7,020
Cost Capitalized Subsequent to Acquisition	76
Gross Amount at which Carried at Close of Period
Land	198
Building and Improvements	6,898
Total	7,096
Accumulated Depreciation and Amortization	$ (659)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Norway Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	791
Buildings and Improvements	3,680
Total	4,471
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	791
Building and Improvements	3,680
Total	4,471
Accumulated Depreciation and Amortization	$ (384)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Brentwood Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	134
Buildings and Improvements	2,072
Total	2,206
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	134
Building and Improvements	2,072
Total	2,206
Accumulated Depreciation and Amortization	$ (232)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Country Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	269
Buildings and Improvements	4,436
Total	4,705
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	269
Building and Improvements	4,436
Total	4,705
Accumulated Depreciation and Amortization	$ (575)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Sachem Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	447
Buildings and Improvements	1,357
Total	1,804
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	447
Building and Improvements	1,357
Total	1,804
Accumulated Depreciation and Amortization	$ (216)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Eliot Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	475
Buildings and Improvements	1,491
Total	1,966
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	475
Building and Improvements	1,491
Total	1,966
Accumulated Depreciation and Amortization	$ (204)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | The Reservoir Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	942
Buildings and Improvements	1,541
Total	2,483
Cost Capitalized Subsequent to Acquisition	8,727
Gross Amount at which Carried at Close of Period
Land	942
Building and Improvements	10,268
Total	11,210
Accumulated Depreciation and Amortization	$ (1,276)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Newton Wellesley Center for Alzheimer’s Care
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,186
Buildings and Improvements	13,917
Total	15,103
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,186
Building and Improvements	13,917
Total	15,103
Accumulated Depreciation and Amortization	$ (1,277)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Colony Center for Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,727
Buildings and Improvements	2,103
Total	3,830
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,727
Building and Improvements	2,103
Total	3,830
Accumulated Depreciation and Amortization	$ (268)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Westgate Center for Rehab & Alzheimer’s Care
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	229
Buildings and Improvements	7,171
Total	7,400
Cost Capitalized Subsequent to Acquisition	203
Gross Amount at which Carried at Close of Period
Land	229
Building and Improvements	7,374
Total	7,603
Accumulated Depreciation and Amortization	$ (716)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | New Orange Hills
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,163
Buildings and Improvements	14,755
Total	18,918
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,163
Building and Improvements	14,755
Total	18,918
Accumulated Depreciation and Amortization	$ (1,390)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Millbrook Healthcare & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	548
Buildings and Improvements	5,794
Total	6,342
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	548
Building and Improvements	5,794
Total	6,342
Accumulated Depreciation and Amortization	$ (600)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pleasant Valley Health & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,118
Buildings and Improvements	7,490
Total	8,608
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,118
Building and Improvements	7,490
Total	8,608
Accumulated Depreciation and Amortization	$ (739)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Clarksville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	279
Buildings and Improvements	4,269
Total	4,548
Cost Capitalized Subsequent to Acquisition	100
Gross Amount at which Carried at Close of Period
Land	279
Building and Improvements	4,369
Total	4,648
Accumulated Depreciation and Amortization	$ (496)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | McKinney Healthcare & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,272
Buildings and Improvements	6,047
Total	7,319
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,272
Building and Improvements	6,047
Total	7,319
Accumulated Depreciation and Amortization	$ (641)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Hopkins
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	807
Buildings and Improvements	4,668
Total	5,475
Cost Capitalized Subsequent to Acquisition	530
Gross Amount at which Carried at Close of Period
Land	807
Building and Improvements	5,198
Total	6,005
Accumulated Depreciation and Amortization	$ (672)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Florence
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	291
Buildings and Improvements	3,778
Total	4,069
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	291
Building and Improvements	3,778
Total	4,069
Accumulated Depreciation and Amortization	$ (418)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - South Shore
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	166
Buildings and Improvements	1,887
Total	2,053
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	166
Building and Improvements	1,887
Total	2,053
Accumulated Depreciation and Amortization	$ (217)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Rochester East
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	645
Buildings and Improvements	7,067
Total	7,712
Cost Capitalized Subsequent to Acquisition	178
Gross Amount at which Carried at Close of Period
Land	645
Building and Improvements	7,245
Total	7,890
Accumulated Depreciation and Amortization	$ (727)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Wisconsin Dells
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,640
Buildings and Improvements	1,599
Total	3,239
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,640
Building and Improvements	1,599
Total	3,239
Accumulated Depreciation and Amortization	$ (238)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Sheboygan
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,038
Buildings and Improvements	2,839
Total	3,877
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,038
Building and Improvements	2,839
Total	3,877
Accumulated Depreciation and Amortization	$ (358)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Golden Living Center - Hendersonville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,611
Buildings and Improvements	3,503
Total	5,114
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,611
Building and Improvements	3,503
Total	5,114
Accumulated Depreciation and Amortization	$ (407)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Corpus
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	366
Buildings and Improvements	6,961
Total	7,327
Cost Capitalized Subsequent to Acquisition	127
Gross Amount at which Carried at Close of Period
Land	51
Building and Improvements	1,061
Total	1,112
Accumulated Depreciation and Amortization	$ (373)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Burnet Bay
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	579
Buildings and Improvements	22,317
Total	22,896
Cost Capitalized Subsequent to Acquisition	103
Gross Amount at which Carried at Close of Period
Land	579
Building and Improvements	22,420
Total	22,999
Accumulated Depreciation and Amortization	$ (2,022)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Cedar Bayou
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	589
Buildings and Improvements	20,475
Total	21,064
Cost Capitalized Subsequent to Acquisition	328
Gross Amount at which Carried at Close of Period
Land	589
Building and Improvements	20,803
Total	21,392
Accumulated Depreciation and Amortization	$ (1,952)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Westwood
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,300
Buildings and Improvements	13,353
Total	14,653
Cost Capitalized Subsequent to Acquisition	31
Gross Amount at which Carried at Close of Period
Land	1,300
Building and Improvements	13,384
Total	14,684
Accumulated Depreciation and Amortization	$ (1,298)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Pasadena
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,148
Buildings and Improvements	23,579
Total	24,727
Cost Capitalized Subsequent to Acquisition	38
Gross Amount at which Carried at Close of Period
Land	1,148
Building and Improvements	23,617
Total	24,765
Accumulated Depreciation and Amortization	$ (2,170)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Webster
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	904
Buildings and Improvements	10,315
Total	11,219
Cost Capitalized Subsequent to Acquisition	24
Gross Amount at which Carried at Close of Period
Land	904
Building and Improvements	10,339
Total	11,243
Accumulated Depreciation and Amortization	$ (1,027)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Summer Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	945
Buildings and Improvements	20,424
Total	21,369
Cost Capitalized Subsequent to Acquisition	253
Gross Amount at which Carried at Close of Period
Land	945
Building and Improvements	20,677
Total	21,622
Accumulated Depreciation and Amortization	$ (1,875)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Focused Care at Orange
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	711
Buildings and Improvements	10,737
Total	11,448
Cost Capitalized Subsequent to Acquisition	171
Gross Amount at which Carried at Close of Period
Land	711
Building and Improvements	10,908
Total	11,619
Accumulated Depreciation and Amortization	$ (1,034)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Whitesburg Gardens
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	634
Buildings and Improvements	28,071
Total	28,705
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	634
Building and Improvements	28,071
Total	28,705
Accumulated Depreciation and Amortization	$ (2,479)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Terre Haute
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	644
Buildings and Improvements	37,451
Total	38,095
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	644
Building and Improvements	37,451
Total	38,095
Accumulated Depreciation and Amortization	$ (3,716)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare at Larkin Springs
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	902
Buildings and Improvements	3,850
Total	4,752
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	902
Building and Improvements	3,850
Total	4,752
Accumulated Depreciation and Amortization	$ (465)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Savannah
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,235
Buildings and Improvements	3,765
Total	5,000
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,235
Building and Improvements	3,765
Total	5,000
Accumulated Depreciation and Amortization	$ (476)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Bluffton
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	254
Buildings and Improvements	5,105
Total	5,359
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	254
Building and Improvements	5,105
Total	5,359
Accumulated Depreciation and Amortization	$ (549)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Bowling Green
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	280
Buildings and Improvements	13,975
Total	14,255
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	280
Building and Improvements	13,975
Total	14,255
Accumulated Depreciation and Amortization	$ (1,364)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Oakview Nursing and Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,176
Buildings and Improvements	7,012
Total	8,188
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,176
Building and Improvements	7,012
Total	8,188
Accumulated Depreciation and Amortization	$ (727)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Fountain Circle Care and Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	554
Buildings and Improvements	13,207
Total	13,761
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	554
Building and Improvements	13,207
Total	13,761
Accumulated Depreciation and Amortization	$ (1,316)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Riverside Care & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	613
Buildings and Improvements	7,643
Total	8,256
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	613
Building and Improvements	7,643
Total	8,256
Accumulated Depreciation and Amortization	$ (814)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Bremen
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	173
Buildings and Improvements	7,393
Total	7,566
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	173
Building and Improvements	7,393
Total	7,566
Accumulated Depreciation and Amortization	$ (720)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Muncie
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	374
Buildings and Improvements	27,429
Total	27,803
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	374
Building and Improvements	27,429
Total	27,803
Accumulated Depreciation and Amortization	$ (2,476)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare at Parkwood
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	612
Buildings and Improvements	11,755
Total	12,367
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	612
Building and Improvements	11,755
Total	12,367
Accumulated Depreciation and Amortization	$ (1,124)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare at Tower Road
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	364
Buildings and Improvements	16,116
Total	16,480
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	364
Building and Improvements	16,116
Total	16,480
Accumulated Depreciation and Amortization	$ (1,580)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Danville Centre for Health and Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	790
Buildings and Improvements	9,356
Total	10,146
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	790
Building and Improvements	9,356
Total	10,146
Accumulated Depreciation and Amortization	$ (1,075)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare at Hillcrest
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,048
Buildings and Improvements	22,587
Total	23,635
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,048
Building and Improvements	22,587
Total	23,635
Accumulated Depreciation and Amortization	$ (2,118)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Elizabethtown
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	239
Buildings and Improvements	4,853
Total	5,092
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	239
Building and Improvements	4,853
Total	5,092
Accumulated Depreciation and Amortization	$ (509)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Primacy
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,633
Buildings and Improvements	9,371
Total	11,004
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,633
Building and Improvements	9,371
Total	11,004
Accumulated Depreciation and Amortization	$ (962)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Harbour Pointe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	705
Buildings and Improvements	16,451
Total	17,156
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	705
Building and Improvements	16,451
Total	17,156
Accumulated Depreciation and Amortization	$ (1,746)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Harrodsburg Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,049
Buildings and Improvements	9,851
Total	10,900
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,049
Building and Improvements	9,851
Total	10,900
Accumulated Depreciation and Amortization	$ (1,077)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Putnam County
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,034
Buildings and Improvements	15,555
Total	16,589
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,034
Building and Improvements	15,555
Total	16,589
Accumulated Depreciation and Amortization	$ (1,493)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Fayette County
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	405
Buildings and Improvements	4,839
Total	5,244
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	405
Building and Improvements	4,839
Total	5,244
Accumulated Depreciation and Amortization	$ (551)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Galion
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	836
Buildings and Improvements	668
Total	1,504
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	836
Building and Improvements	668
Total	1,504
Accumulated Depreciation and Amortization	$ (124)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Roanoke Rapids
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	373
Buildings and Improvements	10,308
Total	10,681
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	373
Building and Improvements	10,308
Total	10,681
Accumulated Depreciation and Amortization	$ (1,088)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Kinston
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	954
Buildings and Improvements	7,987
Total	8,941
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	954
Building and Improvements	7,987
Total	8,941
Accumulated Depreciation and Amortization	$ (945)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Chapel Hill
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	809
Buildings and Improvements	2,703
Total	3,512
Cost Capitalized Subsequent to Acquisition	302
Gross Amount at which Carried at Close of Period
Land	809
Building and Improvements	3,005
Total	3,814
Accumulated Depreciation and Amortization	$ (460)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Chillicothe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	260
Buildings and Improvements	8,924
Total	9,184
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	260
Building and Improvements	8,924
Total	9,184
Accumulated Depreciation and Amortization	$ (972)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Signature Healthcare of Coshocton
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	374
Buildings and Improvements	2,530
Total	2,904
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	374
Building and Improvements	2,530
Total	2,904
Accumulated Depreciation and Amortization	$ (373)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | McCreary Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	208
Buildings and Improvements	7,665
Total	7,873
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	208
Building and Improvements	7,665
Total	7,873
Accumulated Depreciation and Amortization	$ (760)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Colonial Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	634
Buildings and Improvements	4,094
Total	4,728
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	634
Building and Improvements	4,094
Total	4,728
Accumulated Depreciation and Amortization	$ (474)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Glasgow Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	83
Buildings and Improvements	2,057
Total	2,140
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	83
Building and Improvements	2,057
Total	2,140
Accumulated Depreciation and Amortization	$ (288)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Green Valley Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	124
Buildings and Improvements	1,693
Total	1,817
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	124
Building and Improvements	1,693
Total	1,817
Accumulated Depreciation and Amortization	$ (249)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Hart County Health & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	208
Buildings and Improvements	7,070
Total	7,278
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	208
Building and Improvements	7,070
Total	7,278
Accumulated Depreciation and Amortization	$ (765)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Heritage Hall Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	635
Buildings and Improvements	9,861
Total	10,496
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	635
Building and Improvements	9,861
Total	10,496
Accumulated Depreciation and Amortization	$ (992)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Jackson Manor
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	479
Buildings and Improvements	6,078
Total	6,557
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	479
Building and Improvements	6,078
Total	6,557
Accumulated Depreciation and Amortization	$ (599)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Jefferson Manor
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,528
Buildings and Improvements	4,653
Total	8,181
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,528
Building and Improvements	4,653
Total	8,181
Accumulated Depreciation and Amortization	$ (574)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Jefferson Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,207
Buildings and Improvements	20,733
Total	22,940
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,207
Building and Improvements	20,733
Total	22,940
Accumulated Depreciation and Amortization	$ (1,928)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Monroe Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	333
Buildings and Improvements	9,556
Total	9,889
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	333
Building and Improvements	9,556
Total	9,889
Accumulated Depreciation and Amortization	$ (950)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | North Hardin Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,815
Buildings and Improvements	7,470
Total	9,285
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,815
Building and Improvements	7,470
Total	9,285
Accumulated Depreciation and Amortization	$ (941)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Professional Care Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	312
Buildings and Improvements	8,189
Total	8,501
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	312
Building and Improvements	8,189
Total	8,501
Accumulated Depreciation and Amortization	$ (832)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Rockford Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	427
Buildings and Improvements	6,003
Total	6,430
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	427
Building and Improvements	6,003
Total	6,430
Accumulated Depreciation and Amortization	$ (650)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Summerfield Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,134
Buildings and Improvements	9,166
Total	10,300
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,134
Building and Improvements	9,166
Total	10,300
Accumulated Depreciation and Amortization	$ (1,018)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Tanbark Senior Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,558
Buildings and Improvements	4,311
Total	6,869
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,558
Building and Improvements	4,311
Total	6,869
Accumulated Depreciation and Amortization	$ (521)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Summit Manor Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	114
Buildings and Improvements	11,141
Total	11,255
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	114
Building and Improvements	11,141
Total	11,255
Accumulated Depreciation and Amortization	$ (1,084)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Belle View Estates Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	206
Buildings and Improvements	3,179
Total	3,385
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	206
Building and Improvements	3,179
Total	3,385
Accumulated Depreciation and Amortization	$ (371)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | River Chase Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	508
Buildings and Improvements	0
Total	508
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	508
Building and Improvements	0
Total	508
Accumulated Depreciation and Amortization	$ 0
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Heartland Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,336
Buildings and Improvements	7,386
Total	8,722
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,336
Building and Improvements	7,386
Total	8,722
Accumulated Depreciation and Amortization	$ (786)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | River Ridge Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	227
Buildings and Improvements	4,007
Total	4,234
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	227
Building and Improvements	4,007
Total	4,234
Accumulated Depreciation and Amortization	$ (431)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Brookridge Cove Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	412
Buildings and Improvements	2,642
Total	3,054
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	466
Building and Improvements	2,642
Total	3,108
Accumulated Depreciation and Amortization	$ (349)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Southern Trace Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	819
Buildings and Improvements	8,938
Total	9,757
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	819
Building and Improvements	8,938
Total	9,757
Accumulated Depreciation and Amortization	$ (847)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Lake Village Rehabilitation and Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	507
Buildings and Improvements	4,838
Total	5,345
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	507
Building and Improvements	4,838
Total	5,345
Accumulated Depreciation and Amortization	$ (526)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Savannah Specialty Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,194
Buildings and Improvements	11,711
Total	13,905
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,194
Building and Improvements	11,711
Total	13,905
Accumulated Depreciation and Amortization	$ (1,095)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pettigrew Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	470
Buildings and Improvements	9,633
Total	10,103
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	470
Building and Improvements	9,633
Total	10,103
Accumulated Depreciation and Amortization	$ (892)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Sunnybrook Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,155
Buildings and Improvements	11,749
Total	12,904
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,155
Building and Improvements	11,749
Total	12,904
Accumulated Depreciation and Amortization	$ (1,114)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Raleigh Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	926
Buildings and Improvements	17,649
Total	18,575
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	926
Building and Improvements	17,649
Total	18,575
Accumulated Depreciation and Amortization	$ (1,645)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cypress Pointe Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	611
Buildings and Improvements	5,051
Total	5,662
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	611
Building and Improvements	5,051
Total	5,662
Accumulated Depreciation and Amortization	$ (534)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Silas Creek Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	879
Buildings and Improvements	3,283
Total	4,162
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	879
Building and Improvements	3,283
Total	4,162
Accumulated Depreciation and Amortization	$ (396)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Lincolnton Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	9,967
Total	9,967
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	9,967
Total	9,967
Accumulated Depreciation and Amortization	$ (949)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Rehabilitation and Nursing Center of Monroe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	166
Buildings and Improvements	5,906
Total	6,072
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	166
Building and Improvements	5,906
Total	6,072
Accumulated Depreciation and Amortization	$ (626)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Guardian Care of Zebulon
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	594
Buildings and Improvements	8,559
Total	9,153
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	594
Building and Improvements	8,559
Total	9,153
Accumulated Depreciation and Amortization	$ (782)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Guardian Care of Rocky Mount
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	18,314
Total	18,314
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	18,314
Total	18,314
Accumulated Depreciation and Amortization	$ (1,644)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | San Pedro Manor
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	671
Buildings and Improvements	2,504
Total	3,175
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	671
Building and Improvements	2,504
Total	3,175
Accumulated Depreciation and Amortization	$ (302)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor Health Care & Rehabilitation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	942
Buildings and Improvements	6,033
Total	6,975
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	942
Building and Improvements	6,033
Total	6,975
Accumulated Depreciation and Amortization	$ (629)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avalon Place - Trinity
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	363
Buildings and Improvements	3,852
Total	4,215
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	363
Building and Improvements	3,852
Total	4,215
Accumulated Depreciation and Amortization	$ (432)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Avalon Place - Kirbyville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	208
Buildings and Improvements	5,809
Total	6,017
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	208
Building and Improvements	5,809
Total	6,017
Accumulated Depreciation and Amortization	$ (624)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Heritage House of Marshall
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	732
Buildings and Improvements	4,288
Total	5,020
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	732
Building and Improvements	4,288
Total	5,020
Accumulated Depreciation and Amortization	$ (474)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Autumn Woods Residential Health Care Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,052
Buildings and Improvements	25,539
Total	27,591
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,052
Building and Improvements	25,539
Total	27,591
Accumulated Depreciation and Amortization	$ (2,636)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Autumn View Health Care Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,026
Buildings and Improvements	54,086
Total	55,112
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,026
Building and Improvements	54,086
Total	55,112
Accumulated Depreciation and Amortization	$ (4,881)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Brookhaven Health Care Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,181
Buildings and Improvements	30,373
Total	32,554
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,181
Building and Improvements	30,373
Total	32,554
Accumulated Depreciation and Amortization	$ (2,883)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Harris Hill Nursing Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,122
Buildings and Improvements	46,413
Total	47,535
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,122
Building and Improvements	46,413
Total	47,535
Accumulated Depreciation and Amortization	$ (4,112)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Garden Gate Health Care Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,164
Buildings and Improvements	29,905
Total	31,069
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,164
Building and Improvements	29,905
Total	31,069
Accumulated Depreciation and Amortization	$ (2,808)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Northgate Health Care Facility
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	830
Buildings and Improvements	29,488
Total	30,318
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	830
Building and Improvements	29,488
Total	30,318
Accumulated Depreciation and Amortization	$ (2,768)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Seneca Health Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,325
Buildings and Improvements	26,839
Total	28,164
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,325
Building and Improvements	26,839
Total	28,164
Accumulated Depreciation and Amortization	$ (2,473)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Blueberry Hill Rehab and Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,410
Buildings and Improvements	13,588
Total	15,998
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,410
Building and Improvements	13,588
Total	15,998
Accumulated Depreciation and Amortization	$ (1,684)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | River Terrace Rehabilitation and Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	343
Buildings and Improvements	7,733
Total	8,076
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	343
Building and Improvements	7,733
Total	8,076
Accumulated Depreciation and Amortization	$ (740)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | The Crossings East Campus
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	505
Buildings and Improvements	2,248
Total	2,753
Cost Capitalized Subsequent to Acquisition	48
Gross Amount at which Carried at Close of Period
Land	505
Building and Improvements	2,296
Total	2,801
Accumulated Depreciation and Amortization	$ (369)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Parkway Pavilion Healthcare
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	437
Buildings and Improvements	16,461
Total	16,898
Cost Capitalized Subsequent to Acquisition	27
Gross Amount at which Carried at Close of Period
Land	437
Building and Improvements	16,488
Total	16,925
Accumulated Depreciation and Amortization	$ (1,611)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Quincy Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	894
Buildings and Improvements	904
Total	1,798
Cost Capitalized Subsequent to Acquisition	129
Gross Amount at which Carried at Close of Period
Land	894
Building and Improvements	1,033
Total	1,927
Accumulated Depreciation and Amortization	$ (166)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Den-Mar Health & Rehabilitation Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	1,765
Total	1,765
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	1,765
Total	1,765
Accumulated Depreciation and Amortization	$ (221)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Firesteel Healthcare Community
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	621
Buildings and Improvements	14,059
Total	14,680
Cost Capitalized Subsequent to Acquisition	8,716
Gross Amount at which Carried at Close of Period
Land	621
Building and Improvements	22,775
Total	23,396
Accumulated Depreciation and Amortization	$ (3,266)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Fountain Springs Healthcare Community
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,134
Buildings and Improvements	13,109
Total	14,243
Cost Capitalized Subsequent to Acquisition	268
Gross Amount at which Carried at Close of Period
Land	1,134
Building and Improvements	13,377
Total	14,511
Accumulated Depreciation and Amortization	$ (1,260)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Palisade Healthcare Community
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	362
Buildings and Improvements	2,548
Total	2,910
Cost Capitalized Subsequent to Acquisition	297
Gross Amount at which Carried at Close of Period
Land	362
Building and Improvements	2,845
Total	3,207
Accumulated Depreciation and Amortization	$ (346)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Shepherd of the Valley Healthcare Community
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	803
Buildings and Improvements	19,210
Total	20,013
Cost Capitalized Subsequent to Acquisition	1,148
Gross Amount at which Carried at Close of Period
Land	803
Building and Improvements	20,358
Total	21,161
Accumulated Depreciation and Amortization	$ (1,979)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wheatcrest Hills Healthcare Community
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	679
Buildings and Improvements	3,216
Total	3,895
Cost Capitalized Subsequent to Acquisition	331
Gross Amount at which Carried at Close of Period
Land	679
Building and Improvements	3,547
Total	4,226
Accumulated Depreciation and Amortization	$ (400)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Riverview Healthcare Community & Independent Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	240
Buildings and Improvements	6,327
Total	6,567
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	240
Building and Improvements	6,327
Total	6,567
Accumulated Depreciation and Amortization	$ (632)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Prairie View Healthcare Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	383
Buildings and Improvements	2,041
Total	2,424
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	383
Building and Improvements	2,041
Total	2,424
Accumulated Depreciation and Amortization	$ (239)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Dutchess (Fishkill)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	964
Buildings and Improvements	30,107
Total	31,071
Cost Capitalized Subsequent to Acquisition	338
Gross Amount at which Carried at Close of Period
Land	964
Building and Improvements	30,435
Total	31,399
Accumulated Depreciation and Amortization	$ (2,865)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Ulster (Highland)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,371
Buildings and Improvements	11,473
Total	15,844
Cost Capitalized Subsequent to Acquisition	136
Gross Amount at which Carried at Close of Period
Land	4,371
Building and Improvements	11,609
Total	15,980
Accumulated Depreciation and Amortization	$ (1,164)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Beacon
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	25,400
Total	25,400
Cost Capitalized Subsequent to Acquisition	42
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	25,442
Total	25,442
Accumulated Depreciation and Amortization	$ (2,516)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Springfield
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	817
Buildings and Improvements	11,357
Total	12,174
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	817
Building and Improvements	11,357
Total	12,174
Accumulated Depreciation and Amortization	$ (1,090)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Andover
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,123
Buildings and Improvements	5,383
Total	7,506
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,123
Building and Improvements	5,383
Total	7,506
Accumulated Depreciation and Amortization	$ (592)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Reading
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,534
Buildings and Improvements	5,221
Total	6,755
Cost Capitalized Subsequent to Acquisition	159
Gross Amount at which Carried at Close of Period
Land	1,534
Building and Improvements	5,380
Total	6,914
Accumulated Depreciation and Amortization	$ (589)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Sudbury
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,017
Buildings and Improvements	3,458
Total	5,475
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,017
Building and Improvements	3,458
Total	5,475
Accumulated Depreciation and Amortization	$ (450)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Belvidere (Lowell)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,335
Buildings and Improvements	9,019
Total	10,354
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,335
Building and Improvements	9,019
Total	10,354
Accumulated Depreciation and Amortization	$ (935)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at Worcester
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	945
Buildings and Improvements	8,770
Total	9,715
Cost Capitalized Subsequent to Acquisition	50
Gross Amount at which Carried at Close of Period
Land	945
Building and Improvements	8,820
Total	9,765
Accumulated Depreciation and Amortization	$ (891)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at West Springfield
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,022
Buildings and Improvements	7,345
Total	9,367
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,022
Building and Improvements	7,345
Total	9,367
Accumulated Depreciation and Amortization	$ (819)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Wingate at East Longmeadow
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,968
Buildings and Improvements	8,957
Total	11,925
Cost Capitalized Subsequent to Acquisition	190
Gross Amount at which Carried at Close of Period
Land	2,968
Building and Improvements	9,147
Total	12,115
Accumulated Depreciation and Amortization	$ (1,016)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Broadway by the Sea
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,939
Buildings and Improvements	11,782
Total	14,721
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,939
Building and Improvements	11,690
Total	14,629
Accumulated Depreciation and Amortization	$ (1,168)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Coventry Court Health Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,044
Buildings and Improvements	14,167
Total	16,211
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,044
Building and Improvements	14,167
Total	16,211
Accumulated Depreciation and Amortization	$ (1,375)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Fairfield Post-Acute Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	586
Buildings and Improvements	23,582
Total	24,168
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	586
Building and Improvements	23,582
Total	24,168
Accumulated Depreciation and Amortization	$ (2,129)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Garden View Post-Acute Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,270
Buildings and Improvements	17,063
Total	19,333
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,270
Building and Improvements	17,063
Total	19,333
Accumulated Depreciation and Amortization	$ (1,626)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Grand Terrace Health Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	432
Buildings and Improvements	9,382
Total	9,814
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	432
Building and Improvements	9,382
Total	9,814
Accumulated Depreciation and Amortization	$ (901)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Pacifica Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,510
Buildings and Improvements	27,397
Total	28,907
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,510
Building and Improvements	27,397
Total	28,907
Accumulated Depreciation and Amortization	$ (2,440)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Burien Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	823
Buildings and Improvements	17,431
Total	18,254
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	826
Building and Improvements	17,431
Total	18,257
Accumulated Depreciation and Amortization	$ (1,635)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park West Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,802
Buildings and Improvements	7,927
Total	12,729
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,802
Building and Improvements	7,927
Total	12,729
Accumulated Depreciation and Amortization	$ (834)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Beachside Nursing Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,312
Buildings and Improvements	9,885
Total	12,197
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,312
Building and Improvements	9,885
Total	12,197
Accumulated Depreciation and Amortization	$ (945)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Chatsworth Park Health Care
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	7,841
Buildings and Improvements	16,916
Total	24,757
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	7,841
Building and Improvements	16,916
Total	24,757
Accumulated Depreciation and Amortization	$ (1,684)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Cottonwood Post-Acute Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	504
Buildings and Improvements	7,369
Total	7,873
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	504
Building and Improvements	7,369
Total	7,873
Accumulated Depreciation and Amortization	$ (741)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Danville Post-Acute Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,491
Buildings and Improvements	17,157
Total	18,648
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,491
Building and Improvements	17,157
Total	18,648
Accumulated Depreciation and Amortization	$ (1,599)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Lake Balboa Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,456
Buildings and Improvements	16,462
Total	18,918
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,456
Building and Improvements	16,462
Total	18,918
Accumulated Depreciation and Amortization	$ (1,478)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Lomita Post-Acute Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,743
Buildings and Improvements	14,734
Total	17,477
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,743
Building and Improvements	14,734
Total	17,477
Accumulated Depreciation and Amortization	$ (1,437)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | University Post-Acute Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,846
Buildings and Improvements	17,962
Total	20,808
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,846
Building and Improvements	17,962
Total	20,808
Accumulated Depreciation and Amortization	$ (1,653)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Issaquah Nursing & Rehab Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	10,125
Buildings and Improvements	7,771
Total	17,896
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	10,125
Building and Improvements	7,771
Total	17,896
Accumulated Depreciation and Amortization	$ (859)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Alamitos-Belmont Rehab Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,157
Buildings and Improvements	22,067
Total	25,224
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,157
Building and Improvements	22,067
Total	25,224
Accumulated Depreciation and Amortization	$ (2,081)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Edgewater Skilled Nursing Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,857
Buildings and Improvements	5,878
Total	8,735
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,857
Building and Improvements	5,878
Total	8,735
Accumulated Depreciation and Amortization	$ (598)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Fairmont Rehabilitation Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	812
Buildings and Improvements	21,059
Total	21,871
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	812
Building and Improvements	21,059
Total	21,871
Accumulated Depreciation and Amortization	$ (1,848)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Palm Terrace Care Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,717
Buildings and Improvements	13,806
Total	15,523
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,717
Building and Improvements	13,806
Total	15,523
Accumulated Depreciation and Amortization	$ (1,417)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Woodland Nursing & Rehab
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	278
Buildings and Improvements	16,729
Total	17,007
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	278
Building and Improvements	16,729
Total	17,007
Accumulated Depreciation and Amortization	$ (1,555)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Manor at Bee Cave
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,107
Buildings and Improvements	10,413
Total	12,520
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,107
Building and Improvements	10,413
Total	12,520
Accumulated Depreciation and Amortization	$ (1,117)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Ramona
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,058
Buildings and Improvements	19,671
Total	21,729
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,058
Building and Improvements	19,671
Total	21,729
Accumulated Depreciation and Amortization	$ (1,700)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Skilled Nursing/Transitional Care Facilities | Park Ridge
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	8,861
Buildings and Improvements	11,478
Total	20,339
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	8,861
Building and Improvements	11,478
Total	20,339
Accumulated Depreciation and Amortization	$ (1,170)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased
Real Estate and Accumulated Depreciation
Encumbrances	$ 27,409
Initial Cost to Company
Land	58,286
Buildings and Improvements	646,247
Total	704,533
Cost Capitalized Subsequent to Acquisition	23,416
Gross Amount at which Carried at Close of Period
Land	57,412
Building and Improvements	650,222
Total	707,634
Accumulated Depreciation and Amortization	(87,600)
Senior Housing - Leased | Forest Hills (ALF)
Initial Cost to Company
Land	1,803
Buildings and Improvements	3,927
Total	5,730
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,803
Building and Improvements	3,294
Total	5,097
Accumulated Depreciation and Amortization	$ (1,655)
Life on Which Depreciation in Latest Income Statement is Computed	30 years
Senior Housing - Leased | Langdon Place of Exeter
Real Estate and Accumulated Depreciation
Encumbrances	$ 2,547
Initial Cost to Company
Land	571
Buildings and Improvements	7,183
Total	7,754
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	571
Building and Improvements	5,940
Total	6,511
Accumulated Depreciation and Amortization	$ (2,374)
Life on Which Depreciation in Latest Income Statement is Computed	43 years
Senior Housing - Leased | Langdon Place of Nashua
Real Estate and Accumulated Depreciation
Encumbrances	$ 4,887
Initial Cost to Company
Land	0
Buildings and Improvements	5,654
Total	5,654
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	4,605
Total	4,605
Accumulated Depreciation and Amortization	$ (1,638)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Langdon Place of Keene
Real Estate and Accumulated Depreciation
Encumbrances	$ 3,912
Initial Cost to Company
Land	304
Buildings and Improvements	3,992
Total	4,296
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	304
Building and Improvements	3,437
Total	3,741
Accumulated Depreciation and Amortization	$ (1,594)
Life on Which Depreciation in Latest Income Statement is Computed	46 years
Senior Housing - Leased | Langdon Place of Dover
Real Estate and Accumulated Depreciation
Encumbrances	$ 3,164
Initial Cost to Company
Land	801
Buildings and Improvements	10,036
Total	10,837
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	801
Building and Improvements	8,632
Total	9,433
Accumulated Depreciation and Amortization	$ (3,384)
Life on Which Depreciation in Latest Income Statement is Computed	42 years
Senior Housing - Leased | Age-Well Senior Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	256
Buildings and Improvements	2,262
Total	2,518
Cost Capitalized Subsequent to Acquisition	1,032
Gross Amount at which Carried at Close of Period
Land	256
Building and Improvements	3,294
Total	3,550
Accumulated Depreciation and Amortization	$ (1,770)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Gulf Pointe Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	789
Buildings and Improvements	607
Total	1,396
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	789
Building and Improvements	607
Total	1,396
Accumulated Depreciation and Amortization	$ (240)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Aspen Ridge Retirement Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,024
Buildings and Improvements	5,467
Total	7,491
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,024
Building and Improvements	5,467
Total	7,491
Accumulated Depreciation and Amortization	$ (1,569)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Green Acres of Cadillac
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	217
Buildings and Improvements	3,000
Total	3,217
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	217
Building and Improvements	3,000
Total	3,217
Accumulated Depreciation and Amortization	$ (728)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Green Acres of Greenville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	684
Buildings and Improvements	5,832
Total	6,516
Cost Capitalized Subsequent to Acquisition	249
Gross Amount at which Carried at Close of Period
Land	684
Building and Improvements	6,081
Total	6,765
Accumulated Depreciation and Amortization	$ (1,497)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Green Acres of Manistee
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	952
Buildings and Improvements	2,578
Total	3,530
Cost Capitalized Subsequent to Acquisition	2,547
Gross Amount at which Carried at Close of Period
Land	952
Building and Improvements	5,125
Total	6,077
Accumulated Depreciation and Amortization	$ (1,229)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Green Acres of Mason
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	198
Buildings and Improvements	4,131
Total	4,329
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	198
Building and Improvements	4,131
Total	4,329
Accumulated Depreciation and Amortization	$ (1,045)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Nottingham Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	744
Buildings and Improvements	1,745
Total	2,489
Cost Capitalized Subsequent to Acquisition	400
Gross Amount at which Carried at Close of Period
Land	744
Building and Improvements	2,145
Total	2,889
Accumulated Depreciation and Amortization	$ (574)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Royal View
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	307
Buildings and Improvements	2,477
Total	2,784
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	307
Building and Improvements	2,477
Total	2,784
Accumulated Depreciation and Amortization	$ (686)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Tawas Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	258
Buildings and Improvements	3,713
Total	3,971
Cost Capitalized Subsequent to Acquisition	45
Gross Amount at which Carried at Close of Period
Land	258
Building and Improvements	3,758
Total	4,016
Accumulated Depreciation and Amortization	$ (1,227)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Turning Brook
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	546
Buildings and Improvements	13,139
Total	13,685
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	546
Building and Improvements	13,139
Total	13,685
Accumulated Depreciation and Amortization	$ (2,856)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Greenfield of Woodstock
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	597
Buildings and Improvements	5,465
Total	6,062
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	597
Building and Improvements	5,465
Total	6,062
Accumulated Depreciation and Amortization	$ (1,193)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Nye Square
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	504
Buildings and Improvements	17,670
Total	18,174
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	504
Building and Improvements	17,670
Total	18,174
Accumulated Depreciation and Amortization	$ (3,501)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | The Meadows
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	217
Buildings and Improvements	9,906
Total	10,123
Cost Capitalized Subsequent to Acquisition	4,680
Gross Amount at which Carried at Close of Period
Land	217
Building and Improvements	14,586
Total	14,803
Accumulated Depreciation and Amortization	$ (2,362)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Park Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 12,899
Initial Cost to Company
Land	2,300
Buildings and Improvements	21,115
Total	23,415
Cost Capitalized Subsequent to Acquisition	2,747
Gross Amount at which Carried at Close of Period
Land	2,300
Building and Improvements	23,861
Total	26,161
Accumulated Depreciation and Amortization	$ (5,286)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Avalon MC - Boat Club
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	359
Buildings and Improvements	8,126
Total	8,485
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	359
Building and Improvements	8,126
Total	8,485
Accumulated Depreciation and Amortization	$ (1,457)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Avalon MC - 7200
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	123
Buildings and Improvements	4,914
Total	5,037
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	123
Building and Improvements	4,914
Total	5,037
Accumulated Depreciation and Amortization	$ (883)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Avalon MC - 7204
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	215
Buildings and Improvements	4,821
Total	5,036
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	215
Building and Improvements	4,822
Total	5,037
Accumulated Depreciation and Amortization	$ (871)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Avalon MC - 7140
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	143
Buildings and Improvements	6,653
Total	6,796
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	143
Building and Improvements	6,653
Total	6,796
Accumulated Depreciation and Amortization	$ (1,167)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Delaney Creek Lodge
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,283
Buildings and Improvements	8,424
Total	9,707
Cost Capitalized Subsequent to Acquisition	483
Gross Amount at which Carried at Close of Period
Land	1,283
Building and Improvements	8,907
Total	10,190
Accumulated Depreciation and Amortization	$ (1,777)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Nature Coast Lodge
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,031
Buildings and Improvements	5,577
Total	6,608
Cost Capitalized Subsequent to Acquisition	452
Gross Amount at which Carried at Close of Period
Land	1,031
Building and Improvements	6,030
Total	7,061
Accumulated Depreciation and Amortization	$ (1,395)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | West Winds
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,688
Buildings and Improvements	9,098
Total	10,786
Cost Capitalized Subsequent to Acquisition	360
Gross Amount at which Carried at Close of Period
Land	1,688
Building and Improvements	9,459
Total	11,147
Accumulated Depreciation and Amortization	$ (2,025)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Tudor Heights
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	561
Buildings and Improvements	4,865
Total	5,426
Cost Capitalized Subsequent to Acquisition	1,315
Gross Amount at which Carried at Close of Period
Land	344
Building and Improvements	2,906
Total	3,250
Accumulated Depreciation and Amortization	$ 0
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Life’s Journey of Mattoon
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	812
Buildings and Improvements	6,796
Total	7,608
Cost Capitalized Subsequent to Acquisition	63
Gross Amount at which Carried at Close of Period
Land	111
Building and Improvements	720
Total	831
Accumulated Depreciation and Amortization	$ (26)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Life’s Journey of Pana
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	154
Buildings and Improvements	2,098
Total	2,252
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	23
Building and Improvements	227
Total	250
Accumulated Depreciation and Amortization	$ (9)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Life’s Journey of Taylorville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	267
Buildings and Improvements	5,201
Total	5,468
Cost Capitalized Subsequent to Acquisition	50
Gross Amount at which Carried at Close of Period
Land	106
Building and Improvements	1,794
Total	1,900
Accumulated Depreciation and Amortization	$ (226)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Life’s Journey of Paris
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	132
Buildings and Improvements	3,090
Total	3,222
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	49
Building and Improvements	996
Total	1,045
Accumulated Depreciation and Amortization	$ (116)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Ashley Pointe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,559
Buildings and Improvements	9,059
Total	10,618
Cost Capitalized Subsequent to Acquisition	68
Gross Amount at which Carried at Close of Period
Land	1,559
Building and Improvements	9,127
Total	10,686
Accumulated Depreciation and Amortization	$ (1,475)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Farmington Square Eugene
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,428
Buildings and Improvements	16,138
Total	17,566
Cost Capitalized Subsequent to Acquisition	101
Gross Amount at which Carried at Close of Period
Land	1,428
Building and Improvements	16,239
Total	17,667
Accumulated Depreciation and Amortization	$ (2,323)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Farmington Square Tualatin
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	527
Buildings and Improvements	14,659
Total	15,186
Cost Capitalized Subsequent to Acquisition	101
Gross Amount at which Carried at Close of Period
Land	527
Building and Improvements	14,760
Total	15,287
Accumulated Depreciation and Amortization	$ (2,120)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Farmington Square of Salem
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,074
Buildings and Improvements	19,421
Total	20,495
Cost Capitalized Subsequent to Acquisition	408
Gross Amount at which Carried at Close of Period
Land	1,074
Building and Improvements	19,829
Total	20,903
Accumulated Depreciation and Amortization	$ (2,950)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Colorado Springs
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,210
Buildings and Improvements	9,490
Total	10,700
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,210
Building and Improvements	9,490
Total	10,700
Accumulated Depreciation and Amortization	$ (1,463)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Sun City West
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	930
Buildings and Improvements	9,170
Total	10,100
Cost Capitalized Subsequent to Acquisition	248
Gross Amount at which Carried at Close of Period
Land	930
Building and Improvements	9,418
Total	10,348
Accumulated Depreciation and Amortization	$ (1,301)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Poet’s Walk at Fredericksburg
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,379
Buildings and Improvements	21,209
Total	22,588
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,379
Building and Improvements	21,209
Total	22,588
Accumulated Depreciation and Amortization	$ (2,786)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Poet’s Walk at Chandler Oaks
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	679
Buildings and Improvements	13,642
Total	14,321
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	679
Building and Improvements	13,642
Total	14,321
Accumulated Depreciation and Amortization	$ (1,807)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | The Montecito Santa Fe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,536
Buildings and Improvements	19,441
Total	21,977
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,157
Building and Improvements	21,736
Total	23,893
Accumulated Depreciation and Amortization	$ (2,643)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Montecito - MC
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	670
Buildings and Improvements	7,743
Total	8,413
Cost Capitalized Subsequent to Acquisition	409
Gross Amount at which Carried at Close of Period
Land	670
Building and Improvements	8,152
Total	8,822
Accumulated Depreciation and Amortization	$ (38)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | The Golden Crest
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	292
Buildings and Improvements	6,889
Total	7,181
Cost Capitalized Subsequent to Acquisition	97
Gross Amount at which Carried at Close of Period
Land	292
Building and Improvements	6,996
Total	7,288
Accumulated Depreciation and Amortization	$ (976)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Poet’s Walk at Henderson
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,430
Buildings and Improvements	21,850
Total	23,280
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,430
Building and Improvements	21,862
Total	23,292
Accumulated Depreciation and Amortization	$ (2,543)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Kruse Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	476
Buildings and Improvements	11,912
Total	12,388
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	476
Building and Improvements	11,922
Total	12,398
Accumulated Depreciation and Amortization	$ (1,587)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Poet’s Walk of Cedar Parks
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,035
Buildings and Improvements	13,127
Total	14,162
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,035
Building and Improvements	13,127
Total	14,162
Accumulated Depreciation and Amortization	$ (1,386)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Avamere Court at Keizer
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,220
Buildings and Improvements	31,783
Total	33,003
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,220
Building and Improvements	31,783
Total	33,003
Accumulated Depreciation and Amortization	$ (2,861)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Arbor Court Retirement Community at Alvamar
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	584
Buildings and Improvements	4,431
Total	5,015
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	584
Building and Improvements	4,431
Total	5,015
Accumulated Depreciation and Amortization	$ (447)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Arbor Court Retirement Community at Salina
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	584
Buildings and Improvements	3,020
Total	3,604
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	584
Building and Improvements	3,020
Total	3,604
Accumulated Depreciation and Amortization	$ (303)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Arbor Court Retirement Community at Topeka
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	313
Buildings and Improvements	5,492
Total	5,805
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	313
Building and Improvements	5,492
Total	5,805
Accumulated Depreciation and Amortization	$ (509)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Aspen Grove Assisted Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	555
Buildings and Improvements	6,487
Total	7,042
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	555
Building and Improvements	6,487
Total	7,042
Accumulated Depreciation and Amortization	$ (663)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Maurice Griffith Manor Living Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	294
Buildings and Improvements	72
Total	366
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	294
Building and Improvements	72
Total	366
Accumulated Depreciation and Amortization	$ (14)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | The Peaks at Old Laramie Trail (Lafayette)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,085
Buildings and Improvements	19,243
Total	20,328
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,883
Building and Improvements	19,196
Total	21,079
Accumulated Depreciation and Amortization	$ (1,758)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Prairie View
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	263
Buildings and Improvements	3,743
Total	4,006
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	263
Building and Improvements	3,743
Total	4,006
Accumulated Depreciation and Amortization	$ (348)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Arbor View Assisted Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,019
Buildings and Improvements	3,606
Total	4,625
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,019
Building and Improvements	3,606
Total	4,625
Accumulated Depreciation and Amortization	$ (299)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Legacy Assisted Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	661
Buildings and Improvements	5,680
Total	6,341
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	661
Building and Improvements	5,680
Total	6,341
Accumulated Depreciation and Amortization	$ (434)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Greenfield of Strasburg
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	666
Buildings and Improvements	5,551
Total	6,217
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	666
Building and Improvements	5,551
Total	6,217
Accumulated Depreciation and Amortization	$ (437)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Poets Walk of Sarasota
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,440
Buildings and Improvements	22,541
Total	23,981
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,440
Building and Improvements	22,541
Total	23,981
Accumulated Depreciation and Amortization	$ (1,617)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | The Pointe at Lifespring
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,603
Buildings and Improvements	9,219
Total	10,822
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,603
Building and Improvements	9,219
Total	10,822
Accumulated Depreciation and Amortization	$ (722)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Shavano Park Senior Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,131
Buildings and Improvements	11,541
Total	13,672
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,131
Building and Improvements	11,541
Total	13,672
Accumulated Depreciation and Amortization	$ (827)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Traditions of Beavercreek
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,622
Buildings and Improvements	24,215
Total	25,837
Cost Capitalized Subsequent to Acquisition	7,561
Gross Amount at which Carried at Close of Period
Land	1,622
Building and Improvements	31,772
Total	33,394
Accumulated Depreciation and Amortization	$ (2,120)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Cadence at Poway Gardens
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,693
Buildings and Improvements	14,467
Total	18,160
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,693
Building and Improvements	14,467
Total	18,160
Accumulated Depreciation and Amortization	$ (459)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Traditions of Brookside (McCordsville)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,587
Buildings and Improvements	31,315
Total	32,902
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,587
Building and Improvements	31,315
Total	32,902
Accumulated Depreciation and Amortization	$ (872)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Traditions of Beaumont
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,841
Buildings and Improvements	21,827
Total	23,668
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,841
Building and Improvements	21,827
Total	23,668
Accumulated Depreciation and Amortization	$ (552)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Leased | Traditions at Hunter Station (Clarksville)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,060
Buildings and Improvements	28,702
Total	29,762
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,060
Building and Improvements	28,702
Total	29,762
Accumulated Depreciation and Amortization	$ (600)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed
Real Estate and Accumulated Depreciation
Encumbrances	$ 16,090
Initial Cost to Company
Land	78,195
Buildings and Improvements	827,535
Total	905,730
Cost Capitalized Subsequent to Acquisition	11,939
Gross Amount at which Carried at Close of Period
Land	78,343
Building and Improvements	864,653
Total	942,996
Accumulated Depreciation and Amortization	(142,538)
Senior Housing - Managed | Winter Village
Real Estate and Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	5,027
Buildings and Improvements	20,929
Total	25,956
Cost Capitalized Subsequent to Acquisition	1,201
Gross Amount at which Carried at Close of Period
Land	5,027
Building and Improvements	22,130
Total	27,157
Accumulated Depreciation and Amortization	$ (5,304)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Stoney River Marshfield
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	574
Buildings and Improvements	8,733
Total	9,307
Cost Capitalized Subsequent to Acquisition	180
Gross Amount at which Carried at Close of Period
Land	574
Building and Improvements	8,913
Total	9,487
Accumulated Depreciation and Amortization	$ (2,071)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Kensington Court
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,360
Buildings and Improvements	16,855
Total	18,215
Cost Capitalized Subsequent to Acquisition	1,056
Gross Amount at which Carried at Close of Period
Land	1,435
Building and Improvements	18,835
Total	20,270
Accumulated Depreciation and Amortization	$ (3,142)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Masonville Manor
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	960
Buildings and Improvements	19,056
Total	20,016
Cost Capitalized Subsequent to Acquisition	458
Gross Amount at which Carried at Close of Period
Land	1,013
Building and Improvements	20,559
Total	21,572
Accumulated Depreciation and Amortization	$ (3,347)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Okanagan Chateau
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,321
Buildings and Improvements	8,308
Total	10,629
Cost Capitalized Subsequent to Acquisition	1,415
Gross Amount at which Carried at Close of Period
Land	2,448
Building and Improvements	10,179
Total	12,627
Accumulated Depreciation and Amortization	$ (1,864)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Court at Laurelwood
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,823
Buildings and Improvements	22,135
Total	23,958
Cost Capitalized Subsequent to Acquisition	395
Gross Amount at which Carried at Close of Period
Land	1,921
Building and Improvements	23,745
Total	25,666
Accumulated Depreciation and Amortization	$ (3,817)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Fairwinds Lodge
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,187
Buildings and Improvements	20,346
Total	21,533
Cost Capitalized Subsequent to Acquisition	626
Gross Amount at which Carried at Close of Period
Land	1,251
Building and Improvements	22,089
Total	23,340
Accumulated Depreciation and Amortization	$ (3,568)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | The Shores
Real Estate and Accumulated Depreciation
Encumbrances	$ 4,891
Initial Cost to Company
Land	679
Buildings and Improvements	8,024
Total	8,703
Cost Capitalized Subsequent to Acquisition	310
Gross Amount at which Carried at Close of Period
Land	715
Building and Improvements	8,775
Total	9,490
Accumulated Depreciation and Amortization	$ (1,458)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Orchard Valley
Real Estate and Accumulated Depreciation
Encumbrances	$ 6,511
Initial Cost to Company
Land	843
Buildings and Improvements	10,724
Total	11,567
Cost Capitalized Subsequent to Acquisition	457
Gross Amount at which Carried at Close of Period
Land	284
Building and Improvements	11,770
Total	12,054
Accumulated Depreciation and Amortization	$ (1,840)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Cherry Park
Real Estate and Accumulated Depreciation
Encumbrances	$ 4,688
Initial Cost to Company
Land	763
Buildings and Improvements	6,771
Total	7,534
Cost Capitalized Subsequent to Acquisition	775
Gross Amount at which Carried at Close of Period
Land	804
Building and Improvements	7,919
Total	8,723
Accumulated Depreciation and Amortization	$ (1,320)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Maison Senior Living
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,908
Buildings and Improvements	20,996
Total	24,904
Cost Capitalized Subsequent to Acquisition	671
Gross Amount at which Carried at Close of Period
Land	4,121
Building and Improvements	22,818
Total	26,939
Accumulated Depreciation and Amortization	$ (3,386)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Ramsey
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,182
Buildings and Improvements	13,280
Total	14,462
Cost Capitalized Subsequent to Acquisition	73
Gross Amount at which Carried at Close of Period
Land	1,182
Building and Improvements	13,353
Total	14,535
Accumulated Depreciation and Amortization	$ (1,318)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Marshfield II
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	500
Buildings and Improvements	4,134
Total	4,634
Cost Capitalized Subsequent to Acquisition	23
Gross Amount at which Carried at Close of Period
Land	500
Building and Improvements	4,157
Total	4,657
Accumulated Depreciation and Amortization	$ (462)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Dover Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,797
Buildings and Improvements	23,054
Total	25,851
Cost Capitalized Subsequent to Acquisition	169
Gross Amount at which Carried at Close of Period
Land	2,797
Building and Improvements	23,223
Total	26,020
Accumulated Depreciation and Amortization	$ (2,088)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Kanawha Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	419
Buildings and Improvements	4,239
Total	4,658
Cost Capitalized Subsequent to Acquisition	409
Gross Amount at which Carried at Close of Period
Land	419
Building and Improvements	4,648
Total	5,067
Accumulated Depreciation and Amortization	$ (578)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Leighton Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	296
Buildings and Improvements	9,191
Total	9,487
Cost Capitalized Subsequent to Acquisition	240
Gross Amount at which Carried at Close of Period
Land	296
Building and Improvements	9,431
Total	9,727
Accumulated Depreciation and Amortization	$ (907)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Maidencreek Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	684
Buildings and Improvements	12,950
Total	13,634
Cost Capitalized Subsequent to Acquisition	93
Gross Amount at which Carried at Close of Period
Land	684
Building and Improvements	13,043
Total	13,727
Accumulated Depreciation and Amortization	$ (1,202)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Rolling Meadows Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	230
Buildings and Improvements	6,271
Total	6,501
Cost Capitalized Subsequent to Acquisition	312
Gross Amount at which Carried at Close of Period
Land	230
Building and Improvements	6,575
Total	6,805
Accumulated Depreciation and Amortization	$ (742)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Willowbrook Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	406
Buildings and Improvements	9,471
Total	9,877
Cost Capitalized Subsequent to Acquisition	712
Gross Amount at which Carried at Close of Period
Land	406
Building and Improvements	10,183
Total	10,589
Accumulated Depreciation and Amortization	$ (1,051)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Wyncote Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,781
Buildings and Improvements	4,911
Total	6,692
Cost Capitalized Subsequent to Acquisition	366
Gross Amount at which Carried at Close of Period
Land	1,781
Building and Improvements	5,277
Total	7,058
Accumulated Depreciation and Amortization	$ (660)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Amity Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	611
Buildings and Improvements	19,083
Total	19,694
Cost Capitalized Subsequent to Acquisition	146
Gross Amount at which Carried at Close of Period
Land	611
Building and Improvements	19,229
Total	19,840
Accumulated Depreciation and Amortization	$ (1,679)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Milford Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,199
Buildings and Improvements	18,786
Total	19,985
Cost Capitalized Subsequent to Acquisition	237
Gross Amount at which Carried at Close of Period
Land	1,199
Building and Improvements	19,023
Total	20,222
Accumulated Depreciation and Amortization	$ (1,716)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Oak Hill Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	609
Buildings and Improvements	2,636
Total	3,245
Cost Capitalized Subsequent to Acquisition	189
Gross Amount at which Carried at Close of Period
Land	609
Building and Improvements	2,825
Total	3,434
Accumulated Depreciation and Amortization	$ (396)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Seasons Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	355
Buildings and Improvements	5,055
Total	5,410
Cost Capitalized Subsequent to Acquisition	450
Gross Amount at which Carried at Close of Period
Land	355
Building and Improvements	5,505
Total	5,860
Accumulated Depreciation and Amortization	$ (693)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Parkview in Allen
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,190
Buildings and Improvements	45,767
Total	47,957
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,190
Building and Improvements	46,637
Total	48,827
Accumulated Depreciation and Amortization	$ (8,357)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | The Atrium At Gainesville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,139
Buildings and Improvements	44,789
Total	46,928
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,139
Building and Improvements	46,608
Total	48,747
Accumulated Depreciation and Amortization	$ (8,771)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | The Chateau
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,760
Buildings and Improvements	44,397
Total	47,157
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,760
Building and Improvements	45,571
Total	48,331
Accumulated Depreciation and Amortization	$ (8,297)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Gardens At Wakefield Plantation
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,344
Buildings and Improvements	37,506
Total	39,850
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,344
Building and Improvements	38,275
Total	40,619
Accumulated Depreciation and Amortization	$ (6,757)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Las Brisas
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,992
Buildings and Improvements	30,909
Total	35,901
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,992
Building and Improvements	31,487
Total	36,479
Accumulated Depreciation and Amortization	$ (5,741)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Creekside Terrace
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,995
Buildings and Improvements	24,428
Total	27,423
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,995
Building and Improvements	24,782
Total	27,777
Accumulated Depreciation and Amortization	$ (4,614)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Colonial Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	805
Buildings and Improvements	26,498
Total	27,303
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	805
Building and Improvements	27,568
Total	28,373
Accumulated Depreciation and Amortization	$ (5,097)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Garden Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,325
Buildings and Improvements	20,510
Total	21,835
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,325
Building and Improvements	21,466
Total	22,791
Accumulated Depreciation and Amortization	$ (4,231)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Desert Rose
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	530
Buildings and Improvements	21,775
Total	22,305
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	530
Building and Improvements	22,124
Total	22,654
Accumulated Depreciation and Amortization	$ (4,107)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Windland South
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,996
Buildings and Improvements	19,368
Total	21,364
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,996
Building and Improvements	20,507
Total	22,503
Accumulated Depreciation and Amortization	$ (4,159)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Cedar Woods
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,403
Buildings and Improvements	18,821
Total	21,224
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,403
Building and Improvements	19,436
Total	21,839
Accumulated Depreciation and Amortization	$ (3,619)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Virginian
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,080
Buildings and Improvements	19,545
Total	20,625
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,080
Building and Improvements	20,231
Total	21,311
Accumulated Depreciation and Amortization	$ (3,860)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Monarch Estates
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,209
Buildings and Improvements	17,326
Total	20,535
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,209
Building and Improvements	17,768
Total	20,977
Accumulated Depreciation and Amortization	$ (3,419)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Village At The Falls
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,477
Buildings and Improvements	18,778
Total	20,255
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,477
Building and Improvements	19,160
Total	20,637
Accumulated Depreciation and Amortization	$ (3,656)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Holiday At The Atrium
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	978
Buildings and Improvements	18,257
Total	19,235
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	978
Building and Improvements	19,036
Total	20,014
Accumulated Depreciation and Amortization	$ (3,565)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Lake Ridge Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,152
Buildings and Improvements	17,523
Total	18,675
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,152
Building and Improvements	18,904
Total	20,056
Accumulated Depreciation and Amortization	$ (3,620)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Heritage Village
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	4,092
Buildings and Improvements	13,823
Total	17,915
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,092
Building and Improvements	14,468
Total	18,560
Accumulated Depreciation and Amortization	$ (2,867)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Madison Meadows
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,567
Buildings and Improvements	12,029
Total	14,596
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,567
Building and Improvements	12,998
Total	15,565
Accumulated Depreciation and Amortization	$ (2,692)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | South Wind Heights
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,782
Buildings and Improvements	11,244
Total	13,026
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,782
Building and Improvements	11,789
Total	13,571
Accumulated Depreciation and Amortization	$ (2,394)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Harrison Regent
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	794
Buildings and Improvements	10,873
Total	11,667
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	794
Building and Improvements	11,728
Total	12,522
Accumulated Depreciation and Amortization	$ (2,326)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Capital Place
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,477
Buildings and Improvements	23,767
Total	26,244
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,477
Building and Improvements	25,275
Total	27,752
Accumulated Depreciation and Amortization	$ (4,676)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | The Monarch at Richardson
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,282
Buildings and Improvements	10,556
Total	12,838
Cost Capitalized Subsequent to Acquisition	925
Gross Amount at which Carried at Close of Period
Land	2,282
Building and Improvements	11,472
Total	13,754
Accumulated Depreciation and Amortization	$ (415)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Senior Housing - Managed | Elan Westpointe
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,312
Buildings and Improvements	23,108
Total	24,420
Cost Capitalized Subsequent to Acquisition	51
Gross Amount at which Carried at Close of Period
Land	1,312
Building and Improvements	23,159
Total	24,471
Accumulated Depreciation and Amortization	$ (689)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	82,924
Buildings and Improvements	565,842
Total	648,766
Cost Capitalized Subsequent to Acquisition	22,089
Gross Amount at which Carried at Close of Period
Land	82,924
Building and Improvements	587,869
Total	670,793
Accumulated Depreciation and Amortization	(66,021)
Specialty Hospitals and Other | Texas Regional Medical Center
Real Estate and Accumulated Depreciation
Encumbrances	0
Initial Cost to Company
Land	4,020
Buildings and Improvements	57,620
Total	61,640
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	4,020
Building and Improvements	57,620
Total	61,640
Accumulated Depreciation and Amortization	$ (17,774)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Landmark Aurora
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,874
Buildings and Improvements	12,829
Total	15,703
Cost Capitalized Subsequent to Acquisition	483
Gross Amount at which Carried at Close of Period
Land	2,874
Building and Improvements	13,312
Total	16,186
Accumulated Depreciation and Amortization	$ (2,870)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Baylor Orthopedic Spine Hospital at Arlington
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	0
Buildings and Improvements	44,217
Total	44,217
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	0
Building and Improvements	44,217
Total	44,217
Accumulated Depreciation and Amortization	$ (3,787)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Touchstone Neurorecovery Center
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,935
Buildings and Improvements	25,003
Total	27,938
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,935
Building and Improvements	25,003
Total	27,938
Accumulated Depreciation and Amortization	$ (2,421)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | HealthBridge Children’s Hospital (Houston)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,001
Buildings and Improvements	14,581
Total	17,582
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,001
Building and Improvements	14,581
Total	17,582
Accumulated Depreciation and Amortization	$ (1,272)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Nexus Specialty Hospital - Woodlands Campus
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,319
Buildings and Improvements	15,153
Total	16,472
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,319
Building and Improvements	15,153
Total	16,472
Accumulated Depreciation and Amortization	$ (1,324)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | HealthBridge Children’s Hospital (Orange)
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,060
Buildings and Improvements	5,538
Total	7,598
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,060
Building and Improvements	5,538
Total	7,598
Accumulated Depreciation and Amortization	$ (504)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Texas Hill Country School
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	902
Buildings and Improvements	2,384
Total	3,286
Cost Capitalized Subsequent to Acquisition	1
Gross Amount at which Carried at Close of Period
Land	902
Building and Improvements	2,385
Total	3,287
Accumulated Depreciation and Amortization	$ (241)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Chaparral
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	901
Buildings and Improvements	1,198
Total	2,099
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	901
Building and Improvements	1,198
Total	2,099
Accumulated Depreciation and Amortization	$ (146)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Sierra Verde & Roca Vista
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	456
Buildings and Improvements	2,632
Total	3,088
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	456
Building and Improvements	2,632
Total	3,088
Accumulated Depreciation and Amortization	$ (251)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - 618 W. Hutchinson
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	51
Buildings and Improvements	359
Total	410
Cost Capitalized Subsequent to Acquisition	62
Gross Amount at which Carried at Close of Period
Land	51
Building and Improvements	359
Total	410
Accumulated Depreciation and Amortization	$ (35)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Ranch
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	539
Buildings and Improvements	2,627
Total	3,166
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	539
Building and Improvements	2,627
Total	3,166
Accumulated Depreciation and Amortization	$ (319)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Mesquite
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	228
Buildings and Improvements	3,407
Total	3,635
Cost Capitalized Subsequent to Acquisition	79
Gross Amount at which Carried at Close of Period
Land	228
Building and Improvements	3,486
Total	3,714
Accumulated Depreciation and Amortization	$ (352)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Hacienda
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	104
Buildings and Improvements	2,788
Total	2,892
Cost Capitalized Subsequent to Acquisition	27
Gross Amount at which Carried at Close of Period
Land	104
Building and Improvements	2,815
Total	2,919
Accumulated Depreciation and Amortization	$ (260)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | ResCare Tangram - Loma Linda
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	52
Buildings and Improvements	805
Total	857
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	52
Building and Improvements	805
Total	857
Accumulated Depreciation and Amortization	$ (81)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Aurora Chicago Lakeshore Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	8,574
Buildings and Improvements	39,732
Total	48,306
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	8,574
Building and Improvements	39,732
Total	48,306
Accumulated Depreciation and Amortization	$ (3,680)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Aurora Arizona West
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,501
Buildings and Improvements	67,046
Total	68,547
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,501
Building and Improvements	67,046
Total	68,547
Accumulated Depreciation and Amortization	$ (5,863)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Aurora Arizona East
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,137
Buildings and Improvements	50,073
Total	53,210
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,137
Building and Improvements	50,073
Total	53,210
Accumulated Depreciation and Amortization	$ (4,476)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Aurora Charter Oak Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	23,472
Buildings and Improvements	71,542
Total	95,014
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	23,472
Building and Improvements	71,542
Total	95,014
Accumulated Depreciation and Amortization	$ (6,499)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Aurora Vista del Mar Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	8,089
Buildings and Improvements	43,645
Total	51,734
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	8,089
Building and Improvements	43,645
Total	51,734
Accumulated Depreciation and Amortization	$ (4,310)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Aurora San Diego Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	8,403
Buildings and Improvements	55,015
Total	63,418
Cost Capitalized Subsequent to Acquisition	7,599
Gross Amount at which Carried at Close of Period
Land	8,403
Building and Improvements	62,614
Total	71,017
Accumulated Depreciation and Amortization	$ (5,853)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Gateway Rehabilitation Hospital at Florence
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	3,866
Buildings and Improvements	26,447
Total	30,313
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	3,866
Building and Improvements	26,447
Total	30,313
Accumulated Depreciation and Amortization	$ (2,308)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Highlands Regional Rehabilitation Hospital
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,009
Buildings and Improvements	6,639
Total	8,648
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	2,009
Building and Improvements	6,639
Total	8,648
Accumulated Depreciation and Amortization	$ (646)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Landmark New London
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	356
Buildings and Improvements	152
Total	508
Cost Capitalized Subsequent to Acquisition	98
Gross Amount at which Carried at Close of Period
Land	356
Building and Improvements	250
Total	606
Accumulated Depreciation and Amortization	$ (32)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Landmark Carmel
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	963
Buildings and Improvements	4,347
Total	5,310
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	963
Building and Improvements	4,347
Total	5,310
Accumulated Depreciation and Amortization	$ (218)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Landmark Louisville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	1,078
Buildings and Improvements	8,305
Total	9,383
Cost Capitalized Subsequent to Acquisition	0
Gross Amount at which Carried at Close of Period
Land	1,078
Building and Improvements	8,305
Total	9,383
Accumulated Depreciation and Amortization	$ (355)
Life on Which Depreciation in Latest Income Statement is Computed	40 years
Specialty Hospitals and Other | Recovery Centers of America at Monroeville
Real Estate and Accumulated Depreciation
Encumbrances	$ 0
Initial Cost to Company
Land	2,034
Buildings and Improvements	1,758
Total	3,792
Cost Capitalized Subsequent to Acquisition	13,740
Gross Amount at which Carried at Close of Period
Land	2,034
Building and Improvements	15,498
Total	17,532
Accumulated Depreciation and Amortization	$ (144)
Life on Which Depreciation in Latest Income Statement is Computed	40 years

SCHEDULE III - REAL ESTATE AS_3

SCHEDULE III - REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION - Rollforward of Real Estate and Accumulated Depreciation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Real estate:
Balance at the beginning of the year	$ 5,880,583	$ 6,255,883	$ 6,334,855
Acquisitions	110,752	49,483	262,605
Real estate assumed	0	12,962	0
Improvements	47,354	25,451	27,697
Impairment	(6,776)	(143,655)	(1,576)
Sale of real estate	(63,050)	(322,910)	(351,922)
Foreign currency translation	3,448	6,918	(12,639)
Write-off of fully depreciated assets	(5,616)	(3,549)	(3,137)
Balance at the end of the year	5,966,695	5,880,583	6,255,883
Accumulated depreciation:
Balance at the beginning of the year	(539,213)	(402,338)	(340,423)
Depreciation expense	(166,086)	(163,863)	(174,398)
Impairment	2,773	22,070	163
Sale of real estate	15,886	2,092	108,122
Foreign currency translation	(633)	(723)	1,061
Write-off of fully depreciated assets	5,616	3,549	3,137
Balance at the end of the year	$ (681,657)	$ (539,213)	$ (402,338)

SCHEDULE IV - MORTGAGE LOANS _2

SCHEDULE IV - MORTGAGE LOANS ON REAL ESTATE (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2020
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Prior Liens				$ 0
Principal Balance	$ 21,468	$ 23,146	$ 23,146	22,343
Book Value				22,352
Aggregate cost for federal income tax purposes				22,500
SEC Schedule, 12-29, Real Estate Companies, Investment in Movement in Mortgage Loans on Real Estate [Roll Forward]
Balance at the beginning of the year	21,468	23,146	16,033
Additions during period:
Draws	706	1,689	10,943
Interest income added to principal	169	194	1,528
Deductions during period:
Paydowns/repayments	0	(3,561)	(5,358)
Balance at the end of the year	$ 22,343	$ 21,468	$ 23,146
Mortgages | River Vista
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Contractual Interest Rate	10.00%
Prior Liens				0
Principal Balance	$ 19,000			19,000
Book Value				19,000
Deductions during period:
Balance at the end of the year	$ 19,000
Construction Mortgages | Arlington
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Contractual Interest Rate	8.00%
Prior Liens				0
Principal Balance	$ 3,343			3,343
Book Value				$ 3,352
Deductions during period:
Balance at the end of the year	$ 3,343

Uncategorized Items - sbra-2020

Label	Element	Value
Accounting Standards Update [Extensible List]	us-gaap_AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201712Member